View Filing Data

Print Document View Excel Document

Document And Entity Information - USD ($)	12 Months Ended
Document And Entity Information - USD ($)	Dec. 31, 2011	Feb. 22, 2012	Jun. 30, 2011
Entity Registrant Name	MEDICAL PROPERTIES TRUST INC
Entity Central Index Key	0001287865
Document Type	10-K
Document Period End Date	Dec. 31, 2011
Amendment Flag	false
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		135,275,389
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 1,284,688,909
MPT Operating Partnership, L.P. [Member]
Entity Registrant Name	MPT Operating Partnership, L.P.
Entity Central Index Key	0001524607
Document Type	10-K
Document Period End Date	Dec. 31, 2011
Amendment Flag	false
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2011	Dec. 31, 2010
Real estate assets
Land	$ 111,309	$ 91,604
Buildings and improvements	1,079,787	858,571
Construction in progress and other	30,903	6,730
Intangible lease assets	53,400	33,643
Mortgage loans	165,000	165,000
Real estate held for sale		37,514
Gross investment in real estate assets	1,440,399	1,193,062
Accumulated depreciation and amortization	(93,430)	(64,946)
Accumulated amortization	(10,307)	(6,841)
Net investment in real estate assets	1,336,662	1,121,275
Cash and cash equivalents	102,726	98,408
Interest and rent receivables	29,862	26,176
Straight-line rent receivables	33,993	28,912
Other loans	74,839	50,985
Other assets	43,792	23,058
Total Assets	1,621,874	1,348,814
Liabilities
Debt, net	689,849	369,970
Accounts payable and accrued expenses	51,125	35,974
Deferred revenue	23,307	23,137
Lease deposits and other obligations to tenants	28,778	20,157
Total liabilities	793,059	449,238
Commitments and Contingencies
Equity
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding
Common stock, $0.001 par value. Authorized 150,000 shares; issued and outstanding -110,786 shares at December 31, 2011 and 110,225 shares at December 31, 2010	111	110
Additional paid-in capital	1,055,256	1,051,785
Distributions in excess of net income	(214,059)	(148,530)
Accumulated other comprehensive loss	(12,231)	(3,641)
Treasury shares, at cost	(262)	(262)
Total Medical Properties Trust, Inc. stockholders' equity	828,815	899,462
Non-controlling interests		114
Total Equity	828,815	899,576
Total Liabilities and Equity	1,621,874	1,348,814
Common Units [Member]
Equity
Total Equity	111	110
MPT Operating Partnership, L.P. [Member]
Real estate assets
Land	111,309	91,604
Buildings and improvements	1,079,787	858,571
Construction in progress and other	30,903	6,730
Intangible lease assets	53,400	33,643
Mortgage loans	165,000	165,000
Real estate held for sale		37,514
Gross investment in real estate assets	1,440,399	1,193,062
Accumulated depreciation and amortization	(93,430)	(64,946)
Accumulated amortization	(10,307)	(6,841)
Net investment in real estate assets	1,336,662	1,121,275
Cash and cash equivalents	102,726	98,408
Interest and rent receivables	29,862	26,176
Straight-line rent receivables	33,993	28,912
Other loans	74,839	50,985
Other assets	43,792	23,058
Total Assets	1,621,874	1,348,814
Liabilities
Debt, net	689,849	369,970
Accounts payable and accrued expenses	28,780	13,658
Deferred revenue	23,307	23,137
Lease deposits and other obligations to tenants	28,778	20,157
Payable due to Medical Properties Trust, Inc.	21,955	21,943
Total liabilities	792,669	448,865
Commitments and Contingencies
Equity
General partner - issued and outstanding - 1,107 units at December 31, 2011 and 1,102 units at December 31, 2010	8,418	9,035
Accumulated other comprehensive loss	(12,231)	(3,641)
Total MPT Operating Partnership Capital	829,205	899,835
Non-controlling interests		114
Total Equity	829,205	899,949
Total capital	829,205	899,949
Total Liabilities and Equity	1,621,874	1,348,814
MPT Operating Partnership, L.P. [Member] \| Common Units [Member]
Equity
Limited Partners Capital	833,018	894,441
MPT Operating Partnership, L.P. [Member] \| LTIP Units [Member]
Equity
Limited Partners Capital

Consolidated Balance Sheets (Parenthetical) - $ / shares shares in Thousands	Dec. 31, 2011	Dec. 31, 2010
Equity
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	150,000	150,000
Common stock, shares issued	110,786	110,225
Common stock, shares outstanding	110,786	110,225
MPT Operating Partnership, L.P. [Member]
Equity
General Partner, units issued	1,107	1,102
General Partner, units outstanding	1,107	1,102
MPT Operating Partnership, L.P. [Member] \| Common Units [Member]
Equity
Limited Partners, units issued	109,679	109,123
Limited Partners, units outstanding	109,679	109,123
MPT Operating Partnership, L.P. [Member] \| LTIP Units [Member]
Equity
Limited Partners, units issued	150	94
Limited Partners, units outstanding	150	94

Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Revenues
Rent billed	$ 116,035	$ 88,487	$ 77,871
Straight-line rent	5,794	1,933	8,038
Interest and fee income	21,490	26,777	28,129
Total revenues	143,319	117,197	114,038
Expenses
Real estate depreciation and amortization	32,901	22,830	21,588
Impairment charge	564	12,000
Property-related	1,090	4,398	3,801
Acquisition expenses	4,184	2,026
General and administrative	27,219	26,509	21,096
Total operating expense	65,958	67,763	46,485
Operating income	77,361	49,434	67,553
Other income (expense)
Interest and other income	96	1,518	43
Debt refinancing costs	(14,214)	(6,716)
Interest expense	(43,812)	(33,988)	(37,651)
Net other expenses	(57,930)	(39,186)	(37,608)
Income from continuing operations	19,431	10,248	29,945
Income from discontinued operations	7,283	12,764	6,422
Net income	26,714	23,012	36,367
Net income attributable to non-controlling interests	(178)	(99)	(37)
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 26,536	$ 22,913	$ 36,330
Earnings per share - basic
Income from continuing operations attributable to MPT common stockholders/Operating Partnership partners	$ 0.16	$ 0.09	$ 0.37
Income from discontinued operations attributable to MPT common stockholders/Operating Partnership partners	0.07	0.13	0.08
Net income attributable to MPT Operating Partnership partners	$ 0.23	$ 0.22	$ 0.45
Weighted average shares outstanding - basic	110,623	100,706	78,117
Earnings per share - diluted
Income from continuing operations attributable to MPT common stockholders/Operating Partnership partners	$ 0.16	$ 0.09	$ 0.37
Income from discontinued operations - diluted per share/unit	0.07	0.13	0.08
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 0.23	$ 0.22	$ 0.45
Weighted average shares/units outstanding - diluted	110,629	100,708	78,117
MPT Operating Partnership, L.P. [Member]
Revenues
Rent billed	$ 116,035	$ 88,487	$ 77,871
Straight-line rent	5,794	1,933	8,038
Interest and fee income	21,490	26,777	28,129
Total revenues	143,319	117,197	114,038
Expenses
Real estate depreciation and amortization	32,901	22,830	21,588
Impairment charge	564	12,000
Property-related	1,090	4,398	3,801
Acquisition expenses	4,184	2,026
General and administrative	27,202	26,434	21,033
Total operating expense	65,941	67,688	46,422
Operating income	77,378	49,509	67,616
Other income (expense)
Interest and other income	96	1,518	43
Debt refinancing costs	(14,214)	(6,716)
Interest expense	(43,812)	(33,988)	(37,651)
Net other expenses	(57,930)	(39,186)	(37,608)
Income from continuing operations	19,448	10,323	30,008
Income from discontinued operations	7,283	12,764	6,422
Net income	26,731	23,087	36,430
Net income attributable to non-controlling interests	(178)	(99)	(37)
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 26,553	$ 22,988	$ 36,393
Earnings per share - basic
Income from continuing operations attributable to MPT common stockholders/Operating Partnership partners	$ 0.16	$ 0.09	$ 0.37
Income from discontinued operations attributable to MPT common stockholders/Operating Partnership partners	0.07	0.13	0.08
Net income attributable to MPT Operating Partnership partners	$ 0.23	$ 0.22	$ 0.45
Weighted average shares outstanding - basic	110,623	100,706	78,117
Earnings per share - diluted
Income from continuing operations attributable to MPT common stockholders/Operating Partnership partners	$ 0.16	$ 0.09	$ 0.37
Income from discontinued operations - diluted per share/unit	0.07	0.13	0.08
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 0.23	$ 0.22	$ 0.45
Weighted average shares/units outstanding - diluted	110,629	100,708	78,117

Consolidated Statements Of Equity/Capital - USD ($) shares in Thousands, $ in Thousands	General Partner [Member] MPT Operating Partnership, L.P. [Member]	Limited Partners [Member] MPT Operating Partnership, L.P. [Member] Common Units [Member]	Limited Partners [Member] MPT Operating Partnership, L.P. [Member] Long Term Incentive Plan [Member]	MPT Operating Partnership, L.P. [Member] Accumulated Other Comprehensive Loss [Member]	MPT Operating Partnership, L.P. [Member] Non-Controlling Interests [Member]	MPT Operating Partnership, L.P. [Member]	Common Units [Member]	Additional Paid-In Capital [Member]	Distribution In Excess Of Net Income [Member]	Accumulated Other Comprehensive Loss [Member]	Treasury Stock [Member]	Non-Controlling Interests [Member]	Total
Balance, Value at Dec. 31, 2008	$ 6,263	$ 619,886	$ 186		$ 243	$ 626,578	$ 65	$ 686,238	$ (59,941)		$ (262)	$ 243	$ 626,343
Balance, Shares at Dec. 31, 2008	650	64,406	32				65,056
Comprehensive income:
Net income	$ 364	$ 35,856	$ 174		36	36,430			36,330			37	36,367
Net income	364	35,856	174		36	36,430			36,330			37	36,367
Comprehensive income	364	35,856	174		36	36,430			36,330			37	36,367
Deferred stock units issued to directors							$ 1	5	(4)				2
Deferred stock units issued to directors, shares							52
Stock vesting and amortization of stock-based compensation	$ 55	$ 5,433	31			5,488		5,488					5,488
Stock vesting and amortization of stock-based compensation, shares	3	295					246
Proceeds from offering (net of offering costs)	$ 680	$ 67,323				68,003	$ 13	67,990					68,003
Proceeds from offering (net of offering costs), shares	134	13,237					13,371
Distributions to non-controlling interests					(149)	(149)						(150)	(150)
Dividends declared	$ (645)	$ (63,546)	$ (287)			(64,478)			(64,478)				(64,478)
Balance, Shares at Dec. 31, 2009	787	77,938	63				78,725
Balance, Value at Dec. 31, 2009	$ 6,717	$ 664,952	$ 73		130	671,872	$ 79	759,721	(88,093)		(262)	130	671,575
Comprehensive income:
Net income	230	22,601	157		99	23,087			22,913			99	23,012
Net income	230	22,601	157		99	23,087			22,913			99	23,012
Unrealized loss on interest rate swaps				$ (3,641)		(3,641)				$ (3,641)			(3,641)
Comprehensive income	230	22,601	157	(3,641)	99	19,446			22,913	(3,641)		99	19,371
Stock vesting and amortization of stock-based compensation	$ 66	$ 6,550	31			6,616		6,616					6,616
Stock vesting and amortization of stock-based compensation, shares	7	693					700
Proceeds from offering (net of offering costs)	$ 2,882	$ 285,184				288,066	$ 31	288,035					288,066
Proceeds from offering (net of offering costs), shares	308	30,492					30,800
Extinguishment of convertible debt	$ (26)	$ (2,560)				(2,586)		(2,587)					(2,587)
Distributions to non-controlling interests					(115)	(115)						(115)	(115)
Dividends declared	$ (834)	$ (82,286)	(230)			(83,350)			(83,350)				(83,350)
Balance, Shares at Dec. 31, 2010	1,102	109,123					110,225
Balance, Value at Dec. 31, 2010	$ 9,035	$ 894,441	94	(3,641)	114	899,949	$ 110	1,051,785	(148,530)	(3,641)	(262)	114	899,576
Comprehensive income:
Net income	265	26,020	268		178	26,731			26,536			178	26,714
Net income	265	26,020	268		178	26,731			26,536			178	26,714
Unrealized loss on interest rate swaps				(8,590)		(8,590)				(8,590)			(8,590)
Comprehensive income	265	26,020	268	(8,590)	178	18,141			26,536	(8,590)		178	18,124
Stock vesting and amortization of stock-based compensation	$ 69	$ 6,915	56			6,984	$ 1	6,982					6,983
Stock vesting and amortization of stock-based compensation, shares	5	556					561
Extinguishment of convertible debt	$ (55)	$ (5,446)				(5,501)		(3,070)	(2,431)				(5,501)
Purchase of non-controlling interest		(442)			(83)	(525)		(441)				(83)	(524)
Distributions to non-controlling interests					$ (209)	(209)						$ (209)	(209)
Dividends declared	$ (896)	$ (88,470)	(268)			(89,634)			(89,634)				(89,634)
Balance, Shares at Dec. 31, 2011	1,107	109,679					110,786
Balance, Value at Dec. 31, 2011	$ 8,418	$ 833,018	$ 150	$ (12,231)		$ 829,205	$ 111	$ 1,055,256	$ (214,059)	$ (12,231)	$ (262)		$ 828,815

Consolidated Statements Of Equity/Capital (Parenthetical) - $ / shares	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Dividends declared per common share	$ 0.8	$ 0.8	$ 0.8
MPT Operating Partnership, L.P. [Member]
Dividends declared per common share	$ 0.8	$ 0.8	$ 0.8

Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Operating activities
Net income	$ 26,714	$ 23,012	$ 36,367
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	35,477	26,312	26,309
Amortization and write-off of deferred financing costs and debt discount	9,289	6,110	5,824
Premium on extinguishment of debt	13,091	3,833
Straight-line rent revenue	(7,142)	(4,932)	(9,536)
Share/Unit-based compensation expense	6,983	6,616	5,488
(Gain) loss from sale of real estate	(5,431)	(10,566)	(278)
Provision for uncollectible receivables and loans	1,499	14,400
Straight-line rent write-off	2,470	3,694	1,111
Payment of discount on extinguishment of debt	(4,850)	(7,324)
Other adjustments	1,622	(30)	(1,167)
Decrease (increase) in:
Interest and rent receivable	(6,118)	(5,490)	(2,433)
Other assets	142	(566)	126
Accounts payable and accrued expenses	5,354	(3,177)	1,700
Deferred revenue	170	8,745	(760)
Net cash provided by operating activities	79,270	60,637	62,751
Investing activities
Real estate acquired	(246,511)	(137,808)	(421)
Proceeds from sale of real estate	41,130	97,669	15,000
Principal received on loans receivable	4,289	90,486	4,305
Investment in loans receivable	(28,144)	(11,637)	(23,243)
Construction in progress	(22,999)	(6,638)
Other investments, net	(13,386)	(9,291)	(7,777)
Net cash (used for) provided by investing activities	(265,621)	22,781	(12,136)
Financing activities
Proceeds from term debt, net of discount	450,000	148,500
Payments of term debt	(246,262)	(216,765)	(1,232)
Payment of deferred financing costs	(15,454)	(6,796)	232
Revolving credit facilities, net	89,600	(137,200)	(55,800)
Distributions paid	(89,601)	(77,087)	(61,649)
Lease deposits and other obligations to tenants	8,621	3,667	3,390
Proceeds from sale of common shares/units, net of offering costs		288,066	68,003
Other	(6,235)	(2,702)
Net cash provided by (used in) financing activities	190,669	(317)	(47,056)
Increase in cash and cash equivalents for the year	4,318	83,101	3,559
Cash and cash equivalents at beginning of year	98,408	15,307	11,748
Cash and cash equivalents at end of year	102,726	98,408	15,307
Interest paid, including capitalized interest of $896 in 2011, $63 in 2010, and $ - in 2009	38,463	29,679	33,272
Supplemental schedule of non-cash investing activities:
Real estate acquired via assumption of mortgage loan	(14,592)
Supplemental schedule of non-cash financing activities:
Loans Assumed Mortgage Loan Real Estate Acquired	14,592
Assumption of mortgage loan (as part of real estate acquired)	14,592
Dividends declared, not paid	22,407	22,374	16,110
MPT Operating Partnership, L.P. [Member]
Operating activities
Net income	26,731	23,087	36,430
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	35,477	26,312	26,309
Amortization and write-off of deferred financing costs and debt discount	9,289	6,110	5,824
Premium on extinguishment of debt	13,091	3,833
Straight-line rent revenue	(7,142)	(4,932)	(9,536)
Share/Unit-based compensation expense	6,983	6,616	5,488
(Gain) loss from sale of real estate	(5,431)	(10,566)	(278)
Provision for uncollectible receivables and loans	1,499	14,400
Straight-line rent write-off	2,470	3,694	1,111
Payment of discount on extinguishment of debt	(4,850)	(7,324)
Other adjustments	1,622	(30)	(1,167)
Decrease (increase) in:
Interest and rent receivable	(6,118)	(5,490)	(2,433)
Other assets	142	(566)	126
Accounts payable and accrued expenses	5,337	(3,252)	1,642
Deferred revenue	170	8,745	(760)
Net cash provided by operating activities	79,270	60,637	62,756
Investing activities
Real estate acquired	(246,511)	(137,808)	(421)
Proceeds from sale of real estate	41,130	97,669	15,000
Principal received on loans receivable	4,289	90,486	4,305
Investment in loans receivable	(28,144)	(11,637)	(23,243)
Construction in progress	(22,999)	(6,638)
Other investments, net	(13,386)	(9,291)	(7,777)
Net cash (used for) provided by investing activities	(265,621)	22,781	(12,136)
Financing activities
Proceeds from term debt, net of discount	450,000	148,500
Payments of term debt	(246,262)	(216,765)	(1,232)
Payment of deferred financing costs	(15,454)	(6,796)	232
Revolving credit facilities, net	89,600	(137,200)	(55,800)
Distributions paid	(89,601)	(77,087)	(61,649)
Lease deposits and other obligations to tenants	8,621	3,667	3,390
Proceeds from sale of common shares/units, net of offering costs		288,066	68,003
Other	(6,235)	(2,702)
Net cash provided by (used in) financing activities	190,669	(317)	(47,056)
Increase in cash and cash equivalents for the year	4,318	83,101	3,564
Cash and cash equivalents at beginning of year	98,408	15,307	11,743
Cash and cash equivalents at end of year	102,726	98,408	15,307
Interest paid, including capitalized interest of $896 in 2011, $63 in 2010, and $ - in 2009	38,463	29,679	33,272
Supplemental schedule of non-cash investing activities:
Real estate acquired via assumption of mortgage loan	(14,592)
Supplemental schedule of non-cash financing activities:
Loans Assumed Mortgage Loan Real Estate Acquired	14,592
Assumption of mortgage loan (as part of real estate acquired)	14,592
Dividends declared, not paid	$ 22,407	$ 22,374	$ 16,110

Consolidated Statements Of Cash Flows (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Interest paid, capitalized	$ 896	$ 63
MPT Operating Partnership, L.P. [Member]
Interest paid, capitalized	$ 896	$ 63

Organization

12 Months Ended

Dec. 31, 2011

Organization [Abstract]

Organization

1.	Organization

Medical Properties Trust, Inc., a Maryland corporation, was formed on August 27, 2003 under the General Corporation Law of Maryland for the purpose of engaging in the business of investing in, owning, and leasing commercial real estate. Our operating partnership subsidiary, MPT Operating Partnership, L.P. (the "Operating Partnership"), through which we conduct all of our operations, was formed in September 2003. Through another wholly-owned subsidiary, Medical Properties Trust, LLC, we are the sole general partner of the Operating Partnership. At present, we directly own substantially all of the limited partnership interests in the Operating Partnership and have elected to report our required disclosures and that of the Operating Partnership on a combined basis except where material differences exist, MPT Finance Corporation is a wholly owned subsidiary of the Operating Partnership and was formed for the sole purpose of being a co-issuer of some of the Operating Partnership's indebtedness. MPT Finance Corporation has no substantive assets or operations.

Our primary business strategy is to acquire and develop real estate and improvements, primarily for long term lease to providers of healthcare services such as operators of general acute care hospitals, inpatient physical rehabilitation hospitals, long-term acute care hospitals, surgery centers, centers for treatment of specific conditions such as cardiac, pulmonary, cancer, and neurological hospitals, and other healthcare-oriented facilities. We also make mortgage and other loans to operators of similar facilities. In addition, we may obtain profits interest in our tenants, from time to time, in order to enhance our overall return. We manage our business as a single business segment.

- Definition

The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 2-6
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Name Statement of Position (SOP)
-Publisher AICPA
-Number 94-6
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Name FASB Interpretation (FIN)
-Publisher FASB
-Number 46R
-Paragraph 4, 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6359553&loc=d3e288-107754

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6921930&loc=d3e5614-111684

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 915
-SubTopic 235
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 272
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6228881-111685

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2122150

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 720
-SubTopic 15
-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS140-4/FIN46(R)-8
-Paragraph 8, C1, C7
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Summary Of Significant Accounting Policies

12 Months Ended

Dec. 31, 2011

Summary Of Significant Accounting Policies [Abstract]

Summary Of Significant Accounting Policies

2.	Summary of Significant Accounting Policies

Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Principles of Consolidation: Property holding entities and other subsidiaries of which we own 100% of the equity or have a controlling financial interest evidenced by ownership of a majority voting interest are consolidated. All inter-company balances and transactions are eliminated. For entities in which we own less than 100% of the equity interest, we consolidate the property if we have the direct or indirect ability to control the entities' activities based upon the terms of the respective entities' ownership agreements. For these entities, we record a non-controlling interest representing equity held by non-controlling interests.

We continually evaluate all of our transactions and investments to determine if they represent variable interests in a variable interest entity ("VIE"). If we determine that we have a variable interest in a VIE, we then evaluate if we are the primary beneficiary of the VIE. The evaluation is a qualitative assessment as to whether we have the ability to direct the activities of a VIE that most significantly impact the entity's economic performance. We consolidate each VIE in which we, by virtue of or transactions with our investments in the entity, are considered to be the primary beneficiary.

At December 31, 2011, we had loans and/or equity investments in certain VIEs, which are also tenants of our facilities (including but not limited to Monroe and Vibra). We have determined that we are not the primary beneficiary of these VIEs. The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at December 31, 2011 (in thousands):


VIE Type	Maximum Loss Exposure(1)	Asset Type Classification	Carrying Amount(2)
Loans, net	$63,285	Other loans	$	39,552
Equity investments	$12,888	Other assets	$	2,751

(1)

Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rents receivable), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represent the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities.

(2)	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

For the VIE types above, we do not consolidate the VIE because we do not have the ability to control the activities (such as the day-to-day healthcare operations of our borrower or investee) that most significantly impact the VIE's economic performance. As of December 31, 2011, we were not required to provide, financial support through a liquidity arrangement or otherwise, to our unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash short falls).

Typically, our loans are collateralized by assets of the borrower (some assets of which are on the premises of facilities owned by us) and further supported by limited guarantees made by certain principals of the borrower.

See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.

Investments in Unconsolidated Entities: Investments in entities in which we have the ability to influence (but not control) are accounted for by the equity method. Under the equity method of accounting, our share of the investee's earnings or losses are included in our consolidated results of operations. The initial carrying value of investments in unconsolidated entities is based on the amount paid to purchase the interest in the investee entity. To the extent that our cost basis is different from the basis reflected at the investee entity level, the basis difference is generally amortized over the lives of the related assets and liabilities, and such amortization is included in our share of equity in earnings of the investee. We evaluate our equity method investments for impairment based upon a comparison of the fair value of the equity method investment to its carrying value. If we determine a decline in the fair value of an investment in an unconsolidated investee entity below its carrying value is other—than—temporary, an impairment is recorded.

Cash and Cash Equivalents: Certificates of deposit, short-term investments with original maturities of three months or less and money-market mutual funds are considered cash equivalents. The majority of our cash and cash equivalents are held at major commercial banks which at times may exceed the Federal Deposit Insurance Corporation limit. We have not experienced any losses to date on our invested cash. Cash and cash equivalents which have been restricted as to its use are recorded in other assets.

Revenue Recognition: We receive income from operating leases based on the fixed, minimum required rents (base rents) per the lease agreements. Rent revenue from base rents is recorded on the straight-line method over the terms of the related lease agreements for new leases and the remaining terms of existing leases for acquired properties. The straight-line method records the periodic average amount of base rent earned over the term of a lease, taking into account contractual rent increases over the lease term. The straight-line method typically has the effect of recording more rent revenue from a lease than a tenant is required to pay early in the term of the lease. During the later parts of a lease term, this effect reverses with less rent revenue recorded than a tenant is required to pay. Rent revenue as recorded on the straight-line method in the consolidated statements of income is presented as two amounts: billed rent revenue and straight-line revenue. Billed rent revenue is the amount of base rent actually billed to the customer each period as required by the lease. Straight-line rent revenue is the difference between rent revenue earned based on the straight-line method and the amount recorded as billed rent revenue. We record the difference between base rent revenues earned and amounts due per the respective lease agreements, as applicable, as an increase or decrease to straight-line rent receivable.

Certain leases provide for additional rents contingent upon a percentage of the tenant revenue in excess of specified base amounts/thresholds (percentage rents). Percentage rents are recognized in the period in which revenue thresholds are met. Rental payments received prior to their recognition as income are classified as deferred revenue. We may also receive additional rent (contingent rent) under some leases when the U.S. Department of Labor consumer price index exceeds the annual minimum percentage increase in the lease. Contingent rents are recorded as billed rent revenue in the period earned.

In instances where we have a profits interest in our tenant's operations, we record revenue equal to our percentage interest of the tenant's profits, as defined in the lease or tenant's operating agreements, once annual thresholds, if any, are met.

We begin recording base rent income from our development projects when the lessee takes physical possession of the facility, which may be different from the stated start date of the lease. Also, during construction of our development projects, we are generally entitled to accrue rent based on the cost paid during the construction period (construction period rent). We accrue construction period rent as a receivable and deferred revenue during the construction period. When the lessee takes physical possession of the facility, we begin recognizing the accrued construction period rent on the straight-line method over the remaining term of the lease.

We receive interest income from our tenants/borrowers on mortgage loans, working capital loans, and other long-term loans. Interest income from these loans is recognized as earned based upon the principal outstanding and terms of the loans.

Commitment fees received from development and leasing services for lessees are initially recorded as deferred revenue and recognized as income over the initial term of an operating lease to produce a constant effective yield on the lease (interest method). Commitment and origination fees from lending services are recorded as deferred revenue and recognized as income over the life of the loan using the interest method.

Tenant payments for certain taxes, insurance, and other operating expenses related to our facilities (most of which are paid directly by our tenants to the government or related vendor) are recorded net of the respective expense as generally our leases are "triple-net" leases, with terms requiring such expenses to be paid by our tenants. Failure on the part of our tenants to pay such expense or to pay late would result in a violation of the lease agreement, which could lead to an event of default, if not cured.

Acquired Real Estate Purchase Price Allocation: We allocate the purchase price of acquired properties to net tangible and identified intangible assets acquired based on their fair values. In making estimates of fair values for purposes of allocating purchase prices of acquired real estate, we utilize a number of sources, from time to time, including independent appraisals that may be obtained in connection with the acquisition or financing of the respective property and other market data. We also consider information obtained about each property as a result of our pre-acquisition due diligence, marketing and leasing activities in estimating the fair value of the tangible and intangible assets acquired.

We record above-market and below-market in-place lease values, if any, for our facilities, which are based on the present value (using an interest rate which reflects the risks associated with the leases acquired) of the difference between (i) the contractual amounts to be paid pursuant to the in-place leases and (ii) management's estimate of fair market lease rates for the corresponding in-place leases, measured over a period equal to the remaining non-cancelable term of the lease. We amortize any resulting capitalized above-market lease values as a reduction of rental income over the remaining non-cancelable terms of the respective leases. We amortize any resulting capitalized below-market lease values as an increase to rental income over the initial term and any fixed-rate renewal periods in the respective leases.

We measure the aggregate value of other lease intangible assets acquired based on the difference between (i) the property valued with new or in-place leases adjusted to market rental rates and (ii) the property valued as if vacant. Management's estimates of value are made using methods similar to those used by independent appraisers (e.g., discounted cash flow analysis). Factors considered by management in our analysis include an estimate of carrying costs during hypothetical expected lease-up periods considering current market conditions, and costs to execute similar leases. We also consider information obtained about each targeted facility as a result of our pre-acquisition due diligence, marketing, and leasing activities in estimating the fair value of the tangible and intangible assets acquired. In estimating carrying costs, management includes real estate taxes, insurance and other operating expenses and estimates of lost rentals at market rates during the expected lease-up periods, which we expect to be about six months. depending on specific local market conditions. Management also estimates costs to execute similar leases including leasing commissions, legal costs, and other related expenses to the extent that such costs are not already incurred in connection with a new lease origination as part of the transaction.

Other intangible assets acquired, may include customer relationship intangible values which are based on management's evaluation of the specific characteristics of each prospective tenant's lease and our overall relationship with that tenant. Characteristics to be considered by management in allocating these values include the nature and extent of our existing business relationships with the tenant, growth prospects for developing new business with the tenant, the tenant's credit quality and expectations of lease renewals, including those existing under the terms of the lease agreement, among other factors.

We amortize the value of in-place leases, if any, to expense over the initial term of the respective leases. The value of customer relationship intangibles is amortized to expense over the initial term and any renewal periods in the respective leases, but in no event will the amortization period for intangible assets exceed the remaining depreciable life of the building. If a lease is terminated, the unamortized portion of the in-place lease value and customer relationship intangibles are charged to expense.

Real Estate and Depreciation: Real estate, consisting of land, buildings and improvements, are recorded at cost. Although typically paid by our tenants, any expenditures for ordinary maintenance and repairs that we pay are expensed to operations as incurred. Significant renovations and improvements which improve and/or extend the useful life of the asset are capitalized and depreciated over their estimated useful lives. We record impairment losses on long-lived assets used in operations when events and circumstances indicate that the assets might be impaired and the undiscounted cash flows estimated to be generated by those assets, including an estimated liquidation amount, during the expected holding periods are less than the carrying amounts of those assets. Impairment losses are measured as the difference between carrying value and fair value of assets. For assets held for sale, we cease recording depreciation expense and adjust the assets' value to the lower of its carrying value or fair value, less cost of disposal. Fair value is based on estimated cash flows discounted at a risk-adjusted rate of interest. We classify real estate assets as held for sale when we have commenced an active program to sell the assets, and in the opinion of management, it is probable the asset will be sold within the next 12 months. We record the results of operations from material property sales or planned sales (which include real property, loans and any receivables) as discontinued operations in the consolidated statements of income for all periods presented if we do not have any continuing involvement with the property subsequent to its sale. Results of discontinued operations include interest expense from debt which specifically collateralizes the property sold or held for sale.

Construction in progress includes the cost of land, the cost of construction of buildings, improvements and fixed equipment, and costs for design and engineering. Other costs, such as interest, legal, property taxes and corporate project supervision, which can be directly associated with the project during construction, are also included in construction in progress.

Depreciation is calculated on the straight-line method over the weighted average useful lives of the related real estate and other assets, as follows:


Buildings and improvements			37.4 years
Tenant lease intangibles			14.1 years
Tenant improvements			5.4 years
Furniture, equipment and other			9.3 years

Losses from Rent Receivables: We continuously monitor the performance of our existing tenants including, but not limited to,: admission levels and surgery/procedure volumes by type; current operating margins; ratio of our tenant's operating margins both to facility rent and to facility rent plus other fixed costs; trends in revenue and patient mix; and the effect of evolving healthcare regulations on tenant's profitability and liquidity. We utilize this information along with the tenant's payment and default history in evaluating (on a property-by-property basis) whether or not a provision for losses on outstanding rent receivables is needed. A provision for losses on rent receivables (including straight-line rent receivables) is ultimately recorded when it becomes probable that the receivable will not be collected in full. The provision is an amount which reduces the receivable to its estimated net realizable value based on a determination of the eventual amounts to be collected either from the debtor or from the collateral, if any.

Loans: Loans consist of mortgage loans, working capital loans and other long-term loans. Mortgage loans are collateralized by interests in real property. Working capital and other long-term loans are generally collateralized by interests in receivables and corporate and individual guarantees. We record loans at cost. We evaluate the collectability of both interest and principal on a loan-by-loan basis (using the same process as we do for assessing the collectability of rents) to determine whether they are impaired. A loan is considered impaired when, based on current information and events, it is probable that we will be unable to collect all amounts due according to the existing contractual terms. When a loan is considered to be impaired, the amount of the allowance is calculated by comparing the recorded investment to either the value determined by discounting the expected future cash flows using the loan's effective interest rate or to the fair value of the collateral if the loan is collateral dependent. When a loan is deemed to be impaired, we generally place the loan on non-accrual status and record interest income only upon receipt of cash.

Earnings Per Share/Units: Basic earnings per common share/unit is computed by dividing net income applicable to common shares/units by the weighted number of shares/units of common stock/units outstanding during the period. Diluted earnings per common share/units is calculated by including the effect of dilutive securities.

Certain of our unvested restricted and performance stock/unit awards contain non-forfeitable rights to dividends, and accordingly, these awards are deemed to be participating securities. These participating securities are included in the earnings allocation in computing both basic and diluted earnings per common share/unit.

Income Taxes: We conduct our business as a real estate investment trust ("REIT") under Sections 856 through 860 of the Internal Revenue Code. To qualify as a REIT, we must meet certain organizational and operational requirements, including a requirement to distribute to stockholders at least 90% of our ordinary taxable income. As a REIT, we generally are not subject to federal income tax on taxable income that we distribute to our stockholders. If we fail to qualify as a REIT in any taxable year, we will then be subject to federal income taxes on our taxable income at regular corporate rates and will not be permitted to qualify for treatment as a REIT for federal income tax purposes for four years following the year during which qualification is lost, unless the Internal Revenue Service grants us relief under certain statutory provisions. Such an event could materially adversely affect our net income and net cash available for distribution to stockholders. However, we intend to operate in such a manner so that we will remain qualified as a REIT for federal income tax purposes.

Our financial statements include the operations of eight taxable REIT subsidiaries ("TRS"), including MPT Development Services, Inc. ("MDS") and MPT Covington TRS, Inc. ("CVT"), along with six others, which are single member LLCs that are disregarded for tax purposes and are reflected in the tax returns of MDS. Our TRS entities are not entitled to a dividends paid deduction and are subject to federal, state and local income taxes. Our TRS entities are authorized to provide property development, leasing and management services for third-party owned properties, and they make loans to and/or investments in our lessees.

Given our income tax expense is typically not significant, we record such expense along with related penalties and interest, if any, in general administrative expenses.

Stock-Based Compensation: We currently sponsor the Second Amended and Restated Medical Properties Trust, Inc. 2004 Equity Incentive Plan (the "Equity Incentive Plan") that was established in 2004. Awards of restricted stock, stock options and other equity-based awards with service conditions are amortized to compensation expense over the vesting periods which generally range from three to seven years, using the straight-line method. Awards of deferred stock units vest when granted and are charged to expense at the date of grant. Awards that contain market conditions are amortized to compensation expense over the derived vesting periods, which correspond to the periods over which we estimate the awards will be earned, which generally range from three to seven years, using the straight-line method. Awards with performance conditions are amortized using the straight-line method over the service period in which the performance conditions are measured, adjusted for the probability of achieving the performance conditions.

Deferred Costs: Costs incurred prior to the completion of offerings of stock or other capital instruments that directly relate to the offering are deferred and netted against proceeds received from the offering. External costs incurred in connection with anticipated financings and refinancing of debt are generally capitalized as deferred financing costs in other assets and amortized over the lives of the related loans as an addition to interest expense. For debt with defined principal re-payment terms, the deferred costs are amortized to produce a constant effective yield on the loan (interest method). For debt without defined principal repayment terms, such as revolving credit agreements, the deferred costs are amortized on the straight-line method over the term of the debt. Leasing commissions and other leasing costs directly attributable to tenant leases are capitalized as deferred leasing costs and amortized on the straight-line method over the terms of the related lease agreements. Costs identifiable with loans made to borrowers are recognized as a reduction in interest income over the life of the loan.

Derivative Financial Investments and Hedging Activities. During our normal course of business, we may use certain types of derivative instruments for the purpose of managing interest rate risk. We record our derivative and hedging instruments at fair value on the balance sheet. Changes in the estimated fair value of derivative instruments that are not designated as hedges or that do not meet the criteria for hedge accounting are recognized in earnings. For derivatives designated as cash flow hedges, the change in the estimated fair value of the effective portion of the derivative is recognized in accumulated other comprehensive income (loss), whereas the change in the estimated fair value of the ineffective portion is recognized in earnings. For derivatives designated as fair value hedges, the change in the estimated fair value of the effective portion of the derivatives offsets the change in the estimated fair value of the hedged item, whereas the change in the estimated fair value of the ineffective portion is recognized in earnings.

To qualify for hedge accounting, we formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking the hedge prior to entering into a derivative transaction. This process includes specific identification of the hedging instrument and the hedge transaction, the nature of the risk being hedged and how the hedging instrument's effectiveness in hedging the exposure to the hedged transaction's variability in cash flows attributable to the hedged risk will be assessed. Both at the inception of the hedge and on an ongoing basis, we assess whether the derivatives that are used in hedging transactions are highly effective in offsetting changes in cash flows or fair values of hedged items. In addition, for cash flow hedges, we assess whether the underlying forecasted transaction will occur. We discontinue hedge accounting if a derivative is not determined to be highly effective as a hedge or that is probable that the underlying forecasted transaction will not occur.

Exchangeable Senior Notes: In 2006 and 2008, we issued exchangeable senior notes that, based upon the occurrence of specified events, are exchangeable for cash up to their principal amount and our common shares for the remainder of the exchange value in excess, if any, of the principal amount. The initial proceeds from the issuance of the exchangeable senior notes are required to be allocated between a liability component and an equity component such that the interest expense on the exchangeable senior notes is not recorded at the stated rate of interest but rather at an effective rate that reflects our borrowing rate on conventional debt at the date of issuance. We calculate the liability component of the exchangeable senior notes based on the present value of the contractual cash flows discounted at a comparable market rate for conventional debt at the date of issuance. The difference between the principal amount and the fair value of the liability component is reported as a discount on the exchangeable senior notes that is accreted as additional interest expense from the issuance date through the contractual maturity date using the effective interest method. The liability component of the exchangeable senior notes is reported net of discounts on our consolidated balance sheets. We calculate the equity component of the exchangeable senior notes based on the difference between the initial proceeds received from the issuance of the exchangeable senior notes and the fair value of the liability component at the issuance date. The equity component is included in additional paid-in-capital, net of issuance costs, on our consolidated balance sheets. We allocate issuance costs for exchangeable senior notes between the liability and the equity components based on their relative values.

Fair Value Measurement

We measure and disclose the estimated fair value of financial assets and liabilities utilizing a hierarchy of valuation techniques based on whether the inputs to a fair value measurement are considered to be observable or unobservable in a marketplace. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. This hierarchy requires the use of observable market data when available. These inputs have created the following fair value hierarchy:

•

Level 1 — quoted prices for identical instruments in active markets;

•

Level 2 — quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which significant inputs and significant value drivers are observable in active markets; and

•

Level 3 — fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

We measure fair value using a set of standardized procedures that are outlined herein for all assets and liabilities which are required to be measured at their estimated fair value on either a recurring or non-recurring basis. When available, we utilize quoted market prices from an independent third party source to determine fair value and classifies such items in Level 1. In some instances where a market price is available, but the instrument is in an inactive or over-the-counter market, we consistently apply the dealer (market maker) pricing estimate and classify the asset or liability in Level 2.

If quoted market prices or inputs are not available, fair value measurements are based upon valuation models that utilize current market or independently sourced market inputs, such as interest rates, option volatilities, credit spreads, market capitalization rates, etc. Items valued using such internally-generated valuation techniques are classified according to the lowest level input that is significant to the fair value measurement. As a result, the asset or liability could be classified in either Level 2 or 3 even though there may be some significant inputs that are readily observable. Internal fair value models and techniques used by us include discounted cash flow and Black Scholes valuation models. We also consider our counterparty's and own credit risk on derivatives and other liabilities measured at their estimated fair value.

Recent Accounting Developments

In June 2011, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2011-05, Presentation of Comprehensive Income ("ASU 2011-05"). The amendments require that all non-owner changes in stockholders' equity be presented either in a single continuous statement of comprehensive income or in two separate but consecutive statements. In the two-statement approach, the first statement should present total net income and its components followed consecutively by a second statement that should present total other comprehensive income, the components of other comprehensive income, and the total of comprehensive income. In December 2011, the FASB deferred portions of this update in its issuance of ASU 2011-12. We do not expect the adoption of ASU 2011-05 on January 1, 2012 to have an impact on our consolidated financial position or results of operations.

Reclassifications: Certain reclassifications have been made to the consolidated financial statements to conform to the 2011 consolidated financial statement presentation. Assets sold or held for sale have been reclassified to Real Estate Held for Sale on the consolidated balance sheets and related operating results have been reclassified from continuing operations to discontinued operations (see Note 11).

Real Estate And Loans Receivable

12 Months Ended

Dec. 31, 2011

Real Estate And Loans Receivable [Abstract]

Real Estate And Loans Receivable

3.	Real Estate and Loans Receivable

Acquisitions

We acquired the following assets:


	2011		2010		2009
	(Amounts in thousands)
Land	$	19,705	$	8,227	$	421
Buildings		220,769		119,626		—
Intangible lease assets-subject to amortization (weighted-average useful life 13.9 years in 2011 and 19.4 years in 2010)		20,630		9,955		—

	$	261,104	$	137,808	$	421

2011 Activity

On January 4, 2011, we acquired the real estate of the 19-bed, 4-year old Gilbert Hospital in a suburb of Phoenix, Arizona area for $17.1 million. Gilbert Hospital is operated by affiliates of Visionary Health, LLC, the same group that will operate the hospital that we are currently developing in Florence, Arizona. We acquired this asset subject to an existing lease that expires in May 2022. The lease contains three five-year extension options, and the rent escalates annually at 2.5%.

On January 31, 2011, we acquired for $23.5 million the real estate of the 60-bed Atrium Medical Center at Corinth in the Dallas area, a long-term acute care hospital that was completed in 2009 and is subject to a lease that expires in June 2024. The lease has an initial term of 15 years, contains two ten-year extension options, and the rent escalates annually based on consumer price indexed increases and to be not less than 1% or greater than 5%. In addition, through one of our affiliates, we invested $1.3 million to acquire approximately 19% of a joint venture arrangement with an affiliate of Vibra Healthcare, LLC ("Vibra") that will manage and has acquired a 51% interest in the operations of the facility. We also made a $5.2 million working capital loan to the joint venture. The former operators of the hospital, comprised primarily of local physicians, retained ownership of 49% of the operating entity.

On February 4, 2011, we purchased for $58 million the real estate of Bayonne Medical Center, a 6-story, 278-bed acute care hospital in the New Jersey area of metropolitan New York, and leased the facility to the operator under a 15-year lease, with six five-year extension options. The rent escalates annually based on consumer price indexed increases. The operator is an affiliate of a private hospital operating company that acquired the hospital in 2008.

On February 9, 2011, we acquired the real estate of the 306-bed Alvarado Hospital in San Diego, California for $70 million from Prime Healthcare Services, Inc. ("Prime"). Prime is the operator of the facility and will lease the facility under a 10-year lease, with three five-year extension options and annual rent increases based on consumer price indexed increases.

On February 14, 2011, we completed the acquisition of the Northland LTACH Hospital located in Kansas City, a 35-bed hospital that opened in April 2008 and has a lease that expires in 2028. The lease has an initial term of 20 years, contains three five-year extension options, and the rent increases annually at 2.75%. This hospital was part of a three property acquisition announced in December 2010 and is currently being operated by Kindred Healthcare Inc. (formerly RehabCare). The purchase price of this hospital was $19.5 million, which included the assumption of a $16 million existing mortgage loan that matures in January 2018.

On July 18, 2011, we acquired the real estate of the 40-bed Vibra Specialty Hospital of DeSoto in Desoto, Texas for $13.0 million. Vibra Specialty Hospital of DeSoto is a new long-term acute care hospital that is currently ramping up its operations. This facility will be leased to a subsidiary of Vibra for a fixed term of 15 years with three five-year extension options. Rent escalates annually based on consumer priced indexed increases. In addition, we have made a $2.5 million equity investment in the operator of this facility for a 25% equity ownership.

On September 30, 2011, we purchased the real estate of a 40-bed long-term acute care facility in New Braunfels, Texas for $10.0 million. This facility will be leased to an affiliate of Post Acute Medical, LLC for a fixed term of 15 years with three five-year extension options. Rent escalates annually based on consumer priced indexed increases. In addition, we have made a $1.4 million equity investment for a 25% equity ownership in the operator of this facility and funded a $2.0 million working capital loan.

On October 14, 2011, we entered into agreements with a joint venture of Emerus Holding, Inc. and Baptist Health System, to acquire, provide for development funding and lease three acute care hospitals for $30.0 million in the suburban markets of San Antonio, Texas. With the execution of these agreements, we have funded $7.4 million during the fourth quarter of 2011, of which $6.2 million was used to acquire land for these three facilities. The three facilities upon completion will be leased under a master lease structure with an initial term of 15 years and three five-year extension options. Rent escalates annually based on consumer priced indexed increases and to be not less than one percent or greater than three percent. We currently expect construction of these three facilities to be completed in the fourth quarter of 2012.

On November 4, 2011, we made investments in Hoboken University Medical Center in Hoboken, New Jersey, a 350-bed acute care facility. The total investment for this transaction was $75.0 million, comprising $50.0 million for the acquisition of an 100% ownership of the real estate, a secured working capital loan of up to $20.0 million ($15.1 million outstanding at December 31, 2011), and the purchase of a $5.0 million convertible note, which provides us with the option to acquire up to 25% of the hospital operator. The lease with the tenant has an initial term of 15 years, contains six five-year extension options, and the rent escalates annually based on consumer price indexed increases.

From the respective acquisition dates in 2011 through year-end, these 2011 acquisitions contributed $21.2 million of revenue and $14.1 million of income. In addition, we incurred $4.2 million in acquisition related expenses in 2011, of which $1.9 million related to acquisitions consummated as of December 31, 2011.

2010 Activity

On June 17, 2010, we acquired three inpatient rehabilitation hospitals in Texas for an aggregate purchase price of $74 million. The properties acquired had existing leases in place, which we assumed, that have initial terms expiring in 2033. Each lease may, subject to conditions, be renewed by the operator for two additional ten-year terms.

In the fourth quarter of 2010, we acquired two long-term acute care hospital facilities in Texas for an aggregate purchase price of $64 million. The properties acquired had existing leases in place which we assumed. The Triumph Hospital Clear Lake, a 110-bed facility that opened in 2005, is subject to a lease maturing in 2025 and can be renewed by the lessee for two five-year terms. Triumph Hospital Tomball, a 75-bed facility that opened in August 2006, is subject to a lease that matures in 2026 and can be renewed by the lessee for two five-year terms.

From the respective acquisition dates in 2010 through year-end, these 2010 acquisitions contributed $4.3 million of revenue and $3.4 million of income. In addition, we incurred approximately $2.0 million in acquisition related expenses in 2010, of which approximately $1.1 million related to acquisitions consummated as of December 31, 2010.

The results of operations for each of the properties acquired in 2011 and 2010 are included in our consolidated results from the effective date of each acquisition. The following table sets forth certain unaudited pro forma consolidated financial data for 2011 and 2010, as if each acquisition was consummated on the same terms at the beginning of 2010. Supplemental pro forma earnings were adjusted to exclude $1.9 million and $1.1 million of acquisition-related costs on these consummated deals incurred during 2011 and 2010, respectively (dollar amounts in thousands except per share/unit data).


	2011		2010
	(Amounts in thousands except per share/unit amounts)
Total revenues	$	153,707	$	153,214
Net income		27,311		27,746
Net income per share/unit	$	0.24	$	0.26

Disposals

On December 30, 2011, we sold Sherman Oaks Hospital in Sherman Oaks, California to Prime for $20.0 million, resulting in a gain of $3.1 million. Due to this sale, we wrote-off $1.2 million in straight-line rent receivables.

On December 30, 2011, we sold MountainView Regional Rehabilitation Hospital in Morgantown, West Virginia to HealthSouth Corporation for $21.1 million, resulting in a gain of $2.3 million.

In October 2010, we sold the real estate of our Sharpstown facility in Houston, Texas to a third party for net proceeds of $2.7 million resulting in a gain of $0.7 million.

In the second quarter 2010, we sold the real estate of our Inglewood Hospital, a 369-bed acute care medical center located in Inglewood, California, to Prime Healthcare, for $75 million resulting in a gain of approximately $6 million.

In the fourth quarter of 2009, we sold the real estate asset of one acute care facility to Prime for proceeds of $15.0 million, and we realized a gain on the sale of $0.3 million.

For each of these disposals, the operating results of these facilities for the current and all prior periods have been included in discontinued operations, and we have reclassified the related real estate to Real Estate Held for Sale.

Intangible Assets

At December 31, 2011 and 2010, our intangible lease assets were $53.4 million ($43.1 million, net of accumulated amortization) and $33.6 million ($26.8 million, net of accumulated amortization), respectively.

We recorded amortization expense related to intangible lease assets of $5.2 million (including $0.6 million of accelerated amortization as described below), $3.2 million, and $4.5 million (including $0.5 million of accelerated amortization as described below) in 2011, 2010, and 2009, respectively, and expect to recognize amortization expense from existing lease intangible assets as follows: (amounts in thousands)


For the Year Ended December 31:
2012	$	3,865
2013		3,832
2014		3,767
2015		3,578
2016		3,536

As of December 31, 2011, capitalized lease intangibles have a weighted average remaining life of 14.1 years.

Leasing Operations

Minimum rental payments due to us in future periods under operating leases which have non-cancelable terms extending beyond one year at December 31, 2011, are as follows: (amounts in thousands)


2012	$	119,454
2013		120,275
2014		118,661
2015		115,880
2016		116,154
Thereafter		811,272

	$	1,401,696

In the 2011 fourth quarter, we replaced one of our tenants, Vibra, with a new tenant, LifeCare, at our LTACH facility in Dallas, Texas. As a result of this transaction, we wrote off the related straight line rent receivables of $1.3 million and accelerated the amortization of the related lease intangibles resulting in $0.6 million of expense in the 2011 fourth quarter.

The operator of our Denham Springs facility in Louisiana has not made all the payments required by the real estate lease agreement, and thus, the tenant is in default. During the second quarter of 2011, we evaluated alternative strategies for the recovery of our advances and accruals and at that time determined that the future cash flows of the current tenant and/or related collateral would, more likely than not, result in less than a full recovery of our receivables. As a result, we fully reserved for all outstanding receivables at that time (including $1.5 million in billed rent, $0.2 million of unbilled rent, and $0.1 million of other receivables) with the exception of the $0.7 million promissory note that we expect is recoverable from existing collateral. In addition, we recorded a $0.6 million impairment charge against the real estate during the second quarter of 2011. We have not recorded any rental revenue or reversed previously established reserves, except for $0.2 million, which represents payments received from the tenant subsequent to the second quarter. At December 31, 2011, we continue to believe, based on existing collateral and the current real estate market, that the $0.7 million loan and the $4.2 million of real estate are fully recoverable; however, no assurances can be made that future reserves will not be needed.

In September 2010, we exchanged properties with one of our tenants. In exchange for our acute care facility in Cleveland, Texas, we received a similar acute care facility in Hillsboro, Texas. The lease that was in place on our Cleveland facility was carried over to the new facility with no change in lease term or lease rate. This exchange was accounted for at fair value, resulting in a gain of $1.3 million (net of $0.2 million from the write-off of straight-line rent receivables).

In April 2009, we terminated leases on two of our facilities in Louisiana (Covington and Denham Springs) after the operator defaulted on the leases. As a result of the lease terminations, we recorded a $1.1 million charge in order to fully reserve and write off, respectively, the related straight-line rent receivables associated with the Covington and Denham Springs facilities. In addition, we accelerated the amortization of the related lease intangibles resulting in $0.5 million of expense in the 2009 second quarter. In June 2009, we re-leased the Denham Springs facility to a new operator under terms similar to the terminated lease. In March 2010, we re-leased our Covington facility. The lease has a fixed term of 15 years with an option, at the lessee's discretion, to extend the term for three additional periods of five years each. Rent during 2010 was based on an annual rate of $1.4 million and, commencing on January 1, 2011, increases annually by 2%. At the end of each term, the tenant has the right to purchase the facility at a price generally equivalent to the greater of our undepreciated cost and fair market value. Separately, we also obtained an interest in the operations of the tenant whereby we may receive additional consideration based on the profitability of such operations.

In January 2009, the then-operator of our Bucks County facility gave notice of its intentions to close the facility. The associated lease was terminated, which resulted in the write-off of $4.7 million in uncollectible rent and other receivables in December 2008. This write-off excluded $3.8 million of receivables that were guaranteed by the former tenant's parent company. In the 2010 fourth quarter, we agreed to settle our $3.8 million claim of unpaid rent for $1.4 million resulting in a $2.4 million charge to earnings.

In July 2009, we re-leased our Bucks County facility located in Bensalem, Pennsylvania. The lease has a fixed term of five years with an option, at the lessee's discretion, to extend 15 additional periods of one year each. Initial cash rent was $2.0 million per year with annual escalations of 2%. Separately, we also obtained a profits interest whereby we may receive up to an additional $1.0 million annually pursuant to an agreement that provides for our participation in certain cash flows, if any, as defined in the agreement. After the fixed term, the tenant has the right to purchase the facility at a price based on a formula set forth in the lease agreement.

In the third quarter of 2008, we terminated leases on two general acute care hospitals in Houston, Texas and one hospital in Redding, California due to certain tenant defaults. These facilities were previously leased to affiliates of HPA that filed for bankruptcy subsequent to the lease terminations. On November 1, 2008, we entered into a new lease agreement for the Redding hospital. The new operator, an affiliate of Prime, agreed to increase the lease base from $60.0 million to $63.0 million and to pay up to $12.0 million in additional rent and a profits participation of up to $8.0 million based on the future profitability of the new lessee's operations. In the 2010 second quarter, Prime paid us $12 million in additional rent related to our Redding property, and we terminated our agreements with Prime concerning the additional rent and profits interest. Of this $12 million in additional rent, $3.8 million has been recognized in income from lease inception through December 31, 2011, (including $1.2 million in each of 2011, 2010 and 2009) and we expect to recognize the other $8.2 million into income over the remainder of the lease life.

As of December 31, 2011, we have advanced $28.6 million to the operator/lessee of Monroe Hospital in Bloomington, Indiana pursuant to a working capital loan agreement, including additional advances of $0.6 million in 2011. In addition, as of December 31, 2011, we have $14.9 million ($3.4 million accrued in 2011) of rent, interest and other charges outstanding, of which $5.6 million of interest receivables are significantly more than 90 days past due. Because the operator has not made all payments required by the working capital loan agreement and the related real estate lease agreement, we consider the loan to be impaired. During the first quarter of 2010, we evaluated alternative strategies for the recovery of our advances and accruals and at that time determined that the future cash flows of the current tenant or related collateral would, more likely than not, result in less than a full recovery of our loan advances. Accordingly, we recorded a $12 million charge in the 2010 first quarter to recognize the estimated impairment of the working capital loan. During the third quarter of 2010, we determined that it is reasonably likely that the existing tenant will be unable to make certain lease payments that become due in future years. Accordingly, we recorded a valuation allowance for unbilled straight-line rent in the amount of $2.5 million. At December 31, 2011, our net investment (exclusive of the related real estate) of $31.5 million is our maximum exposure to Monroe and the amount is deemed collectible/recoverable. In making this determination, we considered our first priority secured interest in approximately (i) $7 million in hospital patient receivables and (ii) 100% of the membership interests of the operator/lessee and our assessment of the realizable value of our other collateral.

Although Monroe Hospital has seen improvement in almost all key statistics (including census, EBITDA, etc.), we continue to evaluate possible operating strategies for the hospital. We have entered into a forbearance agreement with the operator whereby we have generally agreed, under certain conditions, not to fully exercise our rights and remedies under the lease and loan agreements during limited periods. We have not committed to the adoption of a plan to transition ownership or management of the hospital to any new operator, and there is no assurance that any such plan will be completed. Moreover, there is no assurance that any plan that we ultimately pursue will not result in additional charges for further impairment of our working capital loan. We have not recognized any interest income on the Monroe loan since it was considered impaired in the 2010 first quarter.

Loans

The following is a summary of our loans ($ amounts in thousands):


	As of December 31, 2011						As of December 31, 2010
	Balance			Weighted Average Interest Rate			Balance			Weighted Average Interest Rate
Mortgage loans		$	165,000		10.2	%		$	165,000		10.0	%
Other loans			74,839		10.5	%			50,985		10.8	%

		$	239,839					$	215,985

Including our working capital loans to Monroe and our new properties in 2011 (discussed previously), our other loans primarily consist of loans to our tenants for acquisitions and working capital purposes. In conjunction with our purchase of six healthcare facilities in July and August 2004, we made loans aggregating $41.4 million to Vibra. As of December 31, 2011, Vibra has reduced the balance of the loans to $17.8 million.

Concentration of Credit Risks

For the years ended December 31, 2011, 2010, and 2009, affiliates of Prime (including rent and interest from mortgage and working capital loans) accounted for 30.1%, 31.8%, and 32.5%, respectively, of our total revenues, and Vibra (including rent and interest from working capital loans) accounted for 12.0%, 15.0%, and 15.7%, respectively, of our total revenues. However, from an investment concentration perspective, Prime represented 25.3% and 26.7% of our total assets at December 31, 2011 and 2010, respectively, while Vibra represented 7.9% and 9.96%, respectively.

On an individual property basis, we had no investment of any single property greater than 5.6% of our total assets as of December 31, 2011.

From a geographic perspective, all of our properties are located in the United States with 26.8% of our total assets at December 31, 2011 located in California, down from 28.6% at December 31, 2010.

Related Party Transactions

Lease and interest revenue earned from tenants in which we have an equity interest in were $5.5 million and $1.8 million in 2011 and 2010, respectively. There was no such revenue in 2009.

Debt

12 Months Ended

Dec. 31, 2011

Debt [Abstract]

Debt

Debt

The following is a summary of debt ($ amounts in thousands):


	As of December 31, 2011				As of December 31, 2010
	Balance			Interest Rate	Balance			Interest Rate
Revolving credit facilities	$	89,600		Variable	$	—		Variable
2006 senior unsecured notes		125,000		Various		125,000		7.333%-7.871%
2011 senior unsecured notes		450,000		6.875%		—
Exchangeable senior notes
Principal amount		11,000		9.250%		91,175		6.125%-9.250%
Unamortized discount		(180	)			(2,585	)

		10,820				88,590
Term loans
Principal Amount		14,429		6.200%		157,683		Various
Unamortized discount		—				(1,303	)

		14,429				156,380

	$	689,849			$	369,970

As of December 31, 2011, principal payments due on our debt (which exclude the effects of any discounts recorded) are as follows:


2012	$	39,832
2013		11,249
2014		265
2015		50,283
2016		125,299
Thereafter		463,101

Total	$	690,029

To fund the acquisitions disclosed in Note 3, we used cash on-hand, borrowed on our revolving credit facilities, used a portion of the proceeds from the sale of the 2011 senior unsecured notes, and assumed a $16 million mortgage loan.

In April 2011, our Operating Partnership and a wholly-owned subsidiary of our Operating Partnership closed on a private offering of $450 million unsecured senior notes. Contemporaneously with the closing of the notes, we repaid and terminated our $150 million term loan facility (which was part of the credit facility entered into in 2010) and our $9 million collateralized term loan facility. We also paid down in full our revolving credit facility's outstanding balance with the proceeds from the notes offering. In the 2011 third quarter, we used proceeds from our 2011 senior unsecured notes offering to repurchase 86.6% of the outstanding 9.25% exchangeable senior notes due 2013 at a weighted average price of 118.4% of the principal amount (or $84.1 million) plus accrued and unpaid interest pursuant to a cash tender offer. The interest savings from the retirement of this debt will offset the majority of the premium paid to retire it, and the potential dilution effect from the convertible aspect of these notes is removed.

In connection with these 2011 refinancing activities, we recognized charges of $14.2 million related to the write-off of previously deferred loan costs and discounts associated with the payoff of the debt instruments noted above.

In April 2010, we completed a public offering of common stock (the "Offering") resulting in net proceeds, after underwriting discount and commissions, of approximately $279 million. See Note 9 for further information. We used the net proceeds from the Offering to repurchase 93% of the outstanding 6.125% exchangeable senior notes due 2011 at a price of 103% of the principal amount plus accrued and unpaid interest (or $136.3 million) pursuant to a cash tender offer. In addition, we paid off a $30 million term loan. Finally, in May 2010, we closed on a $450 million credit facility, and the proceeds of such along with the Offering were used to repay in full all outstanding obligations under the previous credit facility. These refinancing activities resulted in a charge of $6.7 million for the year ended December 31, 2010.

Revolving Credit Facilities

In connection with the 2011 senior unsecured notes offering, we amended our 2010 credit agreement to now provide for a $330 million unsecured revolving credit facility that matures in October 2015. As part of this amendment, we also lowered our interest rate to (1) the higher of the "prime rate" or federal funds rate plus 0.5%, plus a spread initially set at 1.60%, but that is adjustable from 1.60% to 2.40% based on current total leverage, or (2) LIBOR plus a spread initially set at 2.60%, but that is adjustable from 2.60% to 3.40% based on current total leverage. In addition to interest expense, we are required to pay a quarterly commitment fee on the undrawn portion of the revolving credit facility, ranging from 0.375% to 0.500% per year. At December 31, 2011 and 2010, our outstanding balance on the revolving credit facility was $50 million and $0, respectively. At December 31, 2011, our availability under our revolving credit facility was $280 million. The weighted average interest rate on this facility was 3.2% and 2.1% for 2011 and 2010, respectively.

In regards to the $220 million credit facility that we paid off in 2010, our outstanding borrowings under the revolving facility were $96 million at December 31, 2009. For 2009, our interest rate was primarily set off the 30-day LIBOR plus 1.75% (1.99% at December 31, 2009). In addition, the old credit facility provided for a quarterly commitment fee on the unused portion ranging from 0.20% to 0.35%. The weighted average interest rate on this facility was 2.21% for 2009.

In June 2007, we signed a collateralized revolving bank credit facility for up to $42 million. The terms are for five years with interest at the 30-day LIBOR plus 1.50% (1.80% at December 31, 2011 and 1.77% at December 31, 2010). The amount available under the facility decreases $0.8 million per year until maturity. The facility is collateralized by one real estate property with a net book value of $55.1 million and $56.5 million at December 31, 2011 and 2010, respectively. This facility had an outstanding balance of $39.6 and $0 million at December 31, 2011 and December 31, 2010, respectively. At December 31, 2011, we had $0 million of availability under this revolving credit facility. The weighted-average interest rate on this revolving bank credit facility was 1.63%, 1.74% and 1.86% for 2011, 2010 and 2009, respectively.

2011 Senior Unsecured Notes

On April 26, 2011, our Operating Partnership and a wholly-owned subsidiary of our Operating Partnership closed on a private placement of $450 million aggregate principal amount of 6.875% Senior Notes due 2021 (the "2011 senior unsecured notes") to qualified institutional buyers in reliance on Rule 144A under the Securities Act. The 2011 senior unsecured notes were subsequently registered under the Securities Act pursuant to an exchange offer. Interest on the 2011 senior unsecured notes is payable semi-annually on May 1 and November 1 of each year. The 2011 senior unsecured notes pay interest in cash at a rate of 6.875% per year and mature on May 1, 2021. We may redeem some or all of the 2011 senior unsecured notes at any time prior to May 1, 2016 at a "make-whole" redemption price. On or after May 1, 2016, we may redeem some or all of the 2011 senior unsecured notes at a premium that will decrease over time, plus accrued and unpaid interest to, but not including, the redemption date. The 2011 senior unsecured notes are guaranteed, jointly and severally, on an unsecured basis, by the certain subsidiary guarantors. In the event of a Change of Control, each holder of the 2011 senior unsecured notes may require us to repurchase some or all of its 2011 senior unsecured notes at a repurchase price equal to 101% of the aggregate principal amount plus accrued and unpaid interest to the date of purchase.

2006 Senior Unsecured Notes

During 2006, we issued $125.0 million of Senior Unsecured Notes (the "Senior Notes"). The Senior Notes were placed in private transactions exempt from registration under the Securities Act of 1933, as amended, (the "Securities Act"). One of the issuances of Senior Notes totaling $65.0 million paid interest quarterly at a fixed annual rate of 7.871% through July 30, 2011, thereafter, at a floating annual rate of three-month LIBOR plus 2.30% and may be called at par value by us at any time on or after July 30, 2011. This portion of the Senior Notes matures in July 2016. The remaining issuances of Senior Notes paid interest quarterly at fixed annual rates ranging from 7.333% to 7.715% through October 30, 2011, thereafter, at a floating annual rate of three-month LIBOR plus 2.30% and may be called at par value by us at any time on or after October 30, 2011. These remaining notes mature in October 2016.

During the second quarter 2010, we entered into an interest rate swap to fix $65 million of our $125 million Senior Notes, which started July 31, 2011 (date on which the interest rate turned variable) through maturity date (or July 2016), at a rate of 5.507%. We also entered into an interest rate swap to fix $60 million of our Senior Notes which started October 31, 2011 (date on which the related interest rate turned variable) through the maturity date (or October 2016) at a rate of 5.675%. At December 31, 2011 and 2010, the fair value of the interest rate swaps was $12.2 million and $3.6 million, respectively, which is reflected in accounts payable and accrued expenses on the condensed consolidated balance sheet.

We account for our interest rate swaps as cash flow hedges. Accordingly, the effective portion of changes in the fair value of our swaps is recorded as a component of accumulated other comprehensive income/loss on the balance sheet and reclassified into earnings in the same period, or periods, during which the hedged transactions effects earnings, while any ineffective portion is recorded through earnings immediately. We did not have any hedge ineffectiveness from inception of our interest rate swaps through December 31, 2011 and therefore, there was no income statement effect recorded during the years ended December 31, 2011 and 2010. We do not expect any of the current losses included in accumulated other comprehensive loss to be reclassified into earnings in the next 12 months.

As noted above under the heading "Revolving Credit Facilities", we, via the amendment to our credit agreement, ceased being secured under our revolving credit facility, which triggered a collateral posting event under our interest rate swap. At December 31, 2011, we have posted $6.3 million of collateral, which is currently reflected in other assets on our consolidated balance sheets.

Exchangeable Senior Notes

In November 2006, our Operating Partnership issued and sold, in a private offering, $138.0 million of Exchangeable Senior Notes (the "2006 Exchangeable Notes"). The 2006 Exchangeable Notes pay interest semi-annually at a rate of 6.125% per annum and mature on November 15, 2011. Net proceeds from the offering of the 2006 Exchangeable Notes were approximately $134 million, after deducting the initial purchasers' discount. During 2010, 93% of the outstanding 6.125% exchangeable senior notes due 2011 were repurchased at a price of 103% of the principal amount plus accrued and unpaid interest (or $136.3 million). The remaining balance on the 2006 Exchangeable Notes of $9.2 million was paid at maturity on November 15, 2011.

In March 2008, our Operating Partnership issued and sold, in a private offering, $75.0 million of Exchangeable Senior Notes (the "2008 Exchangeable Notes") and received proceeds of $72.8 million. In April 2008, the Operating Partnership sold an additional $7.0 million of the 2008 Exchangeable Notes (under the initial purchasers' overallotment option) and received proceeds of $6.8 million. The 2008 Exchangeable Notes pay interest semi-annually at a rate of 9.25% per annum and mature on April 1, 2013. The 2008 Exchangeable Notes have an initial exchange rate of 80.8898 shares of our common stock per $1,000 principal amount, representing an exchange price of $12.36 per common share. The initial exchange rate is subject to adjustment under certain circumstances. The 2008 Exchangeable Notes are exchangeable prior to the close of business on the second day immediately preceding the stated maturity date at any time beginning on January 1, 2013 and also upon the occurrence of specified events, for cash up to their principal amounts and our common shares for the remainder of the exchange value in excess of the principal amount. The 2008 Exchangeable Notes are senior unsecured obligations of the Operating Partnership, guaranteed by us.

In July 2011, we used a portion of the proceeds from the 2011 senior unsecured notes to repurchase 85% of the outstanding 2008 Exchangeable Notes at a price of 118.5% of the principal amount plus accrued and unpaid interest (or $84.2 million) pursuant to a cash tender offer. Additionally, in August 2011, we repurchased $1.5 million of the outstanding 2008 Exchangeable Notes in the open market. The outstanding aggregate principal amount of the 2008 Exchangeable Notes is $11.0 million as of December 31, 2011.

Term Loans

In connection with our acquisition of the Northland LTACH Hospital on February 14, 2011, we assumed a $16.1 million mortgage. The Northland mortgage loan requires monthly principal and interest payments based on a 30-year amortization period. The Northland mortgage loan has a fixed interest rate of 6.2%, matures on January 1, 2018 and can be prepaid after January 1, 2013, subject to a certain prepayment premium. At December 31, 2011, the remaining balance on this term loan was $14.4 million.

In May 2010, we closed on a $150 million term loan that was scheduled to mature on May 17, 2016 and had an interest rate option of (1) LIBOR plus a spread of 3.5% or (2) the higher of the "prime rate" or federal funds rate plus 0.5%, plus a spread of 2.50%. This 2010 term loan was subject to a LIBOR floor of 1.5% (5.00% at December 31, 2010). This term loan was repaid and terminated in 2011 in connection with our 2011 senior unsecured notes offering.

Included in the $220 million credit facility that was paid off in 2010 was a term loan that had an outstanding balance of $64.5 million at December 31, 2009. This term loan's interest rate was based on the 30-day LIBOR plus a spread of 200 basis points (2.26% at December 31, 2009).

In November 2008, we signed a collateralized term loan facility for $9 million with interest fixed at 5.66%. This term loan was repaid and terminated in 2011 in connection with our 2011 senior unsecured notes offering.

Covenants

Our debt facilities impose certain restrictions on us, including restrictions on our ability to: incur debts; create or incur liens; provide guarantees in respect of obligations of any other entity; make redemptions and repurchases of our capital stock; prepay, redeem or repurchase debt; engage in mergers or consolidations; enter into affiliated transactions; dispose of real estate or other assets; and change our business. In addition, the credit agreement governing our revolving credit facility limits the amount of dividends we can pay to 120% of normalized adjusted funds from operations, as defined in the agreements, on a rolling four quarter basis starting for the fiscal quarter ending March 31, 2012. Thereafter, a similar dividend restriction exists but the percentage drops each quarter until reaching 95% at March 31, 2013. The indenture governing our 2011 senior unsecured notes also limits the amount of dividends we can pay based on the sum of 95% of funds from operations, proceeds of equity issuances and certain other net cash proceeds. Finally, our 2011 senior unsecured notes (along with the senior unsecured notes entered into in 2012 in connection with the Ernest acquisition) require us to maintain total unencumbered assets (as defined in the related indenture) of not less than 150% of our unsecured indebtedness.

In addition to these restrictions, the new credit facility contains customary financial and operating covenants, including covenants relating to our total leverage ratio, fixed charge coverage ratio, mortgage secured leverage ratio, recourse mortgage secured leverage ratio, consolidated adjusted net worth, facility leverage ratio, and borrowing base interest coverage ratio. This facility also contains customary events of default, including among others, nonpayment of principal or interest, material inaccuracy of representations and failure to comply with our covenants. If an event of default occurs and is continuing under the facility, the entire outstanding balance may become immediately due and payable. At December 31, 2011, we were in compliance with all such financial and operating covenants.

Income Taxes

12 Months Ended

Dec. 31, 2011

Income Taxes [Abstract]

Income Taxes

5.	Income Taxes

Medical Properties Trust, Inc.

We have maintained and intend to maintain our election as a REIT under the Internal Revenue Code of 1986, as amended. To qualify as a REIT, we must meet a number of organizational and operational requirements, including a requirement to distribute at least 90% of our taxable income to our stockholders. As a REIT, we generally will not be subject to federal income tax if we distribute 100% of our taxable income to our stockholders and satisfy certain other requirements. Income tax is paid directly by our stockholders on the dividends distributed to them. If our taxable income exceeds our dividends in a tax year, REIT tax rules allow us to designate dividends from the subsequent tax year in order to avoid current taxation on undistributed income. If we fail to qualify as a REIT in any taxable year, we will be subject to federal income taxes at regular corporate rates, including any applicable alternative minimum tax. Taxable income from non-REIT activities managed through our taxable REIT subsidiaries is subject to applicable federal, state and local income taxes. For 2011, 2010 and 2009, we recorded tax expense of $0.1 million, $1.6 million and $0.3 million, respectively.

At December 31, 2011 and 2010, we had a net deferred tax asset (prior to valuation allowance) of $8.7 million and $6.7 million respectively. This increase is primarily related to the increase in the federal and state net operating loss carry forwards ("NOLs") at our MDS TRS. NOLs are available to offset future earnings in one of our taxable REIT subsidiaries within the periods specified by law. At December 31, 2011, we had U.S. federal and state NOLs of $12.1 million and $13.0 million, respectively, that expire in 2020 through 2031.

With the continued losses sustained by MDS, we do not believe MDS will generate enough taxable income to use the federal and state net operating losses noted above within the carry forward period specified by law. Therefore, we continue to fully reserve for the net deferred tax asset. At December 31, 2011 and 2010 the valuation allowance was $8.9 million and $6.8 million, respectively. We will continue to monitor this valuation allowance and, if circumstances change (such as entering into new working capital loans or other transactions), we will adjust this valuation allowance accordingly.

Earnings and profits, which determine the taxability of distributions to stockholders, will differ from net income reported for financial reporting purposes due primarily to differences in cost basis, differences in the estimated useful lives used to compute depreciation, and differences between the allocation of our net income and loss for financial reporting purposes and for tax reporting purposes.

A schedule of per share distributions we paid and reported to our stockholders is set forth in the following:


	For the Years Ended December 31,
	2011		2010		2009
Common share distribution	$	0.800000	$	0.800000	$	0.800000
Ordinary income		0.300844		0.388128		0.471792
Capital gains(1)		0.031396		0.027724		0.003708
Unrecaptured Sec. 1250 gain		0.031396		0.022784		0.003708
Return of capital		0.467760		0.384148		0.324500
Allocable to next year		—		—		—

(1)	Capital gains include unrecaptured Sec. 1250 gains.

MPT Operating Partnership, L.P.

As a partnership, the allocated share of income of the Operating Partnership is included in the income tax returns of the general and limited partners. Accordingly, no accounting for income taxes is generally required for such income of the Operating Partnership. However, the Operating Partnership has formed taxable REIT subsidiaries on behalf of Medical Properties Trust, Inc., which are subject to federal, state and local income taxes at regular corporate rates. See discussion above under Medical Properties Trust, Inc. for more details of income taxes associated with our taxable REIT subsidiaries.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 136, 172
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 43, 44, 45, 46, 47, 48, 49
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

+ Details

Earnings Per Share/Unit

12 Months Ended

Dec. 31, 2011

Earnings Per Share/Unit [Abstract]

Earnings Per Share/Unit

6.	Earnings Per Share/Unit

Medical Properties Trust, Inc.

Our earnings per share were calculated based on the following (amounts in thousands):


	For the Years Ended December 31,
	2011			2010			2009
Numerator:
Income from continuing operations	$	19,431		$	10,248		$	29,945
Non-controlling interests' share in continuing operations		(178	)		(99	)		(36	)
Participating securities' share in earnings		(1,090	)		(1,254	)		(1,506	)

Income from continuing operations, less participating securities' share in earnings		18,163			8,895			28,403
Income from discontinued operations		7,283			12,764			6,422
Non-controlling interests' share in discontinued operations		—			—			(1	)

Income from discontinued operations attributable to MPT common stockholders		7,283			12,764			6,421

Net income, less participating securities' share in earnings	$	25,446		$	21,659		$	34,824

Denominator:
Basic weighted-average common shares		110,623			100,706			78,117
Dilutive stock options		6			2			—

Diluted weighted-average common shares		110,629			100,708			78,117

MPT Operating Partnership, L.P.

Our earnings per unit were calculated based on the following (amounts in thousands):


	For the Years Ended December 31,
	2011			2010			2009
Numerator:
Income from continuing operations	$	19,448		$	10,323		$	30,008
Non-controlling interests' share in continuing operations		(178	)		(99	)		(36	)
Participating securities' share in earnings		(1,090	)		(1,254	)		(1,506	)

Income from continuing operations, less participating securities' share in earnings		18,180			8,970			28,466
Income from discontinued operations		7,283			12,764			6,422
Non-controlling interests' share in discontinued operations		—			—			(1	)

Income from discontinued operations attributable to MPT Operating Partnership partners		7,283			12,764			6,421

Net income, less participating securities' share in earnings	$	25,463		$	21,734		$	34,887

Denominator:
Basic weighted-average units		110,623			100,706			78,117
Dilutive options		6			2			—

Diluted weighted-average units		110,629			100,708			78,117

For each of the years ended December 31, 2011, 2010, and 2009, 0.1 million of options were excluded from the diluted earnings per share/unit calculation as they were not determined to be dilutive. Shares/units that may be issued in the future in accordance with our exchangeable senior notes were excluded from the diluted earnings per share/unit calculation as they were not determined to be dilutive.

Stock Awards

12 Months Ended

Dec. 31, 2011

Stock Awards [Abstract]

Stock Awards

7.	Stock Awards

We have adopted the Second Amended and Restated Medical Properties Trust, Inc. 2004 Equity Incentive Plan (the "Equity Incentive Plan"), which authorizes the issuance of common stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance units and awards of interests in our Operating Partnership. The Equity Incentive Plan is administered by the Compensation Committee of the Board of Directors. We have reserved 7,441,180 shares of common stock for awards under the Equity Incentive Plan for which 2,595,161 shares remain available for future stock awards as of December 31, 2011. The Equity Incentive Plan contains a limit of 1,000,000 shares as the maximum number of shares of common stock that may be awarded to an individual in any fiscal year. Awards under the Equity Incentive Plan are subject to forfeiture due to termination of employment prior to vesting. In the event of a change in control, outstanding and unvested options will immediately vest, unless otherwise provided in the participant's award or employment agreement, and restricted stock, restricted stock units, deferred stock units and other stock-based awards will vest if so provided in the participant's award agreement. The term of the awards is set by the Compensation Committee, though Incentive Stock Options may not have terms of more than ten years. Forfeited awards are returned to the Equity Incentive Plan and are then available to be re-issued as future awards. For each share of common stock issued by Medical Properties Trust, Inc. pursuant to its Equity Incentive Plan, the Operating Partnership issues a corresponding number of operating partnership units.

The following awards have been granted pursuant to our Equity Incentive Plan:

Stock Options.

We awarded 50,000 common stock options in 2007, with an exercise price and estimated grant date fair values of $12.09 and $1.36 per option, respectively. The options awarded in 2007 vest annually in equal amounts over three years from the date of award and expire in 2012. We use the Black-Scholes pricing model to calculate the fair values of the options awarded. In 2007, the following assumptions were used to derive the fair values: an option term of four years; expected volatility of 28.34%; a weighted average risk-free rate of return of 4.62%; and a dividend yield of 8.93%. The intrinsic value of options exercisable and outstanding at December 31, 2011, is $-0-. No options were granted, exercised, or forfeited in 2011, 2010, or 2009, but some were settled for cash in 2011. At December 31, 2011, we had 110,000 options outstanding and exercisable, with a weighted-average exercise price of $10.95 per option. The weighted average remaining contractual term of options exercisable and outstanding is 1.8 years.

Restricted Equity Awards

Other stock-based awards are in the form of service-based awards and performance-based awards. The service-based awards vest as the employee provides the required service over periods that generally range from three to seven years. Service based awards are valued at the average price per share of common stock on the date of grant. In 2011, 2010, and 2007, the Compensation Committee granted awards to employees which vest based on us achieving certain performance levels, stock price levels, total shareholder return or comparison to peer total return indices. Generally, dividends are not paid on these performance awards until the award is earned. See below for details of such grants:

2011 performance awards – The 2011 performance awards were granted in three parts:

Approximately 30% of the 2011 performance awards are based on us achieving a simple 9.0% annual total shareholder return over a three year period; however, the award contains both carry forward and carry back provisions through December 31, 2015. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 2.07%; expected volatility of 33%; expected dividend yield of 8.5%; and expected service period of 4 years.

Approximately 18% of the 2011 performance awards are based on us achieving a cumulative total shareholder return from January 1, 2011 to December 31, 2013. The minimum total shareholder return needed to earn a portion of this award is 27% with 100% of the award earned if our total shareholder return reaches 39%. If any shares are earned from this award, the shares will vest in equal annual amounts on January 1, 2014, 2015 and 2016. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 1.07%; expected volatility of 34%; expected dividend yield of 8.5%; and expected service period of 5 years.

The remainder of the 2011 performance awards will be earned if our total shareholder return outpaces that of the MSCI U.S. REIT Index ("Index") over the cumulative period from January 1, 2011 to December 31, 2013. Our total shareholder return must exceed that of the Index to earn the minimum number of shares under this award, while it must exceed the Index by 12% to earn 100% of the award. If any shares are earned from this award, the shares will vest in equal annual amounts on January 1, 2014, 2015 and 2016. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 1.07%; expected volatility of 34%; expected dividend yield of 8.5%; and expected service period of 5 years.

None of the 2011 performance awards were earned in 2011.

2010 performance awards - The 2010 performance awards are based on us achieving a simple 9.5% annual total shareholder return over a three year period; however, the award contains both carry forward and carry back provisions through December 31, 2014. The fair value of this award was estimated on the date of grant using a Monte Carlo valuation model that assumed the following: risk free interest rate of 2.60%; expected volatility of 42%; expected dividend yield of 8.5%; and expected service period of 4 years. None of the 2010 performance awards were earned in 2011; however, 60,866 awards were earned in 2010.

2007 performance awards - The 2007 performance awards were granted under our 2007 Multi-year Incentive Plan and consist of two components: core performance awards ("CPRE") and superior performance awards ("SPRE"). The CPRE awards vest annually and ratably over a seven-year period beginning December 31, 2007, contingent upon our achievement of a simple 9% annual total return to shareholders (prorated to 7.5% for the first vesting period ending December 31, 2007). In years in which the annual total return exceeds 9%, the excess return may be used to earn CPRE awards not earned in a prior or future year. SPRE awards were to be earned based on achievement of specified share price thresholds during the period beginning March 1, 2007 through December 31, 2010, and were to vest annually and ratably over the subsequent three-year period (2011-2013). At December 31, 2010, the share price thresholds were not met. Accordingly, in accordance with the SPRE award agreements, 33.334% of the SPRE awards were earned as we performed at or above the 50th percentile of all real estate investment trusts included in the Morgan Stanley REIT Index in terms of total return to shareholders over the same period. The other 66.666% of the SPRE awards were deemed forfeited.

In 2011, no CPRE awards were earned. In addition to the SPRE awards noted earlier, 79,287 shares/LTIP units (discussed in Note 9) were earned in 2010 under the CPRE award.

The following summarizes restricted equity awards activity in 2011 and 2010, respectively:

For the Year Ended December 31, 2011:


	Vesting Based on Service					Vesting Based on Market/Performance Conditions
	Shares			Weighted Average Value at Award Date		Shares			Weighted Average Value at Award Date
Nonvested awards at beginning of the year		783,305		$	10.43		828,409		$	8.70
Awarded		292,803		$	10.76		853,656		$	5.72
Vested		(453,980	)	$	9.89		(163,575	)	$	6.87
Forfeited		(18,148	)	$	9.70		(7,093	)	$	9.32

Nonvested awards at end of year		603,980		$	11.02		1,511,397		$	7.21

For the Year Ended December 31, 2010:


	Vesting Based on Service					Vesting Based on Market/Performance Conditions
	Shares			Weighted Average Value at Award Date		Shares			Weighted Average Value at Award Date
Nonvested awards at beginning of the year		962,350		$	10.22		1,301,088		$	6.90
Awarded		277,680		$	10.39		182,600		$	9.25
Vested		(454,323	)	$	9.97		(175,279	)	$	10.64
Forfeited		(2,402	)	$	8.66		(480,000	)	$	3.31

Nonvested awards at end of year		783,305		$	10.43		828,409		$	8.70

The value of stock-based awards is charged to compensation expense over the vesting periods. In the years ended December 31, 2011, 2010 and 2009, we recorded $7.0 million, $6.6 million, and $5.5 million respectively, of non-cash compensation expense. The remaining unrecognized cost from restricted equity awards at December 31, 2011, is $10.5 million and will be recognized over a weighted average period of 2.4 years. Restricted equity awards which vested in 2011, 2010, and 2009 had a value of $6.1 million, $6.1 million, and $2.4 million, respectively.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 123R
-Paragraph 64, 65, A240
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 93-6
-Paragraph 53
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 14

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

+ Details

Commitments And Contingencies

12 Months Ended

Dec. 31, 2011

Commitments And Contingencies [Abstract]

Commitments And Contingencies

8.	Commitments and Contingencies

Commitments

Our operating leases primarily consist of ground leases on which certain of our facilities or other related property reside along with corporate office and equipment leases. These ground leases are long-term leases (almost all having terms for approximately 50 years or more), some contain escalation provisions and one contains a purchase option. Properties subject to these ground leases are subleased to our tenants. Lease and rental expense (which is recorded on the straight-line method) for 2011, 2010 and 2009, respectively, were $868,106, $989,170, and $859,570, which was offset by sublease rental income of $443,829, $520,090, and $498,733 for 2011, 2010, and 2009, respectively.

Fixed minimum payments due under operating leases with non-cancelable terms of more than one year at December 31, 2011 are as follows: (amounts in thousands)


2012	$	2,233
2013		2,104
2014		1,609
2015		1,610
2016		1,610
Thereafter		36,378

	$	45,544

The total amount to be received in the future from non-cancellable subleases at December 31, 2011, is $29.4 million.

Contingencies

We are a party to various legal proceedings incidental to our business. In the opinion of management, after consultation with legal counsel, the ultimate liability, if any, with respect to those proceedings is not presently expected to materially affect our financial position, results of operations or cash flows.

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 14
-Paragraph 3
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 9, 10, 11, 12
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

+ Details

Common Stock/Partner's Capital

12 Months Ended

Dec. 31, 2011

Common Stock/Partner's Capital [Abstract]

Common Stock/Partner's Capital

9.	Common Stock/Partner's Capital

Medical Properties Trust, Inc.

In April 2010, we completed a public offering of 26 million shares of common stock at $9.75 per share. Including the underwriters' purchase of 3.9 million additional shares to cover over allotments, net proceeds from the offering, after underwriting discount and commissions, were $279.1 million. We used the net proceeds from the offering to fund our refinancing activities as discussed in Note 4 with any remaining proceeds used for general corporate purposes including funding acquisitions during 2010.

During the first quarter of 2010, we sold 0.9 million shares of our common stock under our at-the-market equity offering program, at an average price of $10.77 per share, for total proceeds, net of a 2% sales commission, of $9.5 million.

In November 2009, we put an at-the-market program in place, and we have the ability to sell up to $50 million of stock under that plan. During the fourth quarter of 2009, we sold 30,000 shares at an average price per share of $10.25 resulting in a proceeds, net of a 2% sales agent commission, of $0.3 million.

On January 9, 2009, we filed Articles of Amendment to our charter with the Maryland State Department of Assessments and Taxation increasing the number of authorized shares of common stock, par value $0.001 per share available for issuance from 100,000,000 to 150,000,000. Subsequent to 2011, we further increased the number of authorized shares of common stock to 250,000,000.

In January 2009, we completed a public offering of 12.0 million shares of our common stock at $5.40 per share. Including the underwriters' purchase of 1.3 million additional shares to cover over allotments, net proceeds from this offering, after underwriting discount and commissions, were $67.8 million. The net proceeds of this offering were generally used to repay borrowings outstanding under our revolving credit facilities.

MPT Operating Partnership, L.P.

The Operating Partnership is made up of a general partner, Medical Properties Trust, LLC ("General Partner") and limited partners, including the Company (which owns 100% of the General Partner) and three other partners who are employees. By virtue of its ownership of the General Partner, the Company has a 99.8% ownership interest in Operating Partnership via its ownership of all the common units. The remaining ownership interest is held by the two employees and one director via their ownership of LTIP units. These LTIP units were issued to the employees pursuant to the 2007 Multi-Year Incentive Plan, which is part of the Equity Incentive Plan discussed in Note 7 and once vested in accordance with their award agreement, may be converted to common units per the Second Amended and Restated Agreement of Limited Partnership of MPT Operating Partnership, L.P. ("Operating Partnership Agreement").

In regards to distributions, the Operating Partnership shall distribute cash at such times and in such amounts as are determined by the General Partner in its sole and absolute discretion, to common unit holders who are common unit holders on the record date. However, per the Operating Partnership Agreement, the General Partner shall use its reasonable efforts to cause the Operating Partnership to distribute amounts sufficient to enable the Company to pay stockholder dividends that will allow the Company to (i) meet its distribution requirement for qualification as a REIT and (ii) avoid any federal income or excise tax liability imposed by the Internal Revenue Code, other than to the extent the Company elects to retain and pay income tax on its net capital gain. In accordance with the Operating Partnership Agreement, LTIP units are treated as common units for distribution purposes.

The Operating Partnership's net income will generally be allocated first to the General Partner to the extent of any cumulative losses and then to the limited partners in accordance with their respective percentage interests in the common units issued by the Operating Partnership. Any losses of the Operating Partnership will generally be allocated first to the limited partners until their capital account is zero and then to the General Partner. In accordance with the Operating Partnership Agreement, LTIP units are treated as common units for purposes of income and loss allocations.

Limited partners have the right to require the Operating Partnership to redeem part or all of their common units. It is at the Operating Partnership's discretion to redeem such common units for cash based on the fair market value of an equivalent number of shares of the Company's common stock at the time of redemption or, alternatively, redeem the common units for shares of the Company's common stock on a one-for-one basis, subject to adjustment in the event of stock splits, stock dividends, or similar events. In order for LTIP units to be redeemed, they must first be converted to common units and then must wait two years from the issuance of the LTIP units to be redeemed.

For each share of common stock issued by Medical Properties Trust, Inc., the Operating Partnership issues a corresponding number of operating partnership units.

Fair Value Of Financial Instruments

12 Months Ended

Dec. 31, 2011

Fair Value Of Financial Instruments [Abstract]

Fair Value Of Financial Instruments

10.

Fair Value of Financial Instruments

We have various assets and liabilities that are considered financial instruments. We estimate that the carrying value of cash and cash equivalents, and accounts payable and accrued expenses approximates their fair values. Included in accounts payable and accrued expenses are our interest rate swaps, which are recorded at fair value based on Level 2 observable market assumptions using standardized derivative pricing models. We estimate the fair value of our loans, interest, and other receivables by discounting the estimated future cash flows using the current rates at which similar receivables would be made to others with similar credit ratings and for the same remaining maturities. We determine the fair value of our exchangeable notes based on quotes from securities dealers and market makers. We estimate the fair value of our senior notes, revolving credit facilities, and term loans based on the present value of future payments, discounted at a rate which we consider appropriate for such debt.

The following table summarizes fair value information for our financial instruments: (amounts in thousands)


	December 31, 2011						December 31, 2010
Asset (Liability)	Book Value			Fair Value			Book Value			Fair Value
Interest and rent receivables	$	29,862		$	22,866		$	26,176		$	20,265
Loans		239,839			243,272			215,985			209,126
Debt, net		(689,849	)		(688,032	)		(369,970	)		(359,910	)

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 44A, 44B
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15C, 15D
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15A
-Subparagraph a-d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15B
-Subparagraph a, b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 3, 10, 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 32, 33, 34
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 17-22, 27, 28
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19207-110258

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13537-108611

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13433-108611

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13504-108611

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19296-110258

+ Details

Discontinued Operations

12 Months Ended

Dec. 31, 2011

Discontinued Operations [Abstract]

Discontinued Operations

11.

Discontinued Operations

On December 30, 2011, we sold MountainView Regional Rehabilitation Hospital in Morgantown, West Virginia to HealthSouth Corporation for $21.1 million, resulting in a gain of $2.3 million. On December 30, 2011, we also sold Sherman Oaks Hospital in Sherman Oaks, California to Prime Healthcare Services, Inc. for approximately $20.0 million, resulting in a gain of $3.1 million. Due to this sale, we wrote-off $1.2 million in straight-line rent receivables.

In the fourth quarter 2010, we sold the real estate of our Montclair Hospital, an acute care medical center to Prime for proceeds of $20.0 million. We realized a gain on the sale of $2.2 million. In October of 2010, we sold the real estate of our Sharpstown hospital in Houston, Texas to a third party for proceeds of $3.0 million resulting in a gain of $0.7 million. In the second quarter of 2010, we sold the real estate of our Inglewood Hospital, a 369-bed acute care medical center located in Inglewood, California, to Prime for $75 million resulting in a gain of approximately $6 million.

In the fourth quarter of 2009, we sold the real estate of a general acute hospital to Prime for proceeds of approximately $15 million. The sale was completed on December 28, 2009, resulting in a gain on the sale of $0.3 million.

We have classified current and prior year activity related to these transactions, along with the related operating results of the facilities prior to these transactions taking place, as discontinued operations. In addition, we have reclassified the related real estate assets to Real Estate Held for Sale in all prior periods.

The following table presents the results of discontinued operations for the years ended December 31, 2011, 2010 and 2009 (in thousands except per share/unit amounts):


	For the Years Ended December 31,
	2011		2010		2009
Revenues	$	3,534	$	8,488	$	16,197
Gain on sale		5,431		10,566		278
Income from discontinued operations		7,283		12,764		6,422
Income from discontinued operations — diluted per share/unit	$	0.07	$	0.13	$	0.08

- Definition

The entire disclosure for the facts and circumstances leading to the completed or expected disposal, manner and timing of disposal, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the segment in which the disposal group was reported, and the classification (whether sold or classified as held for sale) and carrying value of the assets and liabilities comprising the disposal group. Includes all disposal groups, including those classified as components of the entity (discontinued operations).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 43-48
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1510-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1020-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1012-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1474-107760

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6390789&loc=d3e2443-110228

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1436-107760

+ Details

Quarterly Financial Data

12 Months Ended

Dec. 31, 2011

Quarterly Financial Data [Abstract]

Quarterly Financial Data

12.

Quarterly Financial Data (unaudited)

Medical Properties Trust, Inc.

The following is a summary of the unaudited quarterly financial information for the years ended December 31, 2011 and 2010: (amounts in thousands, except for per share data)


	For the Three Month Periods in 2011 Ended
	March 31			June 30			September 30			December 31
Revenues	$	34,347		$	35,396		$	36,774		$	36,802
Income (loss) from continuing operations		9,652			1,934			(237	)		8,082
Income from discontinued operations		1,172			748			705			4,658
Net income		10,824			2,682			468			12,740
Net income attributable to MPT common stockholders		10,780			2,640			424			12,692
Net income attributable to MPT common stockholders per share — basic	$	0.09		$	0.02		$	—		$	0.11
Weighted average shares outstanding — basic		110,400			110,589			110,714			110,788
Net income (loss) attributable to MPT common stockholders per share — diluted	$	0.09		$	0.02		$	—		$	0.11
Weighted average shares outstanding — diluted		110,408			110,600			110,719			110,788

	For the Three Month Periods in 2010 Ended
	March 31			June 30			September 30			December 31
Revenues	$	29,365		$	29,534		$	27,621		$	30,677
Income (loss) from continuing operations		(4,249	)		(1,037	)		7,967			7,567
Income from discontinued operations		1,436			7,269			997			3,062
Net income		(2,813	)		6,232			8,964			10,629
Net income attributable to MPT common stockholders		(2,822	)		6,223			8,919			10,593
Net income attributable to MPT common stockholders per share — basic	$	(0.04	)	$	0.06		$	0.08		$	0.09
Weighted average shares outstanding — basic		79,176			103,498			110,046			110,103
Net income attributable to MPT common stockholders per share — diluted	$	(0.04	)	$	0.06		$	0.08		$	0.09
Weighted average shares outstanding — diluted		79,178			103,498			110,046			110,108

MPT Operating Partnership, L.P.

The following is a summary of the unaudited quarterly financial information for the years ended December 31, 2011 and 2010: (amounts in thousands, except for per unit data)


	For the Three Month Periods in 2011 Ended
	March 31			June 30			September 30			December 31
Revenues	$	34,347		$	35,396		$	36,774		$	36,802
Income (loss) from continuing operations		9,669			1,961			(219	)		8,037
Income from discontinued operations		1,172			748			705			4,658
Net income		10,841			2,709			486			12,695
Net income attributable to MPT Operating Partnership partners		10,796			2,667			443			12,647
Net income attributable to MPT Operating Partnership partners per unit — basic	$	0.09		$	0.02		$	—		$	0.11
Weighted average units outstanding — basic		110,400			110,589			110,714			110,788
Net income attributable to MPT Operating Partnership partners per unit — diluted	$	0.09		$	0.02		$	—		$	0.11
Weighted average units outstanding — diluted		110,408			110,600			110,719			110,788

	For the Three Month Periods in 2010 Ended
	March 31			June 30			September 30			December 31
Revenues	$	29,365		$	29,534		$	27,621		$	30,677
Income (loss) from continuing operations		(4,235	)		(968	)		7,958			7,568
Income from discontinued operations		1,436			7,269			997			3,062
Net income (loss)		(2,799	)		6,301			8,955			10,630
Net income (loss) attributable to MPT Operating Partnership partners		(2,807	)		6,292			8,910			10,593
Net income (loss) attributable to MPT Operating Partnership partners per unit — basic	$	(0.04	)	$	0.06		$	0.08		$	0.09
Weighted average units outstanding — basic		79,176			103,498			110,046			110,103
Net income (loss) attributable to MPT Operating Partnership partners per unit —diluted	$	(0.04	)	$	0.06		$	0.08		$	0.09
Weighted average units outstanding — diluted		79,178			103,498			110,046			110,108

- Definition

The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.

+ References + Details

Subsequent Events

12 Months Ended

Dec. 31, 2011

Subsequent Events [Abstract]

Subsequent Events

13.

Subsequent Events

On January 31, 2012, we entered into definitive agreements to make loans to and acquire assets from Ernest Health, Inc. ("Ernest") and to make an equity contribution in the parent of Ernest for a combined purchase price and investment of $396.5 million, consisting of $200 million to purchase real estate assets, a first mortgage loan of $100 million, an acquisition loan for $93.2 million and a capital contribution of $3.3 million, all as further described below. On February 29, 2012, we closed and funded this acquisition and related investments.

Real estate acquisition

Pursuant to a definitive real property asset purchase agreement (the "Purchase Agreement"), we acquired from Ernest and certain of its subsidiaries (i) a portfolio of five rehabilitation facilities (including a ground lease interest relating to a community-based acute rehabilitation facility in Wyoming), (ii) seven long-term acute care facilities located in seven states and (iii) undeveloped land in Provo, Utah (collectively, the "Acquired Facilities") for an aggregate purchase price of $200 million, subject to certain adjustments. The Acquired Facilities will be leased to subsidiaries of Ernest pursuant to a master lease agreement. The master lease agreement has a 20-year term with three five-year extension options and provides for an initial rental rate of 9%, with consumer price-indexed increases, limited to a 2% floor and 5% ceiling annually thereafter.

Mortgage loan financing

Pursuant to the Purchase Agreement, we also made Ernest a $100 million loan secured by a first mortgage interest in four subsidiaries of Ernest, which has terms similar to the leasing terms described above.

Acquisition loan and equity contribution

In addition, an affiliate of one of our taxable REIT subsidiaries has become a member in Ernest Health Holdings, LLC ("Ernest Holdings"), whose only other member is an entity formed by the present key management personnel of Ernest ("ManageCo"). We made capital contributions of approximately $3.3 million to Ernest Holdings in exchange for a membership interest representing a 49% aggregate initial equity interest. The remaining 51% initial equity interest in Ernest Holdings is owned by ManageCo, which has made contributions valued at $3.5 million in exchange for a membership interest in Ernest Holdings.

Pursuant to the terms of an Agreement and Plan of Merger dated January 31, 2012, a merger subsidiary of Ernest Holdings was merged with and into Ernest, with Ernest surviving the merger as a wholly-owned subsidiary of Ernest Holdings. Finally, we made an acquisition loan of approximately $93.2 million to the merger subsidiary (the "Acquisition Loan"). The Acquisition Loan will bear interest at a rate of 15.0%, with a 6% coupon payable in cash in the first year, a 7% coupon payable in cash in the second year and a 10% coupon payable in cash thereafter. The remaining 9% in year one; 8% in year two and 5% thereafter will be accrued and paid upon the occurrence of any capital or liquidity events of Ernest Holdings and will be payable in all events at maturity. The acquisition loan may be prepaid without penalty at any time.

Financing of Ernest transactions and other general corporate needs

To finance the Ernest transactions along with other general corporate purposes (including potential future acquisitions), we completed or have initiated the following transactions subsequent to December 31, 2011:

Common stock offering — On February 7, 2012, we completed an offering of 23,575,000 shares of our common stock (including 3,075,000 shares sold pursuant to the exercise in full of the underwriters' over-allotment option) at a price of $9.75 per share, resulting in net proceeds (after underwriting discount) of $220.7 million.

Senior unsecured notes offering — On February 17, 2012, we completed a $200 million offering of senior unsecured notes. These senior notes will accrue interest at a fixed rate of 6.375% per year and will mature on February 15, 2022. Net proceeds, after underwriting discount, from this senior notes offering was $196.5 million.

Credit facilities — On January 25, 2012, we received a commitment letter and term sheet for an $80 million senior unsecured term loan facility that provides for customary financial and operating covenants, substantially consistent with our revolving credit facility. We expect to close on our new term loan facility shortly after the closing of the Ernest transactions described above. In addition to the new term loan facility, our existing revolving credit facility includes an accordion feature pursuant to which borrowings thereunder can be increased up to $400 million from $330 million. We have requested a $70 million increase in our revolving credit facility contemporaneously with the closing of our new term loan facility.

Condensed Consolidating Financial Information

12 Months Ended

Dec. 31, 2011

Condensed Consolidating Financial Information [Abstract]

Condensed Consolidating Financial Information

14.

Condensed Consolidating Financial Information

The following tables present the condensed consolidating financial information for (a) Medical Properties Trust, Inc. ("Parent" and a guarantor to our 2011 senior unsecured notes), (b) MPT Operating Partnership, L.P. and MPT Finance Corporation ("Subsidiary Issuer"), (c) on a combined basis, the guarantors of our 2011 senior unsecured notes ("Subsidiary Guarantors"), and (d) on a combined basis, the non-guarantor subsidiaries ("Non-Guarantor Subsidiaries"). Separate financial statements of the Subsidiary Guarantors are not presented because the guarantee by each 100% owned Subsidiary Guarantor is joint and several, and we believe separate financial statements and other disclosures regarding the Subsidiary Guarantors are not material to investors. Furthermore, there are no significant legal restrictions on the Parent's ability to obtain funds from its subsidiaries by dividend or loan.

The guarantees by the Subsidiary Guarantors may be released and discharged upon: (1) any sale, exchange or transfer of all of the capital stock of a Subsidiary Guarantor; (2) the merger or consolidation of a Subsidiary Guarantor with a Subsidiary Issuer or any other Subsidiary Guarantor; (3) the proper designation of any Subsidiary Guarantor by the Subsidiary Issuers as "unrestricted" for covenant purposes under the indenture governing the 2011 senior unsecured notes; (4) the legal defeasance or covenant defeasance or satisfaction and discharge of the indenture; (5) a liquidation or dissolution of a Subsidiary Guarantor permitted under the indenture governing the 2011 senior unsecured notes; or (6) the release or discharge of the Subsidiary Guarantor from its guarantee obligations under our revolving credit facility.

Condensed Consolidated Balance Sheets

December 31, 2011

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	37	$	1,127,441		$	147,921		$	—		$	1,275,399
Mortgage loans		—		—		165,000			—			—			165,000

Gross investment in real estate assets		—		37		1,292,441			147,921			—			1,440,399
Accumulated depreciation and amortization		—		—		(89,788	)		(13,949	)		—			(103,737	)

Net investment in real estate assets		—		37		1,202,653			133,972			—			1,336,662
Cash & cash equivalents		—		101,230		—			1,496			—			102,726
Interest and rent receivables		—		399		22,525			6,938			—			29,862
Straight-line rent receivables		—		—		24,000			9,993			—			33,993
Other loans		—		177		—			74,662			—			74,839
Net intercompany receivable (payable)		21,955		872,382		(888,866	)		(5,471	)		—			—
Investment in subsidiaries		829,205		489,858		43,008			—			(1,362,071	)		—
Other assets		—		27,284		1,727			14,781			—			43,792

Total Assets	$	851,160	$	1,491,367	$	405,047		$	236,371		$	(1,362,071	)	$	1,621,874

Liabilities and Equity
Liabilities
Debt, net	$	—	$	635,820	$	—		$	54,029		$	—		$	689,849
Accounts payable and accrued expenses		22,345		25,783		2,576			421			—			51,125
Deferred revenue		—		559		17,488			5,260			—			23,307
Lease deposits and other obligations to tenants		—		—		27,874			904			—			28,778

Total liabilities		22,345		662,162		47,938			60,614			—			793,059
Total Medical Properties Trust Inc. stockholder's equity		828,815		829,205		357,109			175,757			(1,362,071	)		828,815

Non-controlling interests		—		—		—			—			—			—

Total equity		828,815		829,205		357,109			175,757			(1,362,071	)		828,815

Total Liabilities and Equity	$	851,160	$	1,491,367	$	405,047		$	236,371		$	(1,362,071	)	$	1,621,874

Condensed Consolidated Statements of Income

For the Year Ended December 31, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	100,759	$	18,368		$	(3,092	)	$	116,035
Straight-line rent		—			—			3,538		2,256			—			5,794
Interest and fee income		—			6,123			17,001		4,601			(6,235	)		21,490

Total revenues		—			6,123			121,298		25,225			(9,327	)		143,319
Expenses
Real estate depreciation and amortization		—			—			29,279		3,622			—			32,901
Impairment charge		—			—			564		—			—			564
Property-related		—			217			834		3,131			(3,092	)		1,090
General and administrative		17			27,626			—		3,760			—			31,403

Total operating expenses		17			27,843			30,677		10,513			(3,092	)		65,958

Operating income		(17	)		(21,720	)		90,621		14,712			(6,235	)		77,361
Other income (expense)
Interest income and other		—			26			345		(275	)		—			96
Debt refinancing costs		—			(14,109	)		—		(105	)		—			(14,214	)
Interest expense		—			(43,064	)		880		(7,863	)		6,235			(43,812	)

Net other expense		—			(57,147	)		1,225		(8,243	)		6,235			(57,930	)

Income (loss) from continuing operations		(17	)		(78,867	)		91,846		6,469			—			19,431
Income (loss) from discontinued operations		—			—			98		7,185			—			7,283

Equity in earnings of consolidated subsidiaries net of income taxes		26,731			105,598			4,578		—			(136,907	)		—

Net income		26,714			26,731			96,522		13,654			(136,907	)		26,714
Net income attributable to non-controlling interests		(178	)		(178	)		—		—			178			(178	)

Net income attributable to MPT common stockholders	$	26,536		$	26,553		$	96,522	$	13,654		$	(136,729	)	$	26,536

Condensed Consolidated Statements of Cash Flows

For the Year Ended December 31, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(209	)	$	(48,779	)	$	112,311		$	15,947		$	—		$	79,270
Investing Activities
Real estate acquired		—			—			(241,626	)		(4,885	)		—			(246,511	)
Principal received on loans receivable		—			—			230			4,059			—			4,289
Proceeds from sales of real estate		—			—			—			41,130			—			41,130
Investments in and advances to subsidiaries		89,551			(92,052	)		142,448			(50,605	)		(89,342	)		—
Investments in loans receivable and other investments		—			—			(230	)		(27,914	)		—			(28,144	)
Construction in progress and other		—			(6,466	)		(24,081	)		(5,838	)		—			(36,385	)

Net cash provided by (used in) investing activities		89,551			(98,518	)		(123,259	)		(44,053	)		(89,342	)		(265,621	)

Financing Activities
Revolving credit facilities, net		—			50,000			—			39,600			—			89,600
Proceeds from term debt, net of discount		—			450,000			—			—			—			450,000
Payments of term debt		—			(237,666	)		—			(8,596	)		—			(246,262	)
Distributions paid		(89,342	)		(89,601	)		—			—			89,342			(89,601	)
Proceeds from sale of common shares/units, net of offering costs		—			—			—			—			—			—
Lease deposits and other obligations to tenants		—			—			10,948			(2,327	)		—			8,621
Debt issuance costs paid and other financing activities		—			(21,028	)		—			(661	)		—			(21,689	)

Net cash provided by (used in) financing activities		(89,342	)		151,705			10,948			28,016			89,342			190,669

Increase (decrease) in cash and cash equivalents for period		—			4,408			—			(90	)		—			4,318
Cash and cash equivalents at beginning of period		—			96,822			—			1,586			—			98,408

Cash and cash equivalents at end of period	$	—		$	101,230		$	—		$	1,496		$	—		$	102,726

Condensed Consolidated Balance Sheets

December 31, 2010

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	297	$	861,599		$	128,652		$	—		$	990,548
Real estate held for sale		—		—		—			37,514			—			37,514
Mortgage loans		—		—		165,000			—			—			165,000

Gross investment in real estate assets		—		297		1,026,599			166,166			—			1,193,062
Accumulated depreciation and amortization		—		—		(61,460	)		(10,327	)		—			(71,787	)

Net investment in real estate assets		—		297		965,139			155,839			—			1,121,275
Cash & cash equivalents		—		96,822		—			1,586			—			98,408
Interest and rent receivables		—		157		20,692			5,327			—			26,176
Straight-line rent receivables		—		—		20,052			8,860			—			28,912
Other loans		—		178		—			50,807			—			50,985
Net intercompany receivable (payable)		21,944		774,771		(747,895	)		(48,820	)		—			—
Investment in subsidiaries		899,949		390,232		42,970			—			(1,333,151	)		—
Other assets		—		10,289		1,182			11,587			—			23,058

Total Assets	$	921,893	$	1,272,746	$	302,140		$	185,186		$	(1,333,151	)	$	1,348,814

Liabilities and Equity
Liabilities
Debt, net	$	—	$	361,537	$	—		$	8,433		$	—		$	369,970
Accounts payable and accrued expenses		22,317		10,824		2,378			455			—			35,974
Deferred revenue		—		436		17,616			5,085			—			23,137
Lease deposits and other obligations to tenants		—		—		17,019			3,138			—			20,157

Total liabilities		22,317		372,797		37,013			17,111			—			449,238
Total Medical Properties Trust Inc. stockholder's equity		899,462		899,835		265,127			168,075			(1,333,037	)		899,462

Non-controlling interests		114		114		—			—			(114	)		114

Total equity		899,576		899,949		265,127			168,075			(1,333,151	)		899,576

Total Liabilities and Equity	$	921,893	$	1,272,746	$	302,140		$	185,186		$	(1,333,151	)	$	1,348,814

Condensed Consolidated Statements of Income

For the Year Ended December 31, 2010

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	73,617	$	15,900		$	(1,030	)	$	88,487
Straight-line rent		—			—			222		1,711			—			1,933
Interest and fee income		—			6,964			16,755		10,572			(7,514	)		26,777

Total revenues		—			6,964			90,594		28,183			(8,544	)		117,197
Expenses
Real estate depreciation and amortization		—			—			19,251		3,579			—			22,830
Impairment charge		—			—			—		12,000			—			12,000
Property-related		—			(4	)		4,365		1,067			(1,030	)		4,398
General and administrative		75			27,867			—		593			—			28,535

Total operating expenses		75			27,863			23,616		17,239			(1,030	)		67,763

Operating income		(75	)		(20,899	)		66,978		10,944			(7,514	)		49,434
Other income (expense)
Interest income and other		—			(14	)		—		1,532			—			1,518
Debt refinancing costs		—			(6,716	)		—		—			—			(6,716	)
Interest expense		—			(33,623	)		31		(7,910	)		7,514			(33,988	)

Net other expense		—			(40,353	)		31		(6,378	)		7,514			(39,186	)

Income (loss) from continuing operations		(75	)		(61,252	)		67,009		4,566			—			10,248
Income (loss) from discontinued operations		—			—			121		12,643			—			12,764

Equity in earnings of consolidated subsidiaries net of income taxes		23,087			84,339			4,273		—			(111,699	)		—

Net income		23,012			23,087			71,403		17,209			(111,699	)		23,012
Net income attributable to non-controlling interests		(99	)		(99	)		—		—			99			(99	)

Net income attributable to MPT common stockholders	$	22,913		$	22,988		$	71,403	$	17,209		$	(111,600	)	$	22,913

Condensed Consolidated Statements of Cash Flows

For the Year Ended December 31, 2010

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(29	)	$	(54,909	)	$	89,780		$	25,795		$	—		$	60,637
Investing Activities
Real estate acquired		—			—			(137,808	)		—			—			(137,808	)
Principal received on loans receivable		—			—			—			90,486			—			90,486
Proceeds from sales of real estate		—			—			2,669			95,000			—			97,669
Investments in and advances to subsidiaries		(211,181	)		99,564			54,409			(154,002	)		211,210			—
Investments in loans receivable and other investments		—			—			(5,000	)		(6,637	)		—			(11,637	)
Construction in progress and other		—			(108	)		(8,267	)		(7,554	)		—			(15,929	)

Net cash provided by (used in) investing activities		(211,181	)		99,456			(93,997	)		17,293			211,210			22,781

Financing Activities
Revolving credit facilities, net		—			(96,000	)		—			(41,200	)		—			(137,200	)
Proceeds from term debt, net of discount		—			148,500			—			—			—			148,500
Payments of term debt		—			(216,520	)		—			(245	)		—			(216,765	)
Distributions paid		(76,856	)		(77,087	)		—			—			76,856			(77,087	)
Proceeds from sale of common shares/units, net of offering costs		288,066			288,066			—			—			(288,066	)		288,066
Lease deposits and other obligations to tenants		—			—			4,217			(550	)		—			3,667
Debt issuance costs paid and other financing activities		—			(9,498	)		—			—			—			(9,498	)

Net cash provided by (used in) financing activities		211,210			37,461			4,217			(41,995	)		(211,210	)		(317	)

Increase in cash and cash equivalents for period		—			82,008			—			1,093			—			83,101
Cash and cash equivalents at beginning of period		—			14,814			—			493			—			15,307

Cash and cash equivalents at end of period	$	—		$	96,822		$	—		$	1,586		$	—		$	98,408

Condensed Consolidated Statements of Income

For the Year Ended December 31, 2009

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	63,282		$	14,589		$	—		$	77,871
Straight-line rent		—			—			5,966			2,072			—			8,038
Interest and fee income		—			10,010			14,388			14,150			(10,419	)		28,129

Total revenues		—			10,010			83,636			30,811			(10,419	)		114,038
Expenses
Real estate depreciation and amortization		—			—			17,926			3,662			—			21,588
Impairment charge		—			—			—			—			—			—
Property-related		—			(20	)		3,778			43			—			3,801
General and administrative		63			20,631			—			402			—			21,096

Total operating expenses		63			20,611			21,704			4,107			—			46,485

Operating income		(63	)		(10,601	)		61,932			26,704			(10,419	)		67,553
Other income (expense)
Interest income and other		—			51			—			(8	)		—			43
Debt refinancing costs		—			—			—			—			—			—
Interest expense		—			(36,760	)		—			(11,310	)		10,419			(37,651	)

Net other income (expense)		—			(36,709	)		—			(11,318	)		10,419			(37,608	)

Income (loss) from continuing operations		(63	)		(47,310	)		61,932			15,386			—			29,945
Income (loss) from discontinued operations		—			—			(1,254	)		7,676			—			6,422

Equity in earnings of consolidated subsidiaries net of income taxes		36,430			83,740			3,918			—			(124,088	)		—

Net income		36,367			36,430			64,596			23,062			(124,088	)		36,367
Net income attributable to non-controlling interests		(37	)		(37	)		—			—			37			(37	)

Net income attributable to MPT common stockholders	$	36,330		$	36,393		$	64,596		$	23,062		$	(124,051	)	$	36,330

Condensed Consolidated Statements of Cash Flows

For the Year Ended December 31, 2009

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(268	)	$	(35,554	)	$	69,738		$	28,835		$	—		$	62,751

Investing Activities
Real estate acquired		—			—			(421	)		—			—			(421	)
Principal received on loans receivable		—			—			—			4,305			—			4,305
Proceeds from sales of real estate		—			—			—			15,000			—			15,000
Investments in and advances to subsidiaries		(6,699	)		89,642			(53,811	)		(35,716	)		6,584			—
Investments in loans receivable and other investments		—			—			(15,000	)		(8,243	)		—			(23,243	)
Construction in progress and other		—			—			(3,067	)		(4,710	)		—			(7,777	)

Net cash provided by (used in) investing activities		(6,699	)		89,642			(72,299	)		(29,364	)		6,584			(12,136	)

Financing Activities
Revolving credit facilities, net		—			(55,000	)		—			(800	)		—			(55,800	)
Proceeds from term debt, net of discount		—			—			—			—			—			—
Payments of term debt		—			(960	)		—			(272	)		—			(1,232	)
Distributions paid		(61,419	)		(61,649	)		—			—			61,419			(61,649	)
Proceeds from sale of common shares/units, net of offering costs		68,003			68,003			—			—			(68,003	)		68,003
Lease deposits and other obligations to tenants		—			—			2,561			829			—			3,390
Debt issuance costs paid and other financing activities		378			(149	)		—			3			—			232

Net cash provided by (used in) financing activities		6,962			(49,755	)		2,561			(240	)		(6,584	)		(47,056	)

Increase in cash and cash equivalents for period		(5	)		4,333			—			(769	)		—			3,559
Cash and cash equivalents at beginning of period		5			10,481			—			1,262			—			11,748

Cash and cash equivalents at end of period	$	—		$	14,814		$	—		$	493		$	—		$	15,307

- Definition

The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.

+ References + Details

Valuation And Qualifying Accounts

12 Months Ended

Dec. 31, 2011

Valuation And Qualifying Accounts [Abstract]

Valuation And Qualifying Accounts

Medical Properties Trust, Inc. and MPT Operating Partnership, L.P.

Schedule II: Valuation and Qualifying Accounts

December 31, 2011


Year Ended December 31,	Balance at Beginning of Year(1)		Additions Charged Against Operations(1)			Net Recoveries(1)			Balance at End of Year(1)
	(In thousands)
2011	$	23,926	$	8,692	(3)	$	(—	)	$	32,618

2010	$	4,339	$	22,245	(2)	$	2,658		$	23,926

2009	$	397	$	5,107		$	1,165		$	4,339

(1)	Includes allowance for doubtful accounts, straight-line rent reserves, allowance for loan losses, tax valuation allowances and other reserves.

(2)	Includes $12 million loan loss reserve related to our Monroe property and a $6.5 million increase in valuation allowances to fully reserve for the net deferred tax asset of one of our taxable REIT subsidiaries.

(3)	Includes $3.7 million and $2.9 million in rent and interest reserves, respectively, related to our Denham Springs and Monroe properties and $2.1 million to fully reserve for the net deferred tax asset of one of our taxable REIT subsidiaries.

Real Estate And Accumulated Depreciation

12 Months Ended

Dec. 31, 2011

Real Estate And Accumulated Depreciation [Abstract]

Real Estate And Accumulated Depreciation

Medical Properties Trust, Inc. and MPT Operating Partnership, L.P.

SCHEDULE III — REAL ESTATE AND ACCUMULATED DEPRECIATION

December 31, 2011


Location	Type of Property	Initial Costs				Additions Subsequent to Acquisition					Cost at December 31, 2011						Accumu- lated Depreci- ation		Date of Constr- uction		Date Acquired		Life on which depreci- ation in latest income state- ments is computed (Years)
Location	Type of Property	Land		Buildings		Improve- ments		Carrying Costs			Land		Buildings		Total		Accumu- lated Depreci- ation		Date of Constr- uction		Date Acquired
(Amounts in thousands)
Thornton, CO	Long term acute care hospital	$	2,130	$	6,013	$	2,237	$	—		$	2,130	$	8,250	$	10,380	$	1,276		1962		August 17, 2004		40
New Bedford, MA	Long term acute care hospital		1,400		19,772		256		—			1,400		20,028		21,428		3,660		1942		August 17, 2004		40
Covington, LA	Long term acute care hospital		821		10,238		—		14			821		10,252		11,073		1,687		1984		June 9, 2005		13
Denham Springs, LA	Long term acute care hospital		429		5,340		—		(515	)		429		4,825		5,254		1,014		1960		June 9, 2005		40
Redding, CA	Long term acute care hospital		—		19,952		—		4,361			1,629		22,684		24,313		3,487		1991		June 30, 2005		40
Bloomington, IN	Acute care general hospital		2,457		31,209		—		408			2,576		31,498		34,074		4,223		2006		August 8, 2006		40
Dallas, TX	Long term acute care hospital		1,000		13,589		—		368			1,421		13,536		14,957		1,804		2006		September 5, 2006		40
Huntington Beach, CA	Acute care general hospital		937		10,907		—		3			937		10,910		11,847		1,409		1965		November 8, 2006		40
La Palma, CA	Acute care general hospital		937		10,907		—		3			937		10,910		11,847		1,409		1971		November 8, 2006		40
Anaheim, CA	Acute care general hospital		1,875		21,814		—		10			1,875		21,824		23,699		2,819		1964		November 8, 2006		40
Luling, TX	Long term acute care hospital		811		9,345		—		—			811		9,345		10,156		1,188		2002		December 1, 2006		40
San Antonio, TX	Rehabilitation hospital		—		10,198		—		—			—		10,198		10,198		1,296		1987		December 1, 2006		40
Victoria, TX	Long term acute care hospital		625		7,197		—		—			625		7,197		7,822		915		1998		December 1, 2006		40
Houston, TX	Acute care general hospital		4,757		56,238		—		1,259			5,464		56,790		62,254		7,163		2006		December 1, 2006		40
Bensalem, PA	Acute care general hospital		6,911		38,185		—		(353	)		6,911		37,832		44,743		4,647		2006		March 19, 2007		40
Portland, OR	Long term acute care hospital		3,085		17,859		—		2,559			3,071		20,432		23,503		2,329		1964		April 18, 2007		40
San Diego, CA	Acute care general hospital		6,550		15,653		—		77			6,550		15,730		22,280		1,833		1964		May 9, 2007		40
Redding, CA	Acute care general hospital		1,555		53,863		—		13			1,555		53,876		55,431		5,959		1974		August 10, 2007		40
Houston, TX	Acute care general hospital		3,501		34,530		—		(6,308	)		3,274		28,449		31,723		2,996		1960		August 10, 2007		40
Bennettsville, SC	Acute care general hospital		794		15,772		—		—			794		15,772		16,566		1,480		1984		April 1, 2008		40
Bossier City, LA	Long term acute care hospital		900		17,818		—		—			900		17,818		18,718		1,668		1982		April 1, 2008		40
Bristol, CT	Wellness Center		485		2,267		—		—			485		2,267		2,752		635		1975		April 22, 2008		10
Cheraw, SC	Acute care general hospital		657		19,576		—		—			657		19,576		20,233		1,835		1982		April 1, 2008		40
Detroit, MI	Long term acute care hospital		1,220		8,687		—		(365	)		1,220		8,322		9,542		831		1956		May 22, 2008		40
Enfield, CT	Wellness Center		384		2,257		—		—			384		2,257		2,641		632		1974		April 22, 2008		10
Fayetteville, AR	Rehabilitation hospital		909		18,332		—		—			909		18,332		19,241		1,604		1991		July 14, 2008		40
Fort Lauderdale, FL	Rehabilitation hospital		3,499		21,939		—		1			3,499		21,940		25,439		2,015		1985		April 22, 2008		40
Garden Grove, CA	Acute care general hospital		5,502		10,748		—		51			5,502		10,799		16,301		844		1982		November 25, 2008		40
Garden Grove, CA	Medical Office Building		862		7,888		—		28			862		7,916		8,778		611		1982		November 25, 2008		40
Idaho Falls, ID	Acute care general hospital		1,822		37,467		—		4,665			1,822		42,132		43,954		3,798		2002		April 1, 2008		40
Newington, CT	Wellness Center		270		1,615		—		—			270		1,615		1,885		455		1979		April 22, 2008		10
Petersburg, VA	Rehabilitation hospital		1,302		9,121		—		—			1,302		9,121		10,423		798		2006		July 1, 2008		40
West Valley City, UT	Acute care general hospital		5,516		58,314		—		—			5,516		58,314		63,830		5,356		1980		April 22, 2008		40
Poplar Bluff, MO	Acute care general hospital		2,659		38,694		—		—			2,660		38,694		41,354		3,553		1980		April 22, 2008		40
East Providence, RI	Wellness Center		209		1,265		—		—			209		1,265		1,474		356		1979		April 22, 2008		10
San Dimas, CA	Acute care general hospital		6,160		6,839		—		34			6,160		6,873		13,033		530		1972		November 25, 2008		40
San Dimas, CA	Medical Office Building		1,915		5,085		—		18			1,915		5,103		7,018		394		1979		November 25, 2008		40
West Springfield, MA	Wellness Center		583		3,185		—		—			583		3,185		3,768		897		1976		April 22, 2008		10
Tucson, AZ	Long term acute care hospital		920		6,078		—		—			920		6,078		6,998		570		1987		April 1, 2008		40
Warwick, RI	Wellness Center		1,265		759		—		—			1,265		759		2,024		213		1979		April 22, 2008		10
Webster, TX	Long term acute care hospital		988		10,432		—		—			988		10,433		11,421		978		1986		April 1, 2008		40
Wichita, KS	Rehabilitation hospital		1,019		18,373		—		1			1,019		18,374		19,393		1,721		1992		April 4, 2008		40
Addison, TX	Rehabilitation hospital		2,013		22,531		—		—			2,013		22,531		24,544		845		2008		June 17, 2010		40
Shenandoah, TX	Rehabilitation hospital		2,033		21,943		—		—			2,033		21,943		23,976		823		2008		June 17, 2010		40
Richardson, TX	Rehabilitation hospital		2,219		17,419		—		—			2,219		17,419		19,638		653		2008		June 17, 2010		40
Hill County, TX	Acute care general hospital		1,120		17,882		—		—			1,120		17,882		19,002		1,498		1980		September 17, 2010		40
Webster, TX	Long term acute care hospital		663		33,751		—		—			663		33,751		34,414		844		2004		December 21, 2010		40
Tomball, TX	Long term acute care hospital		1,298		23,982		—		—			1,298		23,982		25,280		600		2005		December 21, 2010		40
Gilbert, AZ	General Acute Care		150		15,553		—		—			150		15,553		15,703		389		2005		January 4, 2011		40
Corinth, TX	LTACH		501		21,175		—		—			501		21,175		21,676		485		2008		January 31, 2011		40
Bayonne, NJ	General Acute Care		2,003		51,495		—		—			2,003		51,495		53,498		2,360		1918		February 4, 2011		20
San Diego, CA	General Acute Care		12,663		52,431		—		—			12,663		52,431		65,094		1,202		1973		February 9, 2011		40
Northland, MO	LTACH		834		17,182		—		—			834		17,182		18,016		394		2007		February 14, 2011		40
DeSoto, TX	LTACH		1,067		10,701		—		—			1,067		10,700		11,767		111		2008		July 18, 2011		40
New Braunfels, TX	LTACH		1,100		7,883		—		—			1,100		7,882		8,982		49		2007		September 30, 2011		40
Hoboken, NJ	General Acute Care		1,387		44,351		—		—			1,388		44,350		45,738		289		1863		November 4, 2011		20

		$	108,672	$	1,073,599	$	2,493	$	6,332		$	111,309	$	1,079,787	$	1,191,096	$	93,430

The changes in total real estate assets including real estate held for sale but excluding construction in progress, intangible lease asset and mortgage loans, for the years ended:


	December 31, 2011			December 31, 2010			December 31, 2009
COST
Balance at beginning of period	$	990,635		$	934,601		$	943,700
Acquisitions		240,474			146,854			421
Additions		1,011			1,709			5,550
Dispositions		(40,460	)		(92,529	)		(15,070	)
Other		(564	)		—			—

Balance at end of period	$	1,191,096		$	990,635	(1)	$	934,601	(1)

The changes in accumulated depreciation; including real estate assets held for sale for the years ended:


	December 31, 2011			December 31, 2010			December 31, 2009
ACCUMULATED DEPRECIATION
Balance at beginning of period	$	68,662		$	51,638		$	30,581
Depreciation		29,523			22,664			21,389
Depreciation on disposed property		(4,755	)		(5,640	)		(332	)

Balance at end of period	$	93,430		$	68,662	(2)	$	51,638	(2)

(1)	Includes real-estate cost included in real estate held for sale of $40,460 and $113,151 for 2010 and 2009, respectively. Excludes intangible lease assets that are included in real estate held for sale of $1,361 and $25,848 for 2010 and 2009, respectively.

(2)	Includes accumulated depreciation in real estate held for sale of $3,716 and $6,350 for 2010 and 2009, respectively. Excludes accumulated amortization related to intangible lease assets that are included in real estate held for sale of $591 and $3,978 for 2010 and 2009, respectively.

- Definition

The entire disclosure for real estate and accumulated depreciation. This may include a schedule that describes the property and lists the initial cost of land, buildings and improvements, improvements and carrying costs capitalized after acquisition, and the total carrying cost for land, buildings and improvements for each property and in aggregate. The schedule also lists the accumulated depreciation for each property and in aggregate, the date each property was constructed and acquired, the useful life used to calculate depreciation and any encumbrances on the properties. The entity provides a reconciliation of the carrying amount of real estate from the beginning of the period to the end of the period. Any real estate investments that have been written down or reserved against are described, including the basis of the write-down. A material amount of intercompany profit in the total carrying amount of real estate is disclosed. The aggregate cost of all real estate investments for federal income tax purposes is also disclosed.

+ References + Details

Mortgage Loan On Real Estate

12 Months Ended

Dec. 31, 2011

Mortgage Loan On Real Estate [Abstract]

Mortgage Loan On Real Estate

SCHEDULE IV — MORTGAGE LOANS ON REAL ESTATE

MEDICAL PROPERTIES TRUST, INC. AND MPT OPERATING PARTNERSHIP, L.P.


Column A	Column B			Column C		Column D	Column E			Column F		Column G(3)		Column H
Description	Interest Rate			Final Maturity Date		Periodic Payment Terms	Prior Liens			Face Amount of Mortgages		Carrying Amount of Mortgages		Principal Amount of Loans Subject to Delinquent Principal or Interest
	(Dollar amounts in thousands)
Long-term first mortgage loan:						Payable in monthly installments of interest plus principal payable in full at maturity
Desert Valley Hospital		10.1	%		2022			(1	)	$	70,000	$	70,000		(2	)
Desert Valley Hospital		10.8	%		2022			(1	)		20,000		20,000		(2	)
Chino Valley Medical Center		10.1	%		2022			(1	)		50,000		50,000		(2	)
Paradise Valley Hospital		9.8	%		2022			(1	)		25,000		25,000		(2	)

										$	165,000	$	165,000

(1)	There were no prior liens on loans as of December 31, 2011.

(2)	The mortgage loan was not delinquent with respect to principal or interest.

(3)	The aggregate cost for Federal income tax purposes is $165,000.

Changes in mortgage loans for the years ended December 31, 2011, 2010, and 2009 are summarized as follows:


	Year Ended December 31,
	2011		2010			2009
	(Dollar amounts in thousands)
Balance at beginning of year	$	165,000	$	200,164		$	185,000
Additions during year:
New mortgage loans and additional advances on existing loans		—		7,836			15,164

		165,000		208,000			200,164

Deductions during year:
Collection of principal		—		(43,000	)		—

		—		(43,000	)		—

Balance at end of year	$	165,000	$	165,000		$	200,164

Summary Of Significant Accounting Policies (Policy) - Medical Properties Trust, Inc. [Member]

12 Months Ended

Dec. 31, 2011

Use Of Estimates

Principles Of Consolidation


VIE Type	Maximum Loss Exposure(1)	Asset Type Classification	Carrying Amount(2)
Loans, net	$63,285	Other loans	$	39,552
Equity investments	$12,888	Other assets	$	2,751

(1)

(2)	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.

Investments In Unconsolidated Entities

Cash And Cash Equivalents

Revenue Recognition

Acquired Real Estate Purchase Price Allocation

Real Estate And Depreciation

Depreciation is calculated on the straight-line method over the weighted average useful lives of the related real estate and other assets, as follows:


Buildings and improvements			37.4 years
Tenant lease intangibles			14.1 years
Tenant improvements			5.4 years
Furniture, equipment and other			9.3 years

Losses From Rent Receivables

Loans

Earnings Per Share

Income Taxes

Given our income tax expense is typically not significant, we record such expense along with related penalties and interest, if any, in general administrative expenses.

Stock-Based Compensation

Deferred Costs

Derivative Financial Investments And Hedging Activities

Exchangeable Senior Notes

Fair Value Measurement

Fair Value Measurement

•

Level 1 — quoted prices for identical instruments in active markets;

•

Level 3 — fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Reclassifications

Summary Of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2011

Summary Of Significant Accounting Policies [Abstract]

Schedule Of Carrying Value Of Variable Interest Entities


VIE Type	Maximum Loss Exposure(1)	Asset Type Classification	Carrying Amount(2)
Loans, net	$63,285	Other loans	$	39,552
Equity investments	$12,888	Other assets	$	2,751

(1)

(2)	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

Useful Lives Of Related Real Estate And Other Assets


Buildings and improvements			37.4 years
Tenant lease intangibles			14.1 years
Tenant improvements			5.4 years
Furniture, equipment and other			9.3 years

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 4
-Subparagraph g
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 2, 14, 15, 16, 23, 24, 25, 26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 140
-Paragraph 35
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6970148&loc=d3e5728-111685

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6970148&loc=d3e5710-111685

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6970148&loc=d3e5747-111685

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Variable Interest Entity
-URI http://asc.fasb.org/extlink&oid=6528138

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS140-4/FIN46(R)-8
-Paragraph C4
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Appendix D
-Paragraph 22B

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Appendix D
-Paragraph 22E

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Appendix D
-Paragraph 23A

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 167
-Appendix D
-Paragraph 24

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 5A
-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6759159-111685

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6228884-111685

+ Details

Real Estate And Loans Receivable (Tables)

12 Months Ended

Dec. 31, 2011

Real Estate And Lending Activities [Line Items]

List Of Assets Purchased As Part Of Acquisitions


	2011		2010		2009
	(Amounts in thousands)
Land	$	19,705	$	8,227	$	421
Buildings		220,769		119,626		—
Intangible lease assets-subject to amortization (weighted-average useful life 13.9 years in 2011 and 19.4 years in 2010)		20,630		9,955		—

	$	261,104	$	137,808	$	421

Pro Forma Consolidated Financial Data


	2011		2010
	(Amounts in thousands except per share/unit amounts)
Total revenues	$	153,707	$	153,214
Net income		27,311		27,746
Net income per share/unit	$	0.24	$	0.26

Summary Of Amortization Expense From Lease Intangible Assets


For the Year Ended December 31:
2012	$	3,865
2013		3,832
2014		3,767
2015		3,578
2016		3,536

Summary Of Minimum Payments Due Under Operating Leases


2012	$	2,233
2013		2,104
2014		1,609
2015		1,610
2016		1,610
Thereafter		36,378

	$	45,544

Summary Of Loans


	As of December 31, 2011						As of December 31, 2010
	Balance			Weighted Average Interest Rate			Balance			Weighted Average Interest Rate
Mortgage loans		$	165,000		10.2	%		$	165,000		10.0	%
Other loans			74,839		10.5	%			50,985		10.8	%

		$	239,839					$	215,985

Minimum Rental Payments [Member]

Real Estate And Lending Activities [Line Items]

Summary Of Minimum Payments Due Under Operating Leases


2012	$	119,454
2013		120,275
2014		118,661
2015		115,880
2016		116,154
Thereafter		811,272

	$	1,401,696

- Definition

Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.

+ References + Details

- Definition

The entire disclosure for claims held for amounts due a company. Examples include trade accounts receivables, notes receivables, loans receivables.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 3, 4
-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 7
-Article 9

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 01-6
-Paragraph 13
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 4
-Section 08
-Paragraph k

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.3,4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6965416&loc=d3e5074-111524

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6965416&loc=d3e5066-111524

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6965416&loc=d3e5162-111524

+ Details

- Definition

Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 52
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Appendix F
-Paragraph F4
-Subparagraph e

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6972119&loc=d3e1392-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6972119&loc=d3e1486-128463

+ Details

Debt (Tables)

12 Months Ended

Dec. 31, 2011

Dec. 31, 2010

Debt [Abstract]

Summary Of Debt


	As of December 31, 2011				As of December 31, 2010
	Balance			Interest Rate	Balance			Interest Rate
Revolving credit facilities	$	89,600		Variable	$	—		Variable
2006 senior unsecured notes		125,000		Various		125,000		7.333%-7.871%
2011 senior unsecured notes		450,000		6.875%		—
Exchangeable senior notes
Principal amount		11,000		9.250%		91,175		6.125%-9.250%
Unamortized discount		(180	)			(2,585	)

		10,820				88,590
Term loans
Principal Amount		14,429		6.200%		157,683		Various
Unamortized discount		—				(1,303	)

		14,429				156,380

	$	689,849			$	369,970

Principal Payments Due For Debt


2012	$	39,832
2013		11,249
2014		265
2015		50,283
2016		125,299
Thereafter		463,101

Total	$	690,029

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2011

Income Taxes [Abstract]

Schedule Of Per Share Distributions To Stockholders


	For the Years Ended December 31,
	2011		2010		2009
Common share distribution	$	0.800000	$	0.800000	$	0.800000
Ordinary income		0.300844		0.388128		0.471792
Capital gains(1)		0.031396		0.027724		0.003708
Unrecaptured Sec. 1250 gain		0.031396		0.022784		0.003708
Return of capital		0.467760		0.384148		0.324500
Allocable to next year		—		—		—

(1)	Capital gains include unrecaptured Sec. 1250 gains.

Earnings Per Share/Unit (Tables)

12 Months Ended

Dec. 31, 2011

Medical Properties Trust, Inc. [Member]

Calculation Of Earnings Per Share/Unit


	For the Years Ended December 31,
	2011			2010			2009
Numerator:
Income from continuing operations	$	19,431		$	10,248		$	29,945
Non-controlling interests' share in continuing operations		(178	)		(99	)		(36	)
Participating securities' share in earnings		(1,090	)		(1,254	)		(1,506	)

Income from continuing operations, less participating securities' share in earnings		18,163			8,895			28,403
Income from discontinued operations		7,283			12,764			6,422
Non-controlling interests' share in discontinued operations		—			—			(1	)

Income from discontinued operations attributable to MPT common stockholders		7,283			12,764			6,421

Net income, less participating securities' share in earnings	$	25,446		$	21,659		$	34,824

Denominator:
Basic weighted-average common shares		110,623			100,706			78,117
Dilutive stock options		6			2			—

Diluted weighted-average common shares		110,629			100,708			78,117

MPT Operating Partnership, L.P. [Member]

Calculation Of Earnings Per Share/Unit


	For the Years Ended December 31,
	2011			2010			2009
Numerator:
Income from continuing operations	$	19,448		$	10,323		$	30,008
Non-controlling interests' share in continuing operations		(178	)		(99	)		(36	)
Participating securities' share in earnings		(1,090	)		(1,254	)		(1,506	)

Income from continuing operations, less participating securities' share in earnings		18,180			8,970			28,466
Income from discontinued operations		7,283			12,764			6,422
Non-controlling interests' share in discontinued operations		—			—			(1	)

Income from discontinued operations attributable to MPT Operating Partnership partners		7,283			12,764			6,421

Net income, less participating securities' share in earnings	$	25,463		$	21,734		$	34,887

Denominator:
Basic weighted-average units		110,623			100,706			78,117
Dilutive options		6			2			—

Diluted weighted-average units		110,629			100,708			78,117

Stock Awards (Tables)

12 Months Ended

Dec. 31, 2011

Stock Awards [Abstract]

Restricted Equity Awards Activity


	Vesting Based on Service					Vesting Based on Market/Performance Conditions
	Shares			Weighted Average Value at Award Date		Shares			Weighted Average Value at Award Date
Nonvested awards at beginning of the year		783,305		$	10.43		828,409		$	8.70
Awarded		292,803		$	10.76		853,656		$	5.72
Vested		(453,980	)	$	9.89		(163,575	)	$	6.87
Forfeited		(18,148	)	$	9.70		(7,093	)	$	9.32

Nonvested awards at end of year		603,980		$	11.02		1,511,397		$	7.21

For the Year Ended December 31, 2010:


	Vesting Based on Service					Vesting Based on Market/Performance Conditions
	Shares			Weighted Average Value at Award Date		Shares			Weighted Average Value at Award Date
Nonvested awards at beginning of the year		962,350		$	10.22		1,301,088		$	6.90
Awarded		277,680		$	10.39		182,600		$	9.25
Vested		(454,323	)	$	9.97		(175,279	)	$	10.64
Forfeited		(2,402	)	$	8.66		(480,000	)	$	3.31

Nonvested awards at end of year		783,305		$	10.43		828,409		$	8.70

Commitments And Contingencies (Tables)

12 Months Ended

Dec. 31, 2011

Commitments And Contingencies [Abstract]

Summary Of Minimum Payments Due Under Operating Leases


2012	$	2,233
2013		2,104
2014		1,609
2015		1,610
2016		1,610
Thereafter		36,378

	$	45,544

Fair Value Of Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2011

Fair Value Of Financial Instruments [Abstract]

Summary Of Fair Value Information Of Financial Instruments


	December 31, 2011						December 31, 2010
Asset (Liability)	Book Value			Fair Value			Book Value			Fair Value
Interest and rent receivables	$	29,862		$	22,866		$	26,176		$	20,265
Loans		239,839			243,272			215,985			209,126
Debt, net		(689,849	)		(688,032	)		(369,970	)		(359,910	)

- Definition

Tabular disclosure of the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments, assets, and liabilities. Such certain disclosures about the financial instruments, assets, and liabilities include: (1) the fair value of the required items together with their carrying amounts (as appropriate) and (2) the methodology and assumptions used in developing such estimates of fair value.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 14
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15
-Subparagraph b-d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 32
-Subparagraph a, c(1), c(2), c(3), d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 18
-Subparagraph c(2), d, e, f
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 19
-Subparagraph a, b, c(1), d(1)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13433-108611

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13467-108611

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13476-108611

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19207-110258

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6447952&loc=d3e13220-108610

+ Details

Discontinued Operations (Tables)

12 Months Ended

Dec. 31, 2011

Discontinued Operations [Abstract]

Schedule Of Discontinued Operations


	For the Years Ended December 31,
	2011		2010		2009
Revenues	$	3,534	$	8,488	$	16,197
Gain on sale		5,431		10,566		278
Income from discontinued operations		7,283		12,764		6,422
Income from discontinued operations — diluted per share/unit	$	0.07	$	0.13	$	0.08

- Definition

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

+ References + Details

Quarterly Financial Data (Tables)

12 Months Ended

Dec. 31, 2011

Medical Properties Trust, Inc. [Member]

Summary Of The Unaudited Quarterly Financial Information


	For the Three Month Periods in 2011 Ended
	March 31			June 30			September 30			December 31
Revenues	$	34,347		$	35,396		$	36,774		$	36,802
Income (loss) from continuing operations		9,652			1,934			(237	)		8,082
Income from discontinued operations		1,172			748			705			4,658
Net income		10,824			2,682			468			12,740
Net income attributable to MPT common stockholders		10,780			2,640			424			12,692
Net income attributable to MPT common stockholders per share — basic	$	0.09		$	0.02		$	—		$	0.11
Weighted average shares outstanding — basic		110,400			110,589			110,714			110,788
Net income (loss) attributable to MPT common stockholders per share — diluted	$	0.09		$	0.02		$	—		$	0.11
Weighted average shares outstanding — diluted		110,408			110,600			110,719			110,788

	For the Three Month Periods in 2010 Ended
	March 31			June 30			September 30			December 31
Revenues	$	29,365		$	29,534		$	27,621		$	30,677
Income (loss) from continuing operations		(4,249	)		(1,037	)		7,967			7,567
Income from discontinued operations		1,436			7,269			997			3,062
Net income		(2,813	)		6,232			8,964			10,629
Net income attributable to MPT common stockholders		(2,822	)		6,223			8,919			10,593
Net income attributable to MPT common stockholders per share — basic	$	(0.04	)	$	0.06		$	0.08		$	0.09
Weighted average shares outstanding — basic		79,176			103,498			110,046			110,103
Net income attributable to MPT common stockholders per share — diluted	$	(0.04	)	$	0.06		$	0.08		$	0.09
Weighted average shares outstanding — diluted		79,178			103,498			110,046			110,108

MPT Operating Partnership, L.P. [Member]

Summary Of The Unaudited Quarterly Financial Information


	For the Three Month Periods in 2011 Ended
	March 31			June 30			September 30			December 31
Revenues	$	34,347		$	35,396		$	36,774		$	36,802
Income (loss) from continuing operations		9,669			1,961			(219	)		8,037
Income from discontinued operations		1,172			748			705			4,658
Net income		10,841			2,709			486			12,695
Net income attributable to MPT Operating Partnership partners		10,796			2,667			443			12,647
Net income attributable to MPT Operating Partnership partners per unit — basic	$	0.09		$	0.02		$	—		$	0.11
Weighted average units outstanding — basic		110,400			110,589			110,714			110,788
Net income attributable to MPT Operating Partnership partners per unit — diluted	$	0.09		$	0.02		$	—		$	0.11
Weighted average units outstanding — diluted		110,408			110,600			110,719			110,788

	For the Three Month Periods in 2010 Ended
	March 31			June 30			September 30			December 31
Revenues	$	29,365		$	29,534		$	27,621		$	30,677
Income (loss) from continuing operations		(4,235	)		(968	)		7,958			7,568
Income from discontinued operations		1,436			7,269			997			3,062
Net income (loss)		(2,799	)		6,301			8,955			10,630
Net income (loss) attributable to MPT Operating Partnership partners		(2,807	)		6,292			8,910			10,593
Net income (loss) attributable to MPT Operating Partnership partners per unit — basic	$	(0.04	)	$	0.06		$	0.08		$	0.09
Weighted average units outstanding — basic		79,176			103,498			110,046			110,103
Net income (loss) attributable to MPT Operating Partnership partners per unit —diluted	$	(0.04	)	$	0.06		$	0.08		$	0.09
Weighted average units outstanding — diluted		79,178			103,498			110,046			110,108

Condensed Consolidating Financial Information (Tables)

12 Months Ended

Dec. 31, 2011

Condensed Consolidating Financial Information [Abstract]

Condensed Consolidated Balance Sheet

Condensed Consolidated Balance Sheets

December 31, 2011

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	37	$	1,173,909		$	101,453		$	—		$	1,275,399
Mortgage loans		—		—		165,000			—			—			165,000

Gross investment in real estate assets		—		37		1,338,909			101,453			—			1,440,399
Accumulated depreciation and amortization		—		—		(94,068	)		(9,669	)		—			(103,737	)

Net investment in real estate assets		—		37		1,244,841			91,784			—			1,336,662
Cash & cash equivalents		—		101,230		—			1,496			—			102,726
Interest and rent receivables		—		399		22,525			6,938			—			29,862
Straight-line rent receivables		—		—		28,317			5,676			—			33,993
Other loans		—		177		—			74,662			—			74,839
Net intercompany receivable (payable)		21,955		872,463		(891,920	)		(2,415	)		(83	)		—
Investment in subsidiaries		829,218		489,761		—			—			(1,318,979	)		—
Other assets		—		27,284		1,727			14,781			—			43,792

Total Assets	$	851,173	$	1,491,351	$	405,490		$	192,922		$	(1,319,062	)	$	1,621,874

Liabilities and Equity
Liabilities
Debt, net	$	—	$	635,820	$	—		$	54,029		$	—		$	689,849
Accounts payable and accrued expenses		22,359		25,769		2,576			421			—			51,125
Deferred revenue		—		559		17,531			5,217			—			23,307
Lease deposits and other obligations to tenants		—		—		28,274			504			—			28,778

Total liabilities		22,359		662,148		48,381			60,171			—			793,059
Total Medical Properties Trust Inc. stockholder's equity		828,815		829,205		357,109			132,749			(1,319,062	)		828,815

Non-controlling interests		—		—		—			—			—			—

Total equity		828,815		829,205		357,109			132,749			(1,319,062	)		828,815

Total Liabilities and Equity	$	851,174	$	1,491,353	$	405,490		$	192,920		$	(1,319,062	)	$	1,621,874

Condensed Consolidated Balance Sheets

December 31, 2010

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	297	$	908,066		$	82,185		$	—		$	990,548
Real estate held for sale		—		—		—			37,514			—			37,514
Mortgage loans		—		—		165,000			—			—			165,000

Gross investment in real estate assets		—		297		1,073,066			119,699			—			1,193,062
Accumulated depreciation and amortization		—		—		(64,553	)		(7,234	)		—			(71,787	)

Net investment in real estate assets		—		297		1,008,513			112,465			—			1,121,275
Cash & cash equivalents		—		96,822		—			1,586			—			98,408
Interest and rent receivables		—		157		20,692			5,327			—			26,176
Straight-line rent receivables		—		—		23,174			5,738			—			28,912
Other loans		—		178		—			50,807			—			50,985
Net intercompany receivable (payable)		21,944		774,771		(751,068	)		(45,647	)		—			—
Investment in subsidiaries		899,949		390,232		—			—			(1,290,181	)		—
Other assets		—		10,289		1,182			11,587			—			23,058

Total Assets	$	921,893	$	1,272,746	$	302,493		$	141,863		$	(1,290,181	)	$	1,348,814

Liabilities and Equity
Liabilities
Debt, net	$	—	$	361,537	$	—		$	8,433		$	—		$	369,970
Accounts payable and accrued expenses		22,317		10,824		2,378			455			—			35,974
Deferred revenue		—		436		17,662			5,039			—			23,137
Lease deposits and other obligations to tenants		—		—		17,326			2,831			—			20,157

Total liabilities		22,317		372,797		37,366			16,758			—			449,238
Total Medical Properties Trust Inc. stockholder's equity		899,462		899,835		265,127			125,105			(1,290,067	)		899,462

Non-controlling interests		114		114		—			—			(114	)		114

Total equity		899,576		899,949		265,127			125,105			(1,290,181	)		899,576

Total Liabilities and Equity	$	921,893	$	1,272,746	$	302,493		$	141,863		$	(1,290,181	)	$	1,348,814

Condensed Consolidated Statements Of Income

Condensed Consolidated Statements of Income

For the Year Ended December 31, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	105,345	$	13,782		$	(3,092	)	$	116,035
Straight-line rent		—			—			4,734		1,060			—			5,794
Interest and fee income		—			6,123			17,004		4,598			(6,235	)		21,490

Total revenues		—			6,123			127,083		19,440			(9,327	)		143,319
Expenses
Real estate depreciation and amortization		—			—			30,465		2,436			—			32,901
Impairment charge		—			—			564		—			—			564
Property-related		—			217			1,848		3,117			(3,092	)		1,090
General and administrative		17			27,626			—		3,760			—			31,403

Total operating expenses		17			27,843			31,877		9,313			(3,092	)		65,958

Operating income		(17	)		(21,720	)		95,206		10,127			(6,235	)		77,361
Other income (expense)
Interest income and other		—			26			335		(265	)		—			96
Debt refinancing costs		—			(14,109	)		—		(105	)		—			(14,214	)
Interest expense		—			(43,031	)		849		(7,865	)		6,235			(43,812	)

Net other expense		—			(57,114	)		1,184		(8,235	)		6,235			(57,930	)

Income (loss) from continuing operations		(17	)		(78,834	)		96,390		1,892			—			19,431
Income (loss) from discontinued operations		—			—			98		7,185			—			7,283

Equity in earnings of consolidated subsidiaries net of income taxes		31,223			105,566			4,578		—			(141,367	)		—

Net income		31,206			26,732			101,066		9,077			(141,367	)		26,714
Net income attributable to non-controlling interests		(178	)		(178	)		—		—			178			(178	)

Net income attributable to MPT common stockholders	$	31,028		$	26,554		$	101,066	$	9,077		$	(141,189	)	$	26,536

Condensed Consolidated Statements of Income

For the Year Ended December 31, 2010

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	78,055		$	11,462		$	(1,030	)	$	88,487
Straight-line rent		—			—			1,256			677			—			1,933
Interest and fee income		—			6,964			16,758			10,569			(7,514	)		26,777

Total revenues		—			6,964			96,069			22,708			(8,544	)		117,197
Expenses
Real estate depreciation and amortization		—			—			20,434			2,396			—			22,830
Impairment charge		—			—			—			12,000			—			12,000
Property-related		—			(4	)		4,375			1,057			(1,030	)		4,398
General and administrative		75			27,867			—			593			—			28,535

Total operating expenses		75			27,863			24,809			16,046			(1,030	)		67,763

Operating income		(75	)		(20,899	)		71,260			6,662			(7,514	)		49,434
Other income (expense)
Interest income and other		—			(14	)		(10	)		1,542			—			1,518
Debt refinancing costs		—			(6,716	)		—			—			—			(6,716	)
Interest expense		—			(33,623	)		31			(7,910	)		7,514			(33,988	)

Net other expense		—			(40,353	)		21			(6,368	)		7,514			(39,186	)

Income (loss) from continuing operations		(75	)		(61,252	)		71,281			294			—			10,248
Income (loss) from discontinued operations		—			—			121			12,643			—			12,764

Equity in earnings of consolidated subsidiaries net of income taxes		23,087			84,339			4,273			—			(111,699	)		—

Net income		23,012			23,087			75,675			12,937			(111,699	)		23,012
Net income attributable to non-controlling interests		(99	)		(99	)		—			—			99			(99	)

Net income attributable to MPT common stockholders	$	22,913		$	22,988		$	75,675		$	12,937		$	(111,600	)	$	22,913

Condensed Consolidated Statements of Income

For the Year Ended December 31, 2009

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	67,159		$	10,712		$	—		$	77,871
Straight-line rent		—			—			7,113			925			—			8,038
Interest and fee income		—			10,010			14,389			14,149			(10,419	)		28,129

Total revenues		—			10,010			88,662			25,785			(10,419	)		114,038
Expenses
Real estate depreciation and amortization		—			—			19,019			2,569			—			21,588
Impairment charge		—			—			—			—			—			—
Property-related		—			(20	)		3,783			38			—			3,801
General and administrative		63			20,631			—			402			—			21,096

Total operating expenses		63			20,611			22,802			3,009			—			46,485

Operating income		(63	)		(10,601	)		65,860			22,776			(10,419	)		67,553
Other income (expense)
Interest income and other		—			51			(10	)		2			—			43
Debt refinancing costs		—			—			—			—			—			—
Interest expense		—			(36,760	)		—			(11,310	)		10,419			(37,651	)

Net other income (expense)		—			(36,709	)		(10	)		(11,308	)		10,419			(37,608	)

Income (loss) from continuing operations		(63	)		(47,310	)		65,850			11,468			—			29,945
Income (loss) from discontinued operations		—			—			(1,254	)		7,676			—			6,422

Equity in earnings of consolidated subsidiaries net of income taxes		36,430			83,741			3,918			—			(124,089	)		—

Net income		36,367			36,430			68,514			19,144			(124,089	)		36,367
Net income attributable to non-controlling interests		(37	)		(37	)		—			—			37			(37	)

Net income attributable to MPT common stockholders	$	36,330		$	36,394		$	68,514		$	19,144		$	(124,052	)	$	36,330

Condensed Consolidated Statements Of Cash Flows

Condensed Consolidated Statements of Cash Flows

For the Year Ended December 31, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(209	)	$	(48,779	)	$	113,907		$	14,351		$	—		$	79,270
Investing Activities
Real estate acquired		—			—			(241,626	)		—			—			(246,511	)
Principal received on loans receivable		—			—			230			4,059			—			4,289
Proceeds from sales of real estate		—			—			—			41,130			—			41,130
Investments in and advances to subsidiaries		89,551			(92,052	)		140,852			(49,009	)		(89,342	)		—
Investments in loans receivable and other investments		—			—			(230	)		(27,914	)		—			(28,144	)
Construction in progress and other		—			(6,466	)		(24,081	)		(5,838	)		—			(36,385	)

Net cash provided by (used in) investing activities		89,551			(98,518	)		(124,855	)		(42,457	)		(89,342	)		(265,621	)

Financing Activities
Revolving credit facilities, net		—			50,000			—			39,600			—			89,600
Proceeds from term debt, net of discount		—			450,000			—			—			—			450,000
Payments of term debt		—			(237,666	)		—			(8,596	)		—			(246,262	)
Distributions paid		(89,342	)		(89,601	)		—			—			89,342			(89,601	)
Proceeds from sale of common shares/units, net of offering costs		—			—			—			—			—			—
Lease deposits and other obligations to tenants		—			—			10,948			(2,327	)		—			8,621
Debt issuance costs paid and other financing activities		—			(21,028	)		—			(661	)		—			(21,689	)

Net cash provided by (used in) financing activities		(89,342	)		151,705			10,948			(28,016	)		89,342			190,669

Increase (decrease) in cash and cash equivalents for period		—			4,408			—			(90	)		—			4,318
Cash and cash equivalents at beginning of period		—			96,822			—			1,586			—			98,408

Cash and cash equivalents at end of period	$	—		$	101,230		$	—		$	1,496		$	—		$	102,726

Condensed Consolidated Statements of Cash Flows

For the Year Ended December 31, 2010

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(29	)	$	(54,909	)	$	95,203		$	20,372		$	—		$	60,637
Investing Activities
Real estate acquired		—			—			(137,808	)		—			—			(137,808	)
Principal received on loans receivable		—			—			—			90,486			—			90,486
Proceeds from sales of real estate		—			—			2,669			95,000			—			97,669
Investments in and advances to subsidiaries		(211,181	)		99,564			48,986			(148,579	)		211,210			—
Investments in loans receivable and other investments		—			—			(5,000	)		(6,637	)		—			(11,637	)
Construction in progress and other		—			(108	)		(8,267	)		(7,554	)		—			(15,929	)

Net cash provided by (used in) investing activities		(211,181	)		99,456			(99,420	)		22,716			211,210			22,781

Financing Activities
Revolving credit facilities, net		—			(96,000	)		—			(41,200	)		—			(137,200	)
Proceeds from term debt, net of discount		—			148,500			—			—			—			148,500
Payments of term debt		—			(216,520	)		—			(245	)		—			(216,765	)
Distributions paid		(76,856	)		(77,087	)		—			—			76,856			(77,087	)
Proceeds from sale of common shares/units, net of offering costs		288,066			288,066			—			—			(288,066	)		288,066
Lease deposits and other obligations to tenants		—			—			4,217			(550	)		—			3,667
Debt issuance costs paid and other financing activities		—			(9,498	)		—			—			—			(9,498	)

Net cash provided by (used in) financing activities		211,210			37,461			4,217			(41,995	)		(211,210	)		(317	)

Increase in cash and cash equivalents for period		—			82,008			—			1,093			—			83,101
Cash and cash equivalents at beginning of period		—			14,814			—			493			—			15,307

Cash and cash equivalents at end of period	$	—		$	96,822		$	—		$	1,586		$	—		$	98,408

Condensed Consolidated Statements of Cash Flows

For the Year Ended December 31, 2009

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(268	)	$	(35,554	)	$	76,583		$	21,990		$	—		$	62,751

Investing Activities
Real estate acquired		—			—			(421	)		—			—			(421	)
Principal received on loans receivable		—			—			—			4,305			—			4,305
Proceeds from sales of real estate		—			—			—			15,000			—			15,000
Investments in and advances to subsidiaries		(6,699	)		89,642			(60,656	)		(28,871	)		6,584			—
Investments in loans receivable and other investments		—			—			(15,000	)		(8,243	)		—			(23,243	)
Construction in progress and other		—			—			(3,067	)		(4,710	)		—			(7,777	)

Net cash provided by (used in) investing activities		(6,699	)		89,642			(79,144	)		(22,519	)		6,584			(12,136	)

Financing Activities
Revolving credit facilities, net		—			(55,000	)		—			(800	)		—			(55,800	)
Proceeds from term debt, net of discount		—			—			—			—			—			—
Payments of term debt		—			(960	)		—			(272	)					(1,232	)
Distributions paid		(61,419	)		(61,649	)		—			—			61,419			(61,649	)
Proceeds from sale of common shares/units, net of offering costs		68,003			68,003			—			—			(68,003	)		68,003
Lease deposits and other obligations to tenants		—			—			2,561			829			—			3,390
Debt issuance costs paid and other financing activities		378			(149	)		—			3			—			232

Net cash provided by (used in) financing activities		6,962			(49,755	)		2,561			(240	)		(6,584	)		(47,056	)

Increase in cash and cash equivalents for period		(5	)		4,333			—			(769	)		—			3,559
Cash and cash equivalents at beginning of period		5			10,481			—			1,262			—			11,748

Cash and cash equivalents at end of period	$	—		$	14,814		$	—		$	493		$	—		$	15,307

Summary Of Significant Accounting Policies (Narrative) (Details)	12 Months Ended
	Dec. 31, 2011 months years	Jan. 31, 2011
Summary Of Significant Accounting Policies [Line Items]
Equity method investment, ownership percentage	100.00%	51.00%
Expected lease-up periods for estimating lost rentals, in months \| months	6
Percentage of ordinary taxable income to be distributed for real estate investment trust qualification	90.00%
Number of years of federal income tax at corporate rates on failure to qualify as REIT \| years	4
Stock award vesting period in years, minimum	three
Stock award vesting period in years, maximum	seven
Time-Based Awards [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock award vesting period in years, minimum	three
Stock award vesting period in years, maximum	seven
Market Conditions Based Awards [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock award vesting period in years, minimum	three
Stock award vesting period in years, maximum	seven

Summary Of Significant Accounting Policies (Schedule Of Carrying Value Of Variable Interest Entities) (Details)
$ in Thousands

Dec. 31, 2011

USD ($)

Loans, Net [Member]

Variable Interest Entity [Line Items]

Maximum Loss Exposure

$ 63,285

^[1]

Equity Investments [Member]

Variable Interest Entity [Line Items]

Maximum Loss Exposure

12,888

^[1]

Other Loans [Member]

Variable Interest Entity [Line Items]

Carrying Amount

39,552

^[2]

Other Assets [Member]

Variable Interest Entity [Line Items]

Carrying Amount

$ 2,751

^[2]

[1]

[2]

Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

Summary Of Significant Accounting Policies (Useful Lives Of Related Real Estate And Other Assets) (Details) - Medical Properties Trust, Inc. [Member]	12 Months Ended
	Dec. 31, 2011 years
Building And Improvements [Member]
Summary Of Significant Accounting Policies [Line Items]
Weighted average useful lives of related real estate and other assets, years	37.4
Tenant Lease Intangibles [Member]
Summary Of Significant Accounting Policies [Line Items]
Weighted average useful lives of related real estate and other assets, years	14.1
Tenant Improvements [Member]
Summary Of Significant Accounting Policies [Line Items]
Weighted average useful lives of related real estate and other assets, years	5.4
Furniture, Equipment And Other [Member]
Summary Of Significant Accounting Policies [Line Items]
Weighted average useful lives of related real estate and other assets, years	9.3

Real Estate And Loans Receivable (Acquisitions) (Details) $ in Thousands									1 Months Ended		3 Months Ended		9 Months Ended	12 Months Ended
	Dec. 31, 2011 USD ($)	Nov. 04, 2011 USD ($) years	Oct. 14, 2011 USD ($) years	Sep. 30, 2011 USD ($) years	Jun. 17, 2011 years	Feb. 14, 2011 years	Jan. 04, 2011 USD ($) years	Jan. 04, 2011 USD ($) years	Feb. 14, 2011 years	Jan. 31, 2011 USD ($) years	Dec. 31, 2011 USD ($)	Dec. 31, 2010 USD ($) years	Dec. 31, 2010 USD ($) years	Dec. 31, 2011 USD ($)	Dec. 31, 2011 USD ($)	Dec. 31, 2010 USD ($) years	Jul. 18, 2011 USD ($) years	Feb. 09, 2011 USD ($) years	Feb. 04, 2011 USD ($) years	Jun. 17, 2010 USD ($)	Dec. 31, 2009 USD ($)	Dec. 31, 2008 USD ($)	Dec. 31, 2004 USD ($)
Real Estate And Lending Activities [Line Items]
Purchase price of real estate	$ 261,104										$ 261,104	$ 137,808	$ 137,808	$ 261,104	$ 261,104	$ 137,808					$ 421
Lease expiration date						2028
Equity method investment, ownership percentage	100.00%									51.00%	100.00%			100.00%	100.00%
Existing mortgage loan	$ 165,000										$ 165,000	$ 165,000	$ 165,000	$ 165,000	$ 165,000	165,000					$ 200,164	$ 185,000
Revenues contributed by acquired entity															153,707	153,214
Income contributed by the acquired entity															27,311	27,746
Acquisition-related costs on consummated deals															$ 1,900	$ 1,100
Gilbert Hospital [Member]
Real Estate And Lending Activities [Line Items]
Date acquired															January 4, 2011
Number of lease extension options in current lease contract							3	3
Term of lease extension, years \| years							5	5
Rent escalations percentage								2.50%
Lease expiration date							May 2022
Atrium Medical Center [Member]
Real Estate And Lending Activities [Line Items]
Date acquired															January 31, 2011
Term of lease, years \| years										15
Number of lease extension options in current lease contract										2
Term of lease extension, years \| years										10
Lease expiration date	June 2024
Bayonne Medical Center [Member]
Real Estate And Lending Activities [Line Items]
Date acquired															February 4, 2011
Term of lease, years \| years																			15
Number of lease extension options in current lease contract																			6
Term of lease extension, years \| years																			5
Alvarado Hospital [Member]
Real Estate And Lending Activities [Line Items]
Date acquired															February 9, 2011
Term of lease, years \| years																		10
Number of lease extension options in current lease contract																		3
Term of lease extension, years \| years																		5
Purchase price of real estate																		$ 70,000
Northland LTACH Hospital [Member]
Real Estate And Lending Activities [Line Items]
Date acquired															February 14, 2011
Kindred Healthcare Inc. [Member]
Real Estate And Lending Activities [Line Items]
Number of properties	3										3			3	3
Term of lease, years \| years						20			20
Number of lease extension options in current lease contract						3			3
Term of lease extension, years \| years						5			5
Rent escalations percentage									2.75%
Existing mortgage loan	$ 16,000										$ 16,000			$ 16,000	$ 16,000
Mortgage loan, matures															January 2018
Vibra Specialty Hospital [Member]
Real Estate And Lending Activities [Line Items]
Date acquired															July 18, 2011
Term of lease, years \| years																	15
Number of lease extension options in current lease contract																	3
Term of lease extension, years \| years																	5
Equity investment																	$ 2,500
Equity method investment, ownership percentage																	25.00%
Triumph Hospital Clear Lake [Member]
Real Estate And Lending Activities [Line Items]
Number of leases renewed												2
Triumph Hospital Tomball [Member]
Real Estate And Lending Activities [Line Items]
Term of lease, years \| years												5	5			5
Number of leases renewed												2
Acute Care Hospitals [Member]
Real Estate And Lending Activities [Line Items]
Number of properties			3
Term of lease, years \| years		15		15
Number of lease extension options in current lease contract		6		3
Term of lease extension, years \| years		5	15	5
Rent escalations percentage			3.00%
Cash paid to acquire land											6,200
Acute Care Facility [Member]
Real Estate And Lending Activities [Line Items]
Date acquired															September 30, 2011
Number of beds acquired		350
Term of lease, years \| years				15
Purchase price of real estate		$ 75,000		$ 10,000
Purchase of convertible note		5,000
Equity investment		$ 50,000		$ 1,400
Equity method investment, ownership percentage		100.00%		25.00%
Wrote off in related straight-line rent receivables															$ 1,000
Working capital loan		$ 20,000		$ 2,000											15,100
Inpatient Rehabilitation Facilities [Member]
Real Estate And Lending Activities [Line Items]
Date acquired																June 17, 2010
Number of properties																				3
Term of lease, years \| years					10
Number of leases renewed					2
Lease expiration date					2033
Vibra Health Care [Member]
Real Estate And Lending Activities [Line Items]
Equity method investment, ownership percentage										19.00%
Existing mortgage loan																							$ 41,400
Business Acquisitions [Member]
Real Estate And Lending Activities [Line Items]
Revenues contributed by acquired entity													$ 4,300		21,200
Income contributed by the acquired entity													3,400		14,100
Acquisition related costs													$ 2,000	4,200	1,900	$ 1,100
Business Acquisitions [Member] \| Gilbert Hospital [Member]
Real Estate And Lending Activities [Line Items]
Number of beds acquired							19	19
Purchase price of real estate							$ 17,100	$ 17,100
Business Acquisitions [Member] \| Atrium Medical Center [Member]
Real Estate And Lending Activities [Line Items]
Number of beds acquired										60
Purchase price of real estate										$ 23,500
Business Acquisitions [Member] \| Bayonne Medical Center [Member]
Real Estate And Lending Activities [Line Items]
Number of beds acquired																			278
Purchase price of real estate																			$ 58,000
Business Acquisitions [Member] \| Alvarado Hospital [Member]
Real Estate And Lending Activities [Line Items]
Number of beds acquired																		306
Business Acquisitions [Member] \| Northland LTACH Hospital [Member]
Real Estate And Lending Activities [Line Items]
Number of beds acquired						35			35
Business Acquisitions [Member] \| Kindred Healthcare Inc. [Member]
Real Estate And Lending Activities [Line Items]
Purchase price of real estate	19,500										19,500			19,500	19,500
Business Acquisitions [Member] \| Vibra Specialty Hospital [Member]
Real Estate And Lending Activities [Line Items]
Number of beds acquired																	40
Purchase price of real estate																	$ 13,000
Business Acquisitions [Member] \| Triumph Hospital Clear Lake [Member]
Real Estate And Lending Activities [Line Items]
Number of beds acquired												110	110			110
Lease expiration date												2025
Business Acquisitions [Member] \| Triumph Hospital Tomball [Member]
Real Estate And Lending Activities [Line Items]
Number of beds acquired												75	75			75
Lease expiration date												2026
Business Acquisitions [Member] \| Acute Care Hospitals [Member]
Real Estate And Lending Activities [Line Items]
Purchase price of real estate	7,400		$ 30,000								$ 7,400			$ 7,400	$ 7,400
Business Acquisitions [Member] \| Long Term Acute Care Hospitals [Member]
Real Estate And Lending Activities [Line Items]
Number of properties												2	2			2
Purchase price of real estate												$ 64,000	$ 64,000			$ 64,000
Business Acquisitions [Member] \| Acute Care Facility [Member]
Real Estate And Lending Activities [Line Items]
Number of beds acquired				40
Business Acquisitions [Member] \| Inpatient Rehabilitation Facilities [Member]
Real Estate And Lending Activities [Line Items]
Purchase price of real estate																				$ 74,000
Business Acquisitions [Member] \| Vibra Health Care [Member]
Real Estate And Lending Activities [Line Items]
Purchase price of real estate										$ 1,300
Working capital loan	$ 5,200
Hospital Operator [Member] \| Acute Care Facility [Member]
Real Estate And Lending Activities [Line Items]
Equity method investment, ownership percentage		25.00%
Former Operators [Member]
Real Estate And Lending Activities [Line Items]
Equity method investment, ownership percentage										49.00%
Maximum [Member] \| Atrium Medical Center [Member]
Real Estate And Lending Activities [Line Items]
Rent escalations percentage										5.00%
Minimum [Member] \| Atrium Medical Center [Member]
Real Estate And Lending Activities [Line Items]
Rent escalations percentage										1.00%
Minimum [Member] \| Acute Care Hospitals [Member]
Real Estate And Lending Activities [Line Items]
Rent escalations percentage			1.00%

Real Estate And Loans Receivable (Disposals) (Details) $ in Thousands		1 Months Ended	3 Months Ended			12 Months Ended
	Dec. 30, 2011 USD ($)	Oct. 31, 2010 USD ($)	Dec. 31, 2010 USD ($)	Jun. 30, 2010 USD ($)	Dec. 31, 2009 USD ($)	Dec. 31, 2011 USD ($)	Dec. 31, 2010 USD ($)	Dec. 31, 2009 USD ($)	Jun. 17, 2010
Real Estate And Lending Activities [Line Items]
Gain on sale of real estate						$ 5,431	$ 10,566	$ 278
Acute Care Facility [Member]
Real Estate And Lending Activities [Line Items]
Wrote off in related straight-line rent receivables						$ 1,000
Inpatient Rehabilitation Facilities [Member]
Real Estate And Lending Activities [Line Items]
Number of properties									3
Business Disposals [Member] \| Sherman Oaks Hospital [Member]
Real Estate And Lending Activities [Line Items]
Selling price of real estate	$ 20,000
Gain on sale of real estate	3,100
Wrote off in related straight-line rent receivables	1,200
Business Disposals [Member] \| MountainView Regional Rehabilitation Hospital [Member]
Real Estate And Lending Activities [Line Items]
Selling price of real estate	21,100
Gain on sale of real estate	$ 2,300
Business Disposals [Member] \| Montclair Hospital [Member]
Real Estate And Lending Activities [Line Items]
Selling price of real estate			$ 20,000
Gain on sale of real estate			$ 2,200
Business Disposals [Member] \| Sharpstown Facility [Member
Real Estate And Lending Activities [Line Items]
Selling price of real estate		$ 2,700
Gain on sale of real estate		$ 700
Business Disposals [Member] \| Acute Care Medical Center [Member]
Real Estate And Lending Activities [Line Items]
Number of beds sold				369
Selling price of real estate				$ 75,000
Gain on sale of real estate				$ 6,000
Business Disposals [Member] \| Acute Care Facility [Member]
Real Estate And Lending Activities [Line Items]
Number of properties					1			1
Selling price of real estate					$ 15,000
Gain on sale of real estate					$ 300

Real Estate And Loans Receivable (Intangible Assets) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2011 USD ($) years	Dec. 31, 2010 USD ($)	Dec. 31, 2009 USD ($)
Real Estate And Lending Activities [Line Items]
Intangible lease assets	$ 53,400	$ 33,643
Capitalized lease intangibles, weighted average life (in years) \| years	14.1
Intangible Assets [Member]
Real Estate And Lending Activities [Line Items]
Intangible lease assets	$ 53,400	33,600
Accumulated amortization, net	43,100	26,800
Amortization expense related to intangible lease assets	5,200	$ 3,200	$ 4,500
Accelerated amortization	$ 600		$ 500

Real Estate And Loans Receivable (Lease Operations) (Details) $ in Thousands			1 Months Ended				3 Months Ended						12 Months Ended
	Nov. 02, 2008 USD ($)	Nov. 01, 2008 USD ($)	Sep. 30, 2010 USD ($)	Jun. 30, 2009 USD ($)	Apr. 30, 2009 USD ($)	Dec. 31, 2008 USD ($)	Dec. 31, 2011 USD ($)	Jun. 30, 2011 USD ($)	Dec. 31, 2010 USD ($)	Jun. 30, 2010 USD ($)	Jun. 30, 2009 USD ($)	Sep. 30, 2008	Dec. 31, 2011 USD ($)	Dec. 31, 2010 USD ($)	Dec. 31, 2009 USD ($)	Jan. 31, 2011	Mar. 31, 2010
Real Estate And Lending Activities [Line Items]
Impairment charges against real estate													$ 2,470	$ 3,694	$ 1,111
Equity method investment, ownership percentage							100.00%						100.00%			51.00%
LTACH Facility [member]
Real Estate And Lending Activities [Line Items]
Wrote off in related straight-line rent receivables							$ 1,300
Amortization expense related to intangible lease assets							600
Denham Springs Facility [Member]
Real Estate And Lending Activities [Line Items]
Billed rent								$ 1,500
Unbilled rent								200
Other receivables								100
Promissory note receivables								700
Payments received from the tenant								200
Loan recovered							700						$ 700
Receivables from real estate													4,200
Impairment charges against real estate								600
Intangible Assets [Member]
Real Estate And Lending Activities [Line Items]
Amortization expense related to intangible lease assets													5,200	3,200	4,500
Accelerated amortization													$ 600		500
Leasing Operations [Member]
Real Estate And Lending Activities [Line Items]
Number of lease extension options in current lease contract																	3
Term of lease extension, years																	5
Early lease termination fees					$ 1,100
Accelerated amortization											$ 500
Revenue contributed by the acquired entity														1,400
Rate of increase in annual rent													2.00%
Gain resulted in exchange of real estate property			$ 1,300
Straight line rent receivables write-off			$ 200
Leasing Operations [Member] \| Bucks County Facility [Member]
Real Estate And Lending Activities [Line Items]
Term of lease, years				5							5
Number of lease extension options in current lease contract				15							15
Term of lease extension, years				1							1
Uncollectible rent and other receivables write-off in lease termination						$ 4,700
Receivables guaranteed by former tenant's parent company						$ 3,800
Agreed to settle unpaid rent									$ 3,800					3,800
Unpaid rent									1,400
Charge to unpaid rent									2,400
Initial cash rent				$ 2,000
Rate of increase in annual rent				2.00%
Additional rent received from lease agreement				$ 1,000
Leasing Operations [Member] \| General Acute Care Hospitals [Member]
Real Estate And Lending Activities [Line Items]
Terminated leases												2
Leasing Operations [Member] \| Redding Hospital [Member]
Real Estate And Lending Activities [Line Items]
Income expected to be recognized from remaining lease period including previous values													$ 1,200	1,200	$ 1,200
Lease base, previous		$ 60,000
Lease base		$ 63,000
Additional rent received from lease agreement	$ 12,000									$ 12,000
Estimated future rent amount expected from lease agreement	$ 8,000
Income expected to recognize from remaining lease period								$ 8,200					3,800
Leasing Operations [Member] \| Monroe Hospital [Member]
Real Estate And Lending Activities [Line Items]
Lease advance							28,600						28,600
Operating leases rent, interest and other charges outstanding													14,900
Accrued operating leases rent, interest and other charges outstanding													3,400
Advanced amount of working capital loan agreement							600						$ 600
Interest receivables									$ 5,600					5,600
Impairment of working capital loan recognized														12,000
Impairment of working capital loan estimation-membership interest of operator/lessee considered for first priority secured interest													100.00%
Net investment to maximum exposure							$ 31,500						$ 31,500
Impairment of working capital loan estimation-patient receivables considered for first priority secured interest													$ 7,000
Straight line rent receivables write-off														$ 2,500
Number of days past due														90

Real Estate And Loans Receivable (Loans, Concentration Of Credit Risk And Related Party Transaction) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008	Dec. 31, 2004
Real Estate And Lending Activities [Line Items]
Mortgage loans expansion		$ (43,000)
Mortgage loans on real estate, new		7,836	$ 15,164
Mortgage loan assumed, value	$ 165,000	165,000	$ 200,164	$ 185,000
Lease and interest revenue earned from tenants	$ 5,500	$ 1,800
Prime Health Care Services [Member]
Real Estate And Lending Activities [Line Items]
Percentage of entity revenue from affiliates	30.10%	31.80%	32.50%
Percentage of assets from affiliates	25.30%	26.70%
Vibra Health Care [Member]
Real Estate And Lending Activities [Line Items]
Mortgage loan assumed, value					$ 41,400
Repayment of loans and accrued interest from affiliates	$ 17,800
Percentage of entity revenue from affiliates	12.00%	15.00%	15.70%
Percentage of assets from affiliates	7.90%	9.96%
Individual Property Basis [Member]
Real Estate And Lending Activities [Line Items]
Percentage of assets from affiliates	5.60%
Maximum [Member]
Real Estate And Lending Activities [Line Items]
Percentage of assets from affiliates		28.60%
Minimum [Member]
Real Estate And Lending Activities [Line Items]
Percentage of assets from affiliates	26.80%

Real Estate And Loans Receivable (List Of Assets Purchased As Part Of Acquisitions) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2011 USD ($)	Dec. 31, 2010 USD ($)	Dec. 31, 2009 USD ($)
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Total	$ 261,104	$ 137,808	$ 421
Land [Member]
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Significant acquisitions and disposals of acquisition	19,705	8,227	$ 421
Buildings [Member]
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Significant acquisitions and disposals of acquisition	220,769	119,626
Intangible Lease Assets-Subject To Amortization [Member]
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Significant acquisitions and disposals of acquisition	$ 20,630	$ 9,955
Weighted-average useful life of acquired intangible assets (in years)	13.9	19.4

Real Estate And Loans Receivable (Pro Forma Consolidated Financial Data) (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Real Estate And Loans Receivable [Abstract]
Total revenues	$ 153,707	$ 153,214
Net income	$ 27,311	$ 27,746
Net income per share/unit	$ 0.24	$ 0.26

Real Estate And Loans Receivable (Summary Of Amortization Expense From Lease Intangible Assets) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2011 USD ($)
Real Estate And Loans Receivable [Abstract]
2012	$ 3,865
2013	3,832
2014	3,767
2015	3,578
2016	$ 3,536

Real Estate And Loans Receivable (Summary Of Minimum Rental Payments) (Details) $ in Thousands	Dec. 31, 2011 USD ($)
2012	$ 2,233
2013	2,104
2014	1,609
2015	1,610
2016	1,610
Thereafter	36,378
Minimum rental payments, total	45,544
Minimum Rental Payments [Member]
2012	119,454
2013	120,275
2014	118,661
2015	115,880
2016	116,154
Thereafter	811,272
Minimum rental payments, total	$ 1,401,696

Real Estate And Loans Receivable (Summary Of Loans) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, Balance	$ 239,839	$ 215,985
Mortgage Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, Balance	$ 165,000	$ 165,000
Loans, Weighted Average Interest Rate	10.20%	10.00%
Other Loans [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans, Balance	$ 74,839	$ 50,985
Loans, Weighted Average Interest Rate	10.50%	10.80%

Debt (Narrative) (Details) - USD ($)	1 Months Ended				3 Months Ended	12 Months Ended
Debt (Narrative) (Details) - USD ($)	Apr. 30, 2011	May 31, 2010	Apr. 30, 2010	Nov. 30, 2006	Sep. 30, 2011	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008	Nov. 30, 2008	Apr. 30, 2008
Debt Instrument [Line Items]
Credit facility paid						$ 246,262,000	$ 216,765,000	$ 1,232,000
Public offering of common stock net proceeds, after underwriting discount and commissions			$ 279,000,000
Mortgages [Member]
Debt Instrument [Line Items]
Mortgage loan						16,000,000
Unsecured Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Credit facilities, amount outstanding						$ 330,000,000
Credit facilities, basis spread of interest rate						1.60%
Secured Credit Facility [Member]
Debt Instrument [Line Items]
Interest rate		6.125%
New secured credit facility		$ 450,000,000
Percentage of outstanding notes purchased from senior unsecured notes offering		93.00%
Interest rate of Senior Notes		6.125%
Paid off term loan		$ 30,000,000
Charge of refinancing activities		$ 6,700,000
Unsecured Senior Notes [Member]
Debt Instrument [Line Items]
Interest rate						6.375%
Private offering	$ 450,000,000
Credit facility paid	150,000,000
Interest rate of Senior Notes						6.375%
Charge of refinancing activities						$ 14,200,000
Debt instrument maturity date						Feb. 15, 2022
Debt face amount						$ 200,000,000
Exchangeable Senior Notes [Member]
Debt Instrument [Line Items]
Interest rate					9.25%	9.25%					9.25%
Percentage of outstanding notes purchased from senior unsecured notes offering					86.60%		93.00%		85.00%
Interest rate of Senior Notes					9.25%	9.25%					9.25%
Fixed rate, minimum							6.125%
Fixed rate, maximum							9.25%
Credit facilities, weighted average interest rate					118.40%
Price of principal amount plus accrued and unpaid interest, in percentage						103.00%			118.50%
Price of principal amount plus accrued and unpaid interest, in amount					$ 84,100,000	$ 136,300,000			$ 84,200,000
Debt face amount						$ 11,000,000	$ 91,175,000
Collateralized Term Loan [Member]
Debt Instrument [Line Items]
Interest rate										5.66%
Credit facility paid	$ 9,000,000
Interest rate of Senior Notes										5.66%
Credit facilities, amount outstanding										$ 9,000,000
6.125% Exchangeable Senior Notes [Member]
Debt Instrument [Line Items]
Interest rate				6.125%
Interest rate of Senior Notes				6.125%
Debt instrument maturity date				Nov. 15, 2011
Price of principal amount plus accrued and unpaid interest, in percentage			103.00%
Price of principal amount plus accrued and unpaid interest, in amount			$ 136,300,000
Minimum [Member] \| Unsecured Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate						1.60%
Maximum [Member] \| Unsecured Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate						2.40%
LIBOR [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate						2.60%
LIBOR [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate						2.60%
LIBOR [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate						3.40%
Federal Funds Rate [Member] \| Unsecured Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate						0.50%

Debt (Revolving Credit Facilities) (Details) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Jun. 30, 2007	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Debt Instrument [Line Items]
Credit facility paid		$ 246,262	$ 216,765	$ 1,232
Revolving Credit Facilities [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate				1.99%
Credit facility paid			220,000
Credit facilities, amount outstanding		$ 50,000	$ 0	$ 96,000
Credit facilities, weighted average interest rate		3.20%	2.10%	2.21%
Revolving facility agreement, availability		$ 280,000
Collateralized Revolving Bank Credit Facility [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate		1.80%	1.77%
Credit facilities, decrease		$ 800
Credit facilities, amount outstanding	$ 42,000	39,600	$ 0
Credit facilities, repayment term	five years
Credit facilities, remaining borrowing capacity		$ 0
Credit facilities, weighted average interest rate		1.63%	1.74%	1.86%
Collateralized real estate property		$ 55,100	$ 56,500
Unsecured Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Credit facility, maturity date		October 2015
Credit facilities, basis spread of interest rate		1.60%
Credit facilities, amount outstanding		$ 330,000
LIBOR [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate		2.60%
LIBOR [Member] \| Revolving Credit Facilities [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate				1.75%
LIBOR [Member] \| Collateralized Revolving Bank Credit Facility [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate	1.50%
Federal Funds Rate [Member] \| Unsecured Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate		0.50%
Minimum [Member] \| Revolving Credit Facilities [Member]
Debt Instrument [Line Items]
Credit facilities, percentage of commitment fee on unused capacity		0.375%		0.20%
Minimum [Member] \| Unsecured Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate		1.60%
Minimum [Member] \| LIBOR [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate		2.60%
Maximum [Member] \| Revolving Credit Facilities [Member]
Debt Instrument [Line Items]
Credit facilities, percentage of commitment fee on unused capacity		0.50%		0.35%
Maximum [Member] \| Unsecured Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate		2.40%
Maximum [Member] \| LIBOR [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate		3.40%

Debt (Senior Unsecured Notes) (Details) - USD ($)	3 Months Ended	7 Months Ended	12 Months Ended
Debt (Senior Unsecured Notes) (Details) - USD ($)	Oct. 30, 2011	Jul. 30, 2011	Dec. 31, 2011	Dec. 31, 2010	Apr. 26, 2011	Jun. 30, 2010	Dec. 31, 2006
Debt Instrument [Line Items]
Interest rate swap, amount fixed						$ 65,000,000
Total senior notes available			$ 689,849,000	$ 369,970,000		$ 125,000,000
Medical Properties Trust, Inc. [Member]
Debt Instrument [Line Items]
Total senior notes available			$ 689,849,000	369,970,000
LIBOR [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate			2.60%
2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Principal amount			$ 125,000,000	$ 125,000,000
Unsecured senior notes, year of maturity			October 2016
Senior Unsecured Notes							$ 125,000,000
Credit facilities, periodic payments of interest		$ 65,000,000
Interest rate		7.871%
Fixed rate, minimum	7.333%			7.333%
Fixed rate, maximum	7.715%			7.871%
Credit facility collateral amount			$ 6,300,000
2006 Senior Unsecured Notes [Member] \| LIBOR [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate	2.30%	2.30%
2011 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Principal amount			$ 450,000,000
Unsecured senior notes, year of maturity			May 1, 2021
Interest rate			6.875%		6.875%
Interest Rate Contract [Member]
Debt Instrument [Line Items]
Fair value of the interest rate swaps			$ 12,200,000	$ 3,600,000
Interest Rate Contract One [Member]
Debt Instrument [Line Items]
Interest rate of interest rate derivative instrument			5.507%
Interest Rate Contract Two [Member]
Debt Instrument [Line Items]
Interest rate swap, amount fixed			$ 60,000,000
Interest rate of interest rate derivative instrument			5.675%

Debt (Exchangeable Senior Notes) (Details)	1 Months Ended				3 Months Ended	12 Months Ended
Debt (Exchangeable Senior Notes) (Details)	Apr. 30, 2010 USD ($)	Apr. 30, 2008 USD ($) $ / shares	Mar. 31, 2008 USD ($)	Nov. 30, 2006 USD ($)	Sep. 30, 2011 USD ($)	Dec. 31, 2011 USD ($)	Dec. 31, 2010 USD ($)	Dec. 31, 2008 USD ($)	Aug. 31, 2011 USD ($)
6.125% Exchangeable Senior Notes [Member]
Debt Instrument [Line Items]
Interest rate				6.125%
Debt instrument maturity date				Nov. 15, 2011
Price of principal amount plus accrued and unpaid interest, in percentage	103.00%
Price of principal amount plus accrued and unpaid interest, in amount	$ 136,300,000
Exchangeable Senior Notes [Member]
Debt Instrument [Line Items]
Senior Notes		$ 7,000,000	$ 75,000,000	$ 138,000,000		$ 9,200,000			$ 1,500,000
Interest rate		9.25%			9.25%	9.25%
Initial exchange rate of notes		80.8898
Principal amount of exchangeable senior notes		$ 1,000
Exchange price of notes per common share \| $ / shares		$ 12.36
Proceeds from senior notes		$ 6,800,000	$ 72,800,000	$ 134,000,000
Percentage of outstanding notes purchased from senior unsecured notes offering					86.60%		93.00%	85.00%
Price of principal amount plus accrued and unpaid interest, in percentage						103.00%		118.50%
Price of principal amount plus accrued and unpaid interest, in amount					$ 84,100,000	$ 136,300,000		$ 84,200,000
Principal amount						$ 11,000,000	$ 91,175,000

Debt (Term Loans And Covenants) (Details)	1 Months Ended		12 Months Ended
Debt (Term Loans And Covenants) (Details)	Apr. 30, 2011 USD ($)	May 31, 2010 USD ($)	Dec. 31, 2011 USD ($) years	Dec. 31, 2010 USD ($)	Dec. 31, 2009 USD ($)	Nov. 30, 2008 USD ($)
Debt Instrument [Line Items]
Credit facility paid			$ 246,262,000	$ 216,765,000	$ 1,232,000
Dividend rate as percentage of normalized adjusted funds from operations			120.00%
Final percentage of dividend rate after quarterly deductions			95.00%
Percentage of maintenance of unencumbered assets			150.00%
Term Loans [Member]
Debt Instrument [Line Items]
Debt instrument face amount			$ 14,429,000	157,683,000
Credit facility paid				$ 220,000,000
Credit facilities, amount outstanding		$ 150,000,000
Credit facilities, basis spread of interest rate				5.00%	2.26%
Debt instrument maturity date		May 17, 2016
Interest rate			6.20%
Collateralized Term Loan [Member]
Debt Instrument [Line Items]
Credit facility paid	$ 9,000,000
Credit facilities, amount outstanding						$ 9,000,000
Interest rate						5.66%
LIBOR [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate			2.60%
LIBOR [Member] \| Term Loans [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate		3.50%
Debt instrument basis spread on variable interest rate					200
Federal Funds Rate [Member] \| Term Loans [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate		2.50%
Interest rate		0.50%
LIBOR Floor [Member] \| Term Loans [Member]
Debt Instrument [Line Items]
Credit facilities, basis spread of interest rate				1.50%
2010 Term Loan [Member] \| Term Loans [Member]
Debt Instrument [Line Items]
Credit facilities, amount outstanding					$ 64,500,000
Northland LTACH Hospital [Member] \| Mortgages [Member]
Debt Instrument [Line Items]
Liabilities acquired			$ 16,100,000
Amortization period \| years			30
Debt instrument maturity date			Jan. 01, 2018
Interest rate			6.20%

Debt (Summary Of Debt) (Details) - USD ($)	3 Months Ended	12 Months Ended
Debt (Summary Of Debt) (Details) - USD ($)	Oct. 30, 2011	Dec. 31, 2011	Dec. 31, 2010	Sep. 30, 2011	Jul. 30, 2011	Apr. 26, 2011	Jun. 30, 2010	Apr. 30, 2008
Debt Instrument [Line Items]
Total senior notes available		$ 689,849,000	$ 369,970,000				$ 125,000,000
Medical Properties Trust, Inc. [Member]
Debt Instrument [Line Items]
Total senior notes available		689,849,000	369,970,000
Revolving Credit Facilities [Member]
Debt Instrument [Line Items]
Principal amount		$ 89,600,000
Interest rate terms		Variable	Variable
2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Principal amount		$ 125,000,000	$ 125,000,000
Unsecured senior notes, interest rate					7.871%
Interest rate, minimum	7.333%		7.333%
Interest rate, maximum	7.715%		7.871%
Interest rate					7.871%
Interest rate terms		Various
2011 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Principal amount		$ 450,000,000
Unsecured senior notes, interest rate		6.875%				6.875%
Interest rate		6.875%				6.875%
Exchangeable Senior Notes [Member]
Debt Instrument [Line Items]
Principal amount		$ 11,000,000	91,175,000
Unamortized discount		(180,000)	(2,585,000)
Debt instrument, net		$ 10,820,000	$ 88,590,000
Unsecured senior notes, interest rate		9.25%		9.25%				9.25%
Interest rate, minimum			6.125%
Interest rate, maximum			9.25%
Interest rate		9.25%		9.25%				9.25%
Term Loans [Member]
Debt Instrument [Line Items]
Principal amount		$ 14,429,000	$ 157,683,000
Unamortized discount			(1,303,000)
Debt instrument, net		$ 14,429,000	$ 156,380,000
Unsecured senior notes, interest rate		6.20%
Interest rate		6.20%
Interest rate terms			Various

Debt (Principal Payments Due For Debt) (Details) $ in Thousands	Dec. 31, 2011 USD ($)
Debt [Abstract]
2012	$ 39,832
2013	11,249
2014	265
2015	50,283
2016	125,299
Thereafter	463,101
Total	$ 690,029

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
Income Taxes (Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Income Taxes [Abstract]
Percentage of ordinary taxable income to be distributed for real estate investment trust qualification	90.00%
Percentage of taxable income to be distributed for federal income tax exemption	100.00%
Tax expense	$ 0.1	$ 1.6	$ 0.3
U.S. federal NOLs	12.1
U.S. state NOLs	13.0
Net deferred tax asset	$ 8.7	6.7
U.S. federal and state NOLs, expiration date	2020 through 2031
Valuation allowance	$ 8.9	$ 6.8

- Definition

The tax effect as of the balance sheet date of the amount of excess of tax deductions over gross income in a year which cannot be used on the tax return of a state or local jurisdiction in the current year but can be carried forward to reduce taxable income or income taxes payable in a future year, for which there must be sufficient tax-basis income to utilize a portion or all of the carryforward amount to realize the deferred tax asset.

+ References + Details

Income Taxes (Schedule Of Per Share Distributions To Stockholders) (Details) - $ / shares

12 Months Ended

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Income Taxes [Abstract]

Common share distribution

$ 0.800000

Ordinary income

0.300844

0.388128

0.471792

Capital gains

^[1]

0.031396

0.027724

0.003708

Unrecaptured Sec. 1250 gain

0.031396

0.022784

0.003708

Return of capital

0.467760

0.384148

0.324500

Allocable to next year

[1]	Capital gains include unrecaptured Sec. 1250 gains.

Earnings Per Share/Unit (Calculation Of Earnings Per Share/Unit) (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income from continuing operations									$ 19,431	$ 10,248	$ 29,945
Income from discontinued operations									$ 7,283	$ 12,764	$ 6,422
Basic weighted-average common shares/units									110,623	100,706	78,117
Diluted weighted-average common shares/units									110,629	100,708	78,117
Stock Options [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Stock options excluded from earnings per share computation									100	100	100
Medical Properties Trust, Inc. [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income from continuing operations									$ 19,431	$ 10,248	$ 29,945
Non-controlling interests' share in continuing operations									(178)	(99)	(36)
Participating securities' share in earnings									(1,090)	(1,254)	(1,506)
Income from continuing operations, less participating securities' share in earnings									18,163	8,895	28,403
Income from discontinued operations									7,283	12,764	6,422
Non-controlling interests' share in discontinued operations											(1)
Income from discontinued operations attributable to MPT common stockholders									7,283	12,764	6,421
Net income, less participating securities' share in earnings									$ 25,446	$ 21,659	$ 34,824
Basic weighted-average common shares/units									110,623	100,706	78,117
Dilutive stock options									6	2
Diluted weighted-average common shares/units									110,629	100,708	78,117
MPT Operating Partnership, L.P. [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income from continuing operations	$ 8,037	$ (219)	$ 1,961	$ 9,669	$ 7,568	$ 7,958	$ (968)	$ (4,235)	$ 19,448	$ 10,323	$ 30,008
Non-controlling interests' share in continuing operations									(178)	(99)	(36)
Participating securities' share in earnings									(1,090)	(1,254)	(1,506)
Income from continuing operations, less participating securities' share in earnings									18,180	8,970	28,466
Income from discontinued operations	$ 4,658	$ 705	$ 748	$ 1,172	$ 3,062	$ 997	$ 7,269	$ 1,436	7,283	12,764	6,422
Non-controlling interests' share in discontinued operations											(1)
Income from discontinued operations attributable to MPT common stockholders									7,283	12,764	6,421
Net income, less participating securities' share in earnings									$ 25,463	$ 21,734	$ 34,887
Basic weighted-average common shares/units	110,788	110,714	110,589	110,400	110,103	110,046	103,498	79,176	110,623	100,706	78,117
Dilutive stock options									6	2
Diluted weighted-average common shares/units	110,788	110,719	110,600	110,408	110,108	110,046	103,498	79,178	110,629	100,708	78,117

Stock Awards (Narrative) (Details) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2011 USD ($) $ / shares shares	Dec. 31, 2010 USD ($) shares	Dec. 31, 2009 USD ($)	Dec. 31, 2007 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved shares of common stock for awards under the Equity Incentive Plan	7,441,180
Common stock remaining for future stock awards	2,595,161
Maximum number of shares of common stock that may be awarded	1,000,000
Stock award vesting period (in years)	ten			four
Number of stock options outstanding		60,866		50,000
Share based payment award, exercise price \| $ / shares				$ 12.09
Share based payment award, estimated grant date fair value \| $ / shares				$ 1.36
Share based payment award, expiration period				2012
Share based payment award, expected volatility rate		42.00%		28.34%
Share based payment award, weighted average risk-free rate of return		2.60%		4.62%
Common stock options awarded, dividend yield		8.50%		8.93%
Common stock options awarded, intrinsic value of options exercisable and outstanding \| $	$ 0.0
Common stock options awarded, options outstanding and exercisable	110,000
Common stock options awarded, weighted-average exercise price \| $ / shares	$ 10.95
Common stock options awarded, weighted average remaining contractual term (in years)	1.8
Stock award vesting period in years, maximum	seven
Stock award vesting period in years, minimum	three
Percentage of shareholder return annually		9.50%
Percentage of shareholder return annually achieving period, (in years)		3
Percentage of superior performance awards will earned if we perform at or above fiftieth percentile		33.334%
Percentage of superior performance awards were deemed forfeited		66.666%
Share-based compensation arrangement by share based payment award, expected term (in years)		4
Stock-based compensation expense \| $	$ 7.0	$ 6.6	$ 5.5
Stock-based compensation expense, unrecognized cost \| $	$ 10.5
Stock-based compensation expense, unrecognized cost, reorganization period (in years)	2.4
Restricted equity awards, fair value \| $	$ 6.1	$ 6.1	$ 2.4
Time-Based Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock award vesting period (in years)				three
Stock award vesting period in years, maximum	seven
Stock award vesting period in years, minimum	three
Service-Based Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock award vesting period (in years)				seven
Superior Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock award vesting period (in years)		three
Core Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options outstanding		79,287
Percentage of shareholder return annually				9.00%
Percentage of shareholder return on a pro-rated basis				7.50%
Percentage of shareholder annual maximum total return				0.00%
30% Of 2011 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based payment award, expected volatility rate	33.00%
Share based payment award, weighted average risk-free rate of return	2.07%
Common stock options awarded, dividend yield	8.50%
Percentage of performance award grant in period	30.00%
Percentage of shareholder return annually	9.00%
Percentage of shareholder return annually achieving period, (in years)	3
Share-based compensation arrangement by share based payment award, expected term (in years)	4
18% Of 2011 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based payment award, expected volatility rate	34.00%
Share based payment award, weighted average risk-free rate of return	1.07%
Common stock options awarded, dividend yield	8.50%
Percentage of performance award grant in period	18.00%
Percentage of performance award to be earned of shareholder return reaches shareholder limit	100.00%
Share-based compensation arrangement by share based payment award, expected term (in years)	5
Remaining % Of 2011 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based payment award, expected volatility rate	34.00%
Share based payment award, weighted average risk-free rate of return	1.07%
Common stock options awarded, dividend yield	8.50%
Percentage of performance award to be earned of shareholder return reaches shareholder limit	100.00%
Percentage of shareholder return to be earned	12.00%
Share-based compensation arrangement by share based payment award, expected term (in years)	5
Minimum [Member] \| 18% Of 2011 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shareholder return to be earned	27.00%
Maximum [Member] \| 18% Of 2011 Performance Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shareholder return to be earned	39.00%

Stock Awards (Restricted Equity Awards Activity) (Details) - $ / shares	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Vesting Based On Service [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Nonvested awards at beginning of the year, Shares	783,305	962,350
Awarded, Shares	292,803	277,680
Vested, Shares	(453,980)	(454,323)
Forfeited, Shares	(18,148)	(2,402)
Nonvested awards at end of year, Shares	603,980	783,305
Nonvested awards at beginning of the year, Weighted Average Value at Award Date	$ 10.43	$ 10.22
Awarded, Weighted Average Value at Award Date	10.76	10.39
Vested, Weighted Average Value at Award Date	9.89	9.97
Forfeited, Weighted Average Value at Award Date	9.70	8.66
Nonvested awards at end of year, Weighted Average Value at Award Date	$ 11.02	$ 10.43
Vesting Based On Market/Performance Conditions [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Nonvested awards at beginning of the year, Shares	828,409	1,301,088
Awarded, Shares	853,656	182,600
Vested, Shares	(163,575)	(175,279)
Forfeited, Shares	(7,093)	(480,000)
Nonvested awards at end of year, Shares	1,511,397	828,409
Nonvested awards at beginning of the year, Weighted Average Value at Award Date	$ 8.70	$ 6.90
Awarded, Weighted Average Value at Award Date	5.72	9.25
Vested, Weighted Average Value at Award Date	6.87	10.64
Forfeited, Weighted Average Value at Award Date	9.32	3.31
Nonvested awards at end of year, Weighted Average Value at Award Date	$ 7.21	$ 8.70

Commitments And Contingencies (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Commitments And Contingencies [Abstract]
Terms of lease period	50 years or more
Lease and rental expense	$ 868,106	$ 989,170	$ 859,570
Sublease rental income	443,829	$ 520,090	$ 498,733
Total amount to be received in the future from non-cancellable subleases	$ 29,400,000

Commitments And Contingencies (Summary Of Minimum Payments Due Under Operating Leases) (Details) $ in Thousands	Dec. 31, 2011 USD ($)
Commitments And Contingencies [Abstract]
2012	$ 2,233
2013	2,104
2014	1,609
2015	1,610
2016	1,610
Thereafter	36,378
Minimum rental payments, total	$ 45,544

Common Stock/Partner's Capital (Details) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended		12 Months Ended
	Apr. 30, 2010 USD ($) $ / shares shares	Jan. 31, 2009 USD ($) $ / shares shares	Mar. 31, 2010 USD ($) $ / shares shares	Dec. 31, 2009 USD ($) $ / shares shares	Dec. 31, 2011 $ / shares shares	Dec. 31, 2010 USD ($) $ / shares shares	Dec. 31, 2009 USD ($) shares	Jan. 31, 2011	Nov. 30, 2009 USD ($)	Jan. 09, 2009 $ / shares shares
Class of Stock [Line Items]
Common stock, shares issued					110,786,000	110,225,000
Net proceeds from issuance of common stock \| $						$ 288,066	$ 68,003
Common stock, par value \| $ / shares					$ 0.001	$ 0.001
Common stock, shares authorized					150,000,000	150,000,000
Common stock, additional shares authorized					250,000,000
Ownership interest in Operating Partnership					100.00%			51.00%
Medical Properties Trust, Inc. [Member]
Class of Stock [Line Items]
Net proceeds from issuance of common stock \| $						$ 288,066	$ 68,003
Common stock, par value \| $ / shares										$ 0.001
Medical Properties Trust, Inc. [Member] \| Public Offering [Member]
Class of Stock [Line Items]
Common stock, shares issued	26,000,000	12,000,000
Public offering price for common stock per share \| $ / shares	$ 9.75	$ 5.40
Underwriters' purchase of shares to cover over allotments	3,900,000	1,300,000
Net proceeds from issuance of common stock \| $	$ 279,100	$ 67,800
Medical Properties Trust, Inc. [Member] \| Market Equity Offering Program [Member]
Class of Stock [Line Items]
Common stock, shares issued			900,000	30,000			30,000
Public offering price for common stock per share \| $ / shares				$ 10.25
Net proceeds from issuance of common stock \| $			$ 9,500	$ 300
Average price of common stock under market equity offering program per share \| $ / shares			$ 10.77
Sales commission			2.00%	2.00%
Number of shares can be sold out \| $									$ 50,000
MPT Operating Partnership, L.P. [Member]
Class of Stock [Line Items]
Net proceeds from issuance of common stock \| $						$ 288,066	$ 68,003
Percentage of ownership of general partner					100.00%
Ownership interest in Operating Partnership					99.80%
Number of other partners					3
Maximum [Member] \| Medical Properties Trust, Inc. [Member]
Class of Stock [Line Items]
Common stock, shares authorized										150,000,000
Minimum [Member] \| Medical Properties Trust, Inc. [Member]
Class of Stock [Line Items]
Common stock, shares authorized										100,000,000

Fair Value Of Financial Instruments (Summary Of Fair Value Information Of Financial Instruments) (Details) - USD ($) $ in Thousands	Dec. 31, 2011	Dec. 31, 2010	Jun. 30, 2010
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest and rent receivables, Book Value	$ 29,862	$ 26,176
Debt, net, Book Value	(689,849)	(369,970)	$ (125,000)
Medical Properties Trust, Inc. [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest and rent receivables, Book Value	29,862	26,176
Loans, Book Value	239,839	215,985
Debt, net, Book Value	(689,849)	(369,970)
Interest and rent receivables, Fair Value	22,866	20,265
Loans, Fair Value	243,272	209,126
Debt, net, Fair Value	$ (688,032)	$ (359,910)

Discontinued Operations (Narrative) (Details) $ in Thousands		1 Months Ended	3 Months Ended			12 Months Ended
	Dec. 30, 2011 USD ($)	Oct. 31, 2010 USD ($)	Dec. 31, 2010 USD ($)	Jun. 30, 2010 USD ($)	Dec. 31, 2009 USD ($)	Dec. 31, 2011 USD ($)	Dec. 31, 2010 USD ($)	Dec. 31, 2009 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate						$ 41,130	$ 97,669	$ 15,000
Real Estate Held for Sale			$ 37,514				$ 37,514
Medical Properties Trust, Inc. [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate					$ 15,000
Gain on sale of real estate					$ 300
MountainView Regional Rehabilitation Hospital [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Selling price of real estate	$ 21,100
Gain on sale of real estate	2,300
Sherman Oaks Hospital [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Selling price of real estate	20,000
Gain on sale of real estate	3,100
Wrote off in related straight-line rent receivables	$ 1,200
Montclair Hospital [Member] \| Medical Properties Trust, Inc. [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate			20,000
Gain on sale of real estate			$ 2,200
Sharpstown Hospital [Member] \| Medical Properties Trust, Inc. [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate		$ 3,000
Gain on sale of real estate		$ 700
Inglewood Hospital [Member] \| Medical Properties Trust, Inc. [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate				$ 75,000
Gain on sale of real estate				$ 6,000
Number of beds sold				369

Discontinued Operations (Schedule Of Discontinued Operations) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Income from discontinued operations									$ 7,283	$ 12,764	$ 6,422
Income from discontinued operations - diluted per share/unit									$ 0.07	$ 0.13	$ 0.08
Medical Properties Trust, Inc. [Member]
Revenues									$ 3,534	$ 8,488	$ 16,197
Gain on sale									5,431	10,566	278
Income from discontinued operations	$ 4,658	$ 705	$ 748	$ 1,172	$ 3,062	$ 997	$ 7,269	$ 1,436	$ 7,283	$ 12,764	$ 6,422
Income from discontinued operations - diluted per share/unit									$ 0.07	$ 0.13	$ 0.08

- Definition

Gain (loss) after tax expense or benefit, not previously recognized and resulting from the sale of a business component, which is recognized at the date of sale. A gain (loss) reflects the amount by which the consideration received exceeds (is exceeded by) the net carrying amount (reflecting previous provisions for loss on disposal, if any) of the disposal group.

+ References + Details

- Definition

This element represents the overall income (loss) from a disposal group that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items before deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 43
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 47
-Subparagraph c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 29
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 5
-Section 03
-Paragraph 15

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 13
-Article 7

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.12)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.14)
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Quarterly Financial Data (Summary Of The Unaudited Quarterly Financial Information) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Revenues									$ 143,319	$ 117,197	$ 114,038
Income (loss) from continuing operations									19,431	10,248	29,945
Income from discontinued operations									7,283	12,764	6,422
Net income									26,714	23,012	36,367
Net income attributable to MPT common stockholders									$ 26,536	$ 22,913	$ 36,330
Net income attributable to MPT common stockholders per share - basic									$ 0.23	$ 0.22	$ 0.45
Weighted average shares outstanding - basic									110,623	100,706	78,117
Net income (loss) attributable to MPT common stockholders per share - diluted									$ 0.23	$ 0.22	$ 0.45
Weighted average shares outstanding - diluted									110,629	100,708	78,117
Medical Properties Trust, Inc. [Member]
Revenues	$ 36,802	$ 36,774	$ 35,396	$ 34,347	$ 30,677	$ 27,621	$ 29,534	$ 29,365
Income (loss) from continuing operations	8,082	(237)	1,934	9,652	7,567	7,967	(1,037)	(4,249)	$ (17)	$ (75)	$ (63)
Income from discontinued operations	4,658	705	748	1,172	3,062	997	7,269	1,436	7,283	12,764	6,422
Net income	12,740	468	2,682	10,824	10,629	8,964	6,232	(2,813)	26,714	23,012	36,367
Net income attributable to MPT common stockholders	$ 12,692	$ 424	$ 2,640	$ 10,780	$ 10,593	$ 8,919	$ 6,223	$ (2,822)	26,536	22,913	36,330
Net income attributable to MPT common stockholders per share - basic	$ 0.11		$ 0.02	$ 0.09	$ 0.09	$ 0.08	$ 0.06	$ (0.04)
Weighted average shares outstanding - basic	110,788	110,714	110,589	110,400	110,103	110,046	103,498	79,176
Net income (loss) attributable to MPT common stockholders per share - diluted	$ 0.11		$ 0.02	$ 0.09	$ 0.09	$ 0.08	$ 0.06	$ (0.04)
Weighted average shares outstanding - diluted	110,788	110,719	110,600	110,408	110,108	110,046	103,498	79,178
MPT Operating Partnership, L.P. [Member]
Revenues	$ 36,802	$ 36,774	$ 35,396	$ 34,347	$ 30,677	$ 27,621	$ 29,534	$ 29,365	143,319	117,197	114,038
Income (loss) from continuing operations	8,037	(219)	1,961	9,669	7,568	7,958	(968)	(4,235)	19,448	10,323	30,008
Income from discontinued operations	4,658	705	748	1,172	3,062	997	7,269	1,436	7,283	12,764	6,422
Net income	12,695	486	2,709	10,841	10,630	8,955	6,301	(2,799)	26,731	23,087	36,430
Net income attributable to MPT common stockholders	$ 12,647	$ 443	$ 2,667	$ 10,796	$ 10,593	$ 8,910	$ 6,292	$ (2,807)	$ 26,553	$ 22,988	$ 36,393
Net income attributable to MPT common stockholders per share - basic	$ 0.11		$ 0.02	$ 0.09	$ 0.09	$ 0.08	$ 0.06	$ (0.04)	$ 0.23	$ 0.22	$ 0.45
Weighted average shares outstanding - basic	110,788	110,714	110,589	110,400	110,103	110,046	103,498	79,176	110,623	100,706	78,117
Net income (loss) attributable to MPT common stockholders per share - diluted	$ 0.11		$ 0.02	$ 0.09	$ 0.09	$ 0.08	$ 0.06	$ (0.04)	$ 0.23	$ 0.22	$ 0.45
Weighted average shares outstanding - diluted	110,788	110,719	110,600	110,408	110,108	110,046	103,498	79,178	110,629	100,708	78,117

Subsequent Events (Details)	12 Months Ended
Subsequent Events (Details)	Dec. 31, 2011 USD ($) years $ / shares shares	Dec. 31, 2010 USD ($)	Dec. 31, 2009 USD ($)
Subsequent Event [Line Items]
Purchase price and investment	$ 261,104,000	$ 137,808,000	$ 421,000
Purchase of real estate assets	$ 240,474,000	146,854,000	421,000
Closure of acquisition and related investments	February 29, 2012
Capital contribution	$ 3,300,000
Lease period in years \| years	20
Number of five year extensions in excess of lease period	3
Lease agreement, initial rental rate	9.00%
Lease agreement, increase in consumer price index floor rate	2.00%
Lease agreement, increase in consumer price index ceiling rate	5.00%
Acquisition loan, interest rate	15.00%
Coupon rate payable in cash in year one	6.00%
Coupon rate payable in cash in year two	7.00%
Coupon rate payable in cash in thereafter	10.00%
Coupon rate accrued and paid upon occurrence of any capital or liquidity events in year one	9.00%
Coupon rate accrued and paid upon occurrence of any capital or liquidity events in year two	8.00%
Coupon rate accrued and paid upon occurrence of any capital or liquidity events in year thereafter	5.00%
Net proceeds from issuance of common stock		288,066,000	68,003,000
Medical Properties Trust, Inc. [Member]
Subsequent Event [Line Items]
Net proceeds from issuance of common stock		$ 288,066,000	$ 68,003,000
Ernest Health Inc [Member]
Subsequent Event [Line Items]
Purchase price and investment	$ 396,500,000
Purchase of real estate assets	200,000,000
First mortgage loan	100,000,000
Acquisition loan	93,200,000
49% Interest [Member]
Subsequent Event [Line Items]
Expected capital contributions to acquire membership interest	$ 3,300,000
Expected membership interest acquire through capital contributions	49.00%
51% Interest [Member]
Subsequent Event [Line Items]
Expected capital contributions to acquire membership interest	$ 3,500,000
Expected membership interest acquire through capital contributions	51.00%
Common Stock Offering [Member]
Subsequent Event [Line Items]
Sale of stock, transaction date	Feb. 07, 2012
Common stock, shares offering \| shares	23,575,000
Shares sold pursuant to exercise of underwriters' over-allotment option \| shares	3,075,000
Sale of stock, price per share \| $ / shares	$ 9.75
Net proceeds from issuance of common stock	$ 220,700,000
Unsecured Senior Notes [Member]
Subsequent Event [Line Items]
Debt instrument face amount	$ 200,000,000
Debt instrument, issuance date	February 17, 2012
Interest rate	6.375%
Debt instrument, maturity date	Feb. 15, 2022
Net proceeds from unsecured notes payable	$ 196,500,000
Credit Facilities [Member]
Subsequent Event [Line Items]
Credit facility, initiation date	January 25, 2012
Senior unsecured term loan facility	$ 80,000,000
Credit facility, maximum capacity	400,000,000
Credit facility, current capacity	330,000,000
Increase in revolving credit facility	$ 70,000,000

Condensed Consolidating Financial Information (Condensed Consolidated Balance Sheet) (Details) - USD ($) $ in Thousands	Dec. 31, 2011	Dec. 31, 2010	Jun. 30, 2010	Dec. 31, 2009	Dec. 31, 2008
Real estate assets [Abstract]
Land, buildings and improvements and intangible lease assets	$ 1,275,399	$ 990,548
Real estate held for sale		37,514
Mortgage loans	165,000	165,000
Gross investment in real estate assets	1,440,399	1,193,062
Accumulated depreciation and amortization	(103,737)	(71,787)
Net investment in real estate assets	1,336,662	1,121,275
Cash & cash equivalents	102,726	98,408		$ 15,307	$ 11,748
Interest and rent receivables	29,862	26,176
Straight-line rent receivables	33,993	28,912
Other loans	74,839	50,985
Other assets	43,792	23,058
Total Assets	1,621,874	1,348,814
Liabilities
Debt, net	689,849	369,970	$ 125,000
Accounts payable and accrued expenses	51,125	35,974
Deferred revenue	23,307	23,137
Lease deposits and other obligations to tenants	28,778	20,157
Total liabilities	793,059	449,238
Total Medical Properties Trust, Inc. stockholder's equity	828,815	899,462
Non-controlling interests		114
Total equity	828,815	899,576		671,575	626,343
Total Liabilities and Equity	1,621,874	1,348,814
Medical Properties Trust, Inc. [Member]
Real estate assets [Abstract]
Cash & cash equivalents					5
Interest and rent receivables	29,862	26,176
Net intercompany receivable (payable)	21,955	21,944
Investment in subsidiaries	829,205	899,949
Total Assets	851,160	921,893
Liabilities
Debt, net	689,849	369,970
Accounts payable and accrued expenses	22,345	22,317
Total liabilities	22,345	22,317
Total Medical Properties Trust, Inc. stockholder's equity	828,815	899,462
Non-controlling interests		114
Total equity	828,815	899,576
Total Liabilities and Equity	851,160	921,893
Subsidiary Issuers [Member]
Real estate assets [Abstract]
Land, buildings and improvements and intangible lease assets	37	297
Gross investment in real estate assets	37	297
Net investment in real estate assets	37	297
Cash & cash equivalents	101,230	96,822		14,814	10,481
Interest and rent receivables	399	157
Other loans	177	178
Net intercompany receivable (payable)	872,382	774,771
Investment in subsidiaries	489,858	390,232
Other assets	27,284	10,289
Total Assets	1,491,367	1,272,746
Liabilities
Debt, net	635,820	361,537
Accounts payable and accrued expenses	25,783	10,824
Deferred revenue	559	436
Total liabilities	662,162	372,797
Total Medical Properties Trust, Inc. stockholder's equity	829,205	899,835
Non-controlling interests		114
Total equity	829,205	899,949
Total Liabilities and Equity	1,491,367	1,272,746
Subsidiary Guarantors [Member]
Real estate assets [Abstract]
Land, buildings and improvements and intangible lease assets	1,127,441	861,599
Mortgage loans	165,000	165,000
Gross investment in real estate assets	1,292,441	1,026,599
Accumulated depreciation and amortization	(89,788)	(61,460)
Net investment in real estate assets	1,202,653	965,139
Interest and rent receivables	22,525	20,692
Straight-line rent receivables	24,000	20,052
Net intercompany receivable (payable)	(888,866)	(747,895)
Investment in subsidiaries	43,008	42,970
Other assets	1,727	1,182
Total Assets	405,047	302,140
Liabilities
Accounts payable and accrued expenses	2,576	2,378
Deferred revenue	17,488	17,616
Lease deposits and other obligations to tenants	27,874	17,019
Total liabilities	47,938	37,013
Total Medical Properties Trust, Inc. stockholder's equity	357,109	265,127
Non-controlling interests
Total equity	357,109	265,127
Total Liabilities and Equity	405,047	302,140
Non-Guarantor Subsidiaries [Member]
Real estate assets [Abstract]
Land, buildings and improvements and intangible lease assets	147,921	128,652
Real estate held for sale		37,514
Gross investment in real estate assets	147,921	166,166
Accumulated depreciation and amortization	(13,949)	(10,327)
Net investment in real estate assets	133,972	155,839
Cash & cash equivalents	1,496	1,586		$ 493	$ 1,262
Interest and rent receivables	6,938	5,327
Straight-line rent receivables	9,993	8,860
Other loans	74,662	50,807
Net intercompany receivable (payable)	(5,471)	(48,820)
Other assets	14,781	11,587
Total Assets	236,371	185,186
Liabilities
Debt, net	54,029	8,433
Accounts payable and accrued expenses	421	455
Deferred revenue	5,260	5,085
Lease deposits and other obligations to tenants	904	3,138
Total liabilities	60,614	17,111
Total Medical Properties Trust, Inc. stockholder's equity	175,757	168,075
Non-controlling interests
Total equity	175,757	168,075
Total Liabilities and Equity	236,371	185,186
Eliminations [Member]
Real estate assets [Abstract]
Investment in subsidiaries	(1,362,071)	(1,333,151)
Total Assets	(1,362,071)	(1,333,151)
Liabilities
Total Medical Properties Trust, Inc. stockholder's equity	(1,362,071)	(1,333,037)
Non-controlling interests		(114)
Total equity	(1,362,071)	(1,333,151)
Total Liabilities and Equity	$ (1,362,071)	$ (1,333,151)

Condensed Consolidating Financial Information (Condensed Consolidated Statements Of Income) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Revenues
Rent billed									$ 116,035	$ 88,487	$ 77,871
Straight-line rent									5,794	1,933	8,038
Interest and fee income									21,490	26,777	28,129
Total revenues									143,319	117,197	114,038
Expenses
Real estate depreciation and amortization									32,901	22,830	21,588
Impairment charge									564	12,000
Property-related									1,090	4,398	3,801
General and administrative									31,403	28,535	21,096
Total operating expenses									65,958	67,763	46,485
Operating income									77,361	49,434	67,553
Other income (expense)
Interest income and other									96	1,518	43
Debt refinancing costs									(14,214)	(6,716)
Interest expense									(43,812)	(33,988)	(37,651)
Net other expense									(57,930)	(39,186)	(37,608)
Income (loss) from continuing operations									19,431	10,248	29,945
Income from discontinued operations									7,283	12,764	6,422
Net income									26,714	23,012	36,367
Net income attributable to non-controlling interests									(178)	(99)	(37)
Net income attributable to MPT common stockholders									26,536	22,913	36,330
Medical Properties Trust, Inc. [Member]
Revenues
Total revenues	$ 36,802	$ 36,774	$ 35,396	$ 34,347	$ 30,677	$ 27,621	$ 29,534	$ 29,365
Expenses
General and administrative									17	75	63
Total operating expenses									17	75	63
Operating income									(17)	(75)	(63)
Other income (expense)
Income (loss) from continuing operations	8,082	(237)	1,934	9,652	7,567	7,967	(1,037)	(4,249)	(17)	(75)	(63)
Income from discontinued operations	4,658	705	748	1,172	3,062	997	7,269	1,436	7,283	12,764	6,422
Equity in earnings of consolidated subsidiaries net of income taxes									26,731	23,087	36,430
Net income	12,740	468	2,682	10,824	10,629	8,964	6,232	(2,813)	26,714	23,012	36,367
Net income attributable to non-controlling interests									(178)	(99)	(37)
Net income attributable to MPT common stockholders	$ 12,692	$ 424	$ 2,640	$ 10,780	$ 10,593	$ 8,919	$ 6,223	$ (2,822)	26,536	22,913	36,330
Subsidiary Issuers [Member]
Revenues
Interest and fee income									6,123	6,964	10,010
Total revenues									6,123	6,964	10,010
Expenses
Property-related									217	(4)	(20)
General and administrative									27,626	27,867	20,631
Total operating expenses									27,843	27,863	20,611
Operating income									(21,720)	(20,899)	(10,601)
Other income (expense)
Interest income and other									26	(14)	51
Debt refinancing costs									(14,109)	(6,716)
Interest expense									(43,064)	(33,623)	(36,760)
Net other expense									(57,147)	(40,353)	(36,709)
Income (loss) from continuing operations									(78,867)	(61,252)	(47,310)
Equity in earnings of consolidated subsidiaries net of income taxes									105,598	84,339	83,740
Net income									26,731	23,087	36,430
Net income attributable to non-controlling interests									(178)	(99)	(37)
Net income attributable to MPT common stockholders									26,553	22,988	36,393
Subsidiary Guarantors [Member]
Revenues
Rent billed									100,759	73,617	63,282
Straight-line rent									3,538	222	5,966
Interest and fee income									17,001	16,755	14,388
Total revenues									121,298	90,594	83,636
Expenses
Real estate depreciation and amortization									29,279	19,251	17,926
Impairment charge									564
Property-related									834	4,365	3,778
Total operating expenses									30,677	23,616	21,704
Operating income									90,621	66,978	61,932
Other income (expense)
Interest income and other									345
Interest expense									880	31
Net other expense									1,225	31
Income (loss) from continuing operations									91,846	67,009	61,932
Income from discontinued operations									98	121	(1,254)
Equity in earnings of consolidated subsidiaries net of income taxes									4,578	4,273	3,918
Net income									96,522	71,403	64,596
Net income attributable to MPT common stockholders									96,522	71,403	64,596
Non-Guarantor Subsidiaries [Member]
Revenues
Rent billed									18,368	15,900	14,589
Straight-line rent									2,256	1,711	2,072
Interest and fee income									4,601	10,572	14,150
Total revenues									25,225	28,183	30,811
Expenses
Real estate depreciation and amortization									3,622	3,579	3,662
Impairment charge										12,000
Property-related									3,131	1,067	43
General and administrative									3,760	593	402
Total operating expenses									10,513	17,239	4,107
Operating income									14,712	10,944	26,704
Other income (expense)
Interest income and other									(275)	1,532	(8)
Debt refinancing costs									(105)
Interest expense									(7,863)	(7,910)	(11,310)
Net other expense									(8,243)	(6,378)	(11,318)
Income (loss) from continuing operations									6,469	4,566	15,386
Income from discontinued operations									7,185	12,643	7,676
Net income									13,654	17,209	23,062
Net income attributable to MPT common stockholders									13,654	17,209	23,062
Eliminations [Member]
Revenues
Rent billed									(3,092)	(1,030)
Interest and fee income									(6,235)	(7,514)	(10,419)
Total revenues									(9,327)	(8,544)	(10,419)
Expenses
Property-related									(3,092)	(1,030)
Total operating expenses									(3,092)	(1,030)
Operating income									(6,235)	(7,514)	(10,419)
Other income (expense)
Interest expense									6,235	7,514	10,419
Net other expense									6,235	7,514	10,419
Equity in earnings of consolidated subsidiaries net of income taxes									(136,907)	(111,699)	(124,088)
Net income									(136,907)	(111,699)	(124,088)
Net income attributable to non-controlling interests									178	99	37
Net income attributable to MPT common stockholders									$ (136,729)	$ (111,600)	$ (124,051)

Condensed Consolidating Financial Information (Condensed Consolidated Statements Of Cash Flows) (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Dec. 31, 2009	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Operating activities
Net cash provided by (Used in) operating activities		$ 79,270	$ 60,637	$ 62,751
Investing activities
Real estate acquired		(246,511)	(137,808)	(421)
Principal received on loans receivable		4,289	90,486	4,305
Proceeds from sale of real estate		41,130	97,669	15,000
Investment in loans receivable		(28,144)	(11,637)	(23,243)
Construction in progress and other		(36,385)	(15,929)	(7,777)
Net cash provided by (used for) investing activities		(265,621)	22,781	(12,136)
Financing activities
Revolving credit facilities, net		89,600	(137,200)	(55,800)
Proceeds from term debt, net of discount		450,000	148,500
Payments of term debt		(246,262)	(216,765)	(1,232)
Distributions paid		(89,601)	(77,087)	(61,649)
Proceeds from sale of common shares/units, net of offering costs			288,066	68,003
Lease deposits and other obligations to tenants		8,621	3,667	3,390
Debt issuance costs paid and other financing activities		(21,689)	(9,498)	232
Net cash provided by (used in) financing activities		190,669	(317)	(47,056)
Increase (decrease) in cash and cash equivalents for period		4,318	83,101	3,559
Cash and cash equivalents at beginning of year		98,408	15,307	11,748
Cash and cash equivalents at end of year	$ 15,307	102,726	98,408	15,307
Medical Properties Trust, Inc. [Member]
Operating activities
Net cash provided by (Used in) operating activities		(209)	(29)	(268)
Investing activities
Proceeds from sale of real estate	15,000
Investments in and advances to subsidiaries		89,551	(211,181)	(6,699)
Net cash provided by (used for) investing activities		89,551	(211,181)	(6,699)
Financing activities
Distributions paid		(89,342)	(76,856)	(61,419)
Proceeds from sale of common shares/units, net of offering costs			288,066	68,003
Debt issuance costs paid and other financing activities				378
Net cash provided by (used in) financing activities		(89,342)	211,210	6,962
Increase (decrease) in cash and cash equivalents for period				(5)
Cash and cash equivalents at beginning of year				5
Subsidiary Issuers [Member]
Operating activities
Net cash provided by (Used in) operating activities		(48,779)	(54,909)	(35,554)
Investing activities
Investments in and advances to subsidiaries		(92,052)	99,564	89,642
Construction in progress and other		(6,466)	(108)
Net cash provided by (used for) investing activities		(98,518)	99,456	89,642
Financing activities
Revolving credit facilities, net		50,000	(96,000)	(55,000)
Proceeds from term debt, net of discount		450,000	148,500
Payments of term debt		(237,666)	(216,520)	(960)
Distributions paid		(89,601)	(77,087)	(61,649)
Proceeds from sale of common shares/units, net of offering costs			288,066	68,003
Debt issuance costs paid and other financing activities		(21,028)	(9,498)	(149)
Net cash provided by (used in) financing activities		151,705	37,461	(49,755)
Increase (decrease) in cash and cash equivalents for period		4,408	82,008	4,333
Cash and cash equivalents at beginning of year		96,822	14,814	10,481
Cash and cash equivalents at end of year	14,814	101,230	96,822	14,814
Subsidiary Guarantors [Member]
Operating activities
Net cash provided by (Used in) operating activities		112,311	89,780	69,738
Investing activities
Real estate acquired		(241,626)	(137,808)	(421)
Principal received on loans receivable		230
Proceeds from sale of real estate			2,669
Investments in and advances to subsidiaries		142,448	54,409	(53,811)
Investment in loans receivable		(230)	(5,000)	(15,000)
Construction in progress and other		(24,081)	(8,267)	(3,067)
Net cash provided by (used for) investing activities		(123,259)	(93,997)	(72,299)
Financing activities
Lease deposits and other obligations to tenants		10,948	4,217	2,561
Net cash provided by (used in) financing activities		10,948	4,217	2,561
Non-Guarantor Subsidiaries [Member]
Operating activities
Net cash provided by (Used in) operating activities		15,947	25,795	28,835
Investing activities
Real estate acquired		(4,885)
Principal received on loans receivable		4,059	90,486	4,305
Proceeds from sale of real estate		41,130	95,000	15,000
Investments in and advances to subsidiaries		(50,605)	(154,002)	(35,716)
Investment in loans receivable		(27,914)	(6,637)	(8,243)
Construction in progress and other		(5,838)	(7,554)	(4,710)
Net cash provided by (used for) investing activities		(44,053)	17,293	(29,364)
Financing activities
Revolving credit facilities, net		39,600	(41,200)	(800)
Payments of term debt		(8,596)	(245)	(272)
Lease deposits and other obligations to tenants		(2,327)	(550)	829
Debt issuance costs paid and other financing activities		(661)		3
Net cash provided by (used in) financing activities		28,016	(41,995)	(240)
Increase (decrease) in cash and cash equivalents for period		(90)	1,093	(769)
Cash and cash equivalents at beginning of year		1,586	493	1,262
Cash and cash equivalents at end of year	$ 493	1,496	1,586	493
Eliminations [Member]
Investing activities
Investments in and advances to subsidiaries		(89,342)	211,210	6,584
Net cash provided by (used for) investing activities		(89,342)	211,210	6,584
Financing activities
Distributions paid		89,342	76,856	61,419
Proceeds from sale of common shares/units, net of offering costs			(288,066)	(68,003)
Net cash provided by (used in) financing activities		$ 89,342	$ (211,210)	$ (6,584)

Valuation And Qualifying Accounts (Schedule Of Valuation And Qualifying Accounts) (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Valuation And Qualifying Accounts Disclosure [Line Items]

Balance at Beginning of Year

^[1]

$ 23,926

$ 4,339

$ 397

Additions Charged Against Operations

^[1]

8,692

^[2]

22,245

^[3]

5,107

Net Recoveries

^[1]

2,658

1,165

Balance at End of Year

^[1]

32,618

$ 23,926

$ 4,339

Increase in valuation allowances

6,500

Full reserve for net deferred tax asset

2,100

Monroe Property [Member]

Valuation And Qualifying Accounts Disclosure [Line Items]

Allowance for loan and lease losses

12,000

Interest reserves

2,900

Denham Springs, LA [Member]

Valuation And Qualifying Accounts Disclosure [Line Items]

Rent reserves

$ 3,700

[1]	Includes allowance for doubtful accounts, straight-line rent reserves, allowance for loan losses, tax valuation allowances and other reserves.
[2]	Includes $3.7 million and $2.9 million in rent and interest reserves, respectively, related to our Denham Springs and Monroe properties and $2.1 million to fully reserve for the net deferred tax asset of one of our taxable REIT subsidiaries.
[3]	Includes $12 million loan loss reserve related to our Monroe property and a $6.5 million increase in valuation allowances to fully reserve for the net deferred tax asset of one of our taxable REIT subsidiaries.

Real Estate And Accumulated Depreciation (Schedule Of Real Estate Investments And Accumulated Depreciation) (Details)
$ in Thousands

12 Months Ended

Dec. 31, 2011

USD ($)

years

Dec. 31, 2010

USD ($)

Dec. 31, 2009

USD ($)

^[1]

Dec. 31, 2008

USD ($)

Real Estate and Accumulated Depreciation [Line Items]

Initial Costs, Land

$ 108,672

Initial Costs, Buildings

1,073,599

Additions Subsequent to Acquisition, Improvements

2,493

Additions Subsequent to Acquisition, Carrying Costs

6,332

Land at Cost

111,309

Buildings at Cost

1,079,787

Total at Cost

1,191,096

$ 990,635

^[1]

$ 934,601

$ 943,700

Accumulated depreciation

$ 93,430

$ 64,946

Thornton, CO [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acutecare hospital

Initial Costs, Land

$ 2,130

Initial Costs, Buildings

6,013

Additions Subsequent to Acquisition, Improvements

2,237

Land at Cost

2,130

Buildings at Cost

8,250

Total at Cost

10,380

Accumulated depreciation

$ 1,276

Date of Construction

1962

Date Acquired

August 17, 2004

Life on which depreciation in latest income statements is computed (Years) | years

New Bedford, MA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acutecare hospital

Initial Costs, Land

$ 1,400

Initial Costs, Buildings

19,772

Additions Subsequent to Acquisition, Improvements

256

Land at Cost

1,400

Buildings at Cost

20,028

Total at Cost

21,428

Accumulated depreciation

$ 3,660

Date of Construction

1942

Date Acquired

August 17, 2004

Life on which depreciation in latest income statements is computed (Years) | years

Covington, LA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acutecare hospital

Initial Costs, Land

$ 821

Initial Costs, Buildings

10,238

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

821

Buildings at Cost

10,252

Total at Cost

11,073

Accumulated depreciation

$ 1,687

Date of Construction

1984

Date Acquired

June 9, 2005

Life on which depreciation in latest income statements is computed (Years) | years

Denham Springs, LA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acutecare hospital

Initial Costs, Land

$ 429

Initial Costs, Buildings

5,340

Additions Subsequent to Acquisition, Carrying Costs

(515)

Land at Cost

429

Buildings at Cost

4,825

Total at Cost

5,254

Accumulated depreciation

$ 1,014

Date of Construction

1960

Date Acquired

June 9, 2005

Life on which depreciation in latest income statements is computed (Years) | years

Redding, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acutecare hospital

Initial Costs, Buildings

$ 19,952

Additions Subsequent to Acquisition, Carrying Costs

4,361

Land at Cost

1,629

Buildings at Cost

22,684

Total at Cost

24,313

Accumulated depreciation

$ 3,487

Date of Construction

1991

Date Acquired

June 30, 2005

Life on which depreciation in latest income statements is computed (Years) | years

Bloomington, IN [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 2,457

Initial Costs, Buildings

31,209

Additions Subsequent to Acquisition, Carrying Costs

408

Land at Cost

2,576

Buildings at Cost

31,498

Total at Cost

34,074

Accumulated depreciation

$ 4,223

Date of Construction

2006

Date Acquired

August 8, 2006

Life on which depreciation in latest income statements is computed (Years) | years

Dallas, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acutecare hospital

Initial Costs, Land

$ 1,000

Initial Costs, Buildings

13,589

Additions Subsequent to Acquisition, Carrying Costs

368

Land at Cost

1,421

Buildings at Cost

13,536

Total at Cost

14,957

Accumulated depreciation

$ 1,804

Date of Construction

2006

Date Acquired

September 5, 2006

Life on which depreciation in latest income statements is computed (Years) | years

Huntington Beach, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 937

Initial Costs, Buildings

10,907

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

937

Buildings at Cost

10,910

Total at Cost

11,847

Accumulated depreciation

$ 1,409

Date of Construction

1965

Date Acquired

November 8, 2006

Life on which depreciation in latest income statements is computed (Years) | years

La Palma, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 937

Initial Costs, Buildings

10,907

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

937

Buildings at Cost

10,910

Total at Cost

11,847

Accumulated depreciation

$ 1,409

Date of Construction

1971

Date Acquired

November 8, 2006

Life on which depreciation in latest income statements is computed (Years) | years

Anaheim, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 1,875

Initial Costs, Buildings

21,814

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

1,875

Buildings at Cost

21,824

Total at Cost

23,699

Accumulated depreciation

$ 2,819

Date of Construction

1964

Date Acquired

November 8, 2006

Life on which depreciation in latest income statements is computed (Years) | years

Luling, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acutecare hospital

Initial Costs, Land

$ 811

Initial Costs, Buildings

9,345

Land at Cost

811

Buildings at Cost

9,345

Total at Cost

10,156

Accumulated depreciation

$ 1,188

Date of Construction

2002

Date Acquired

December 1, 2006

Life on which depreciation in latest income statements is computed (Years) | years

San Antonio, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitationhospital

Initial Costs, Buildings

$ 10,198

Buildings at Cost

10,198

Total at Cost

10,198

Accumulated depreciation

$ 1,296

Date of Construction

1987

Date Acquired

December 1, 2006

Life on which depreciation in latest income statements is computed (Years) | years

Victoria, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acutecare hospital

Initial Costs, Land

$ 625

Initial Costs, Buildings

7,197

Land at Cost

625

Buildings at Cost

7,197

Total at Cost

7,822

Accumulated depreciation

$ 915

Date of Construction

1998

Date Acquired

December 1, 2006

Life on which depreciation in latest income statements is computed (Years) | years

Houston, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 4,757

Initial Costs, Buildings

56,238

Additions Subsequent to Acquisition, Carrying Costs

1,259

Land at Cost

5,464

Buildings at Cost

56,790

Total at Cost

62,254

Accumulated depreciation

$ 7,163

Date of Construction

2006

Date Acquired

December 1, 2006

Life on which depreciation in latest income statements is computed (Years) | years

Bensalem, PA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 6,911

Initial Costs, Buildings

38,185

Additions Subsequent to Acquisition, Carrying Costs

(353)

Land at Cost

6,911

Buildings at Cost

37,832

Total at Cost

44,743

Accumulated depreciation

$ 4,647

Date of Construction

2006

Date Acquired

March 19, 2007

Life on which depreciation in latest income statements is computed (Years) | years

Portland, OR [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acutecare hospital

Initial Costs, Land

$ 3,085

Initial Costs, Buildings

17,859

Additions Subsequent to Acquisition, Carrying Costs

2,559

Land at Cost

3,071

Buildings at Cost

20,432

Total at Cost

23,503

Accumulated depreciation

$ 2,329

Date of Construction

1964

Date Acquired

April 18, 2007

Life on which depreciation in latest income statements is computed (Years) | years

San Diego, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 6,550

Initial Costs, Buildings

15,653

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

6,550

Buildings at Cost

15,730

Total at Cost

22,280

Accumulated depreciation

$ 1,833

Date of Construction

1964

Date Acquired

May 9, 2007

Life on which depreciation in latest income statements is computed (Years) | years

Redding, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 1,555

Initial Costs, Buildings

53,863

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

1,555

Buildings at Cost

53,876

Total at Cost

55,431

Accumulated depreciation

$ 5,959

Date of Construction

1974

Date Acquired

August 10, 2007

Life on which depreciation in latest income statements is computed (Years) | years

Houston, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 3,501

Initial Costs, Buildings

34,530

Additions Subsequent to Acquisition, Carrying Costs

(6,308)

Land at Cost

3,274

Buildings at Cost

28,449

Total at Cost

31,723

Accumulated depreciation

$ 2,996

Date of Construction

1960

Date Acquired

August 10, 2007

Life on which depreciation in latest income statements is computed (Years) | years

Bennettsville, SC [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 794

Initial Costs, Buildings

15,772

Land at Cost

794

Buildings at Cost

15,772

Total at Cost

16,566

Accumulated depreciation

$ 1,480

Date of Construction

1984

Date Acquired

April 1, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Bossier City, LA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acutecare hospital

Initial Costs, Land

$ 900

Initial Costs, Buildings

17,818

Land at Cost

900

Buildings at Cost

17,818

Total at Cost

18,718

Accumulated depreciation

$ 1,668

Date of Construction

1982

Date Acquired

April 1, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Bristol, CT [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

WellnessCenter

Initial Costs, Land

$ 485

Initial Costs, Buildings

2,267

Land at Cost

485

Buildings at Cost

2,267

Total at Cost

2,752

Accumulated depreciation

$ 635

Date of Construction

1975

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Cheraw, SC [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 657

Initial Costs, Buildings

19,576

Land at Cost

657

Buildings at Cost

19,576

Total at Cost

20,233

Accumulated depreciation

$ 1,835

Date of Construction

1982

Date Acquired

April 1, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Detroit, MI [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acutecare hospital

Initial Costs, Land

$ 1,220

Initial Costs, Buildings

8,687

Additions Subsequent to Acquisition, Carrying Costs

(365)

Land at Cost

1,220

Buildings at Cost

8,322

Total at Cost

9,542

Accumulated depreciation

$ 831

Date of Construction

1956

Date Acquired

May 22, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Enfield, CT [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

WellnessCenter

Initial Costs, Land

$ 384

Initial Costs, Buildings

2,257

Land at Cost

384

Buildings at Cost

2,257

Total at Cost

2,641

Accumulated depreciation

$ 632

Date of Construction

1974

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Fayetteville, AR [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitationhospital

Initial Costs, Land

$ 909

Initial Costs, Buildings

18,332

Land at Cost

909

Buildings at Cost

18,332

Total at Cost

19,241

Accumulated depreciation

$ 1,604

Date of Construction

1991

Date Acquired

July 14, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Fort Lauderdale, FL [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitationhospital

Initial Costs, Land

$ 3,499

Initial Costs, Buildings

21,939

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

3,499

Buildings at Cost

21,940

Total at Cost

25,439

Accumulated depreciation

$ 2,015

Date of Construction

1985

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Garden Grove, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 5,502

Initial Costs, Buildings

10,748

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

5,502

Buildings at Cost

10,799

Total at Cost

16,301

Accumulated depreciation

$ 844

Date of Construction

1982

Date Acquired

November 25, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Garden Grove, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Medical OfficeBuilding

Initial Costs, Land

$ 862

Initial Costs, Buildings

7,888

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

862

Buildings at Cost

7,916

Total at Cost

8,778

Accumulated depreciation

$ 611

Date of Construction

1982

Date Acquired

November 25, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Idaho Falls, ID [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 1,822

Initial Costs, Buildings

37,467

Additions Subsequent to Acquisition, Carrying Costs

4,665

Land at Cost

1,822

Buildings at Cost

42,132

Total at Cost

43,954

Accumulated depreciation

$ 3,798

Date of Construction

2002

Date Acquired

April 1, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Newington, CT [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

WellnessCenter

Initial Costs, Land

$ 270

Initial Costs, Buildings

1,615

Land at Cost

270

Buildings at Cost

1,615

Total at Cost

1,885

Accumulated depreciation

$ 455

Date of Construction

1979

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Petersburg, VA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitationhospital

Initial Costs, Land

$ 1,302

Initial Costs, Buildings

9,121

Land at Cost

1,302

Buildings at Cost

9,121

Total at Cost

10,423

Accumulated depreciation

$ 798

Date of Construction

2006

Date Acquired

July 1, 2008

Life on which depreciation in latest income statements is computed (Years) | years

West Valley City, UT [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 5,516

Initial Costs, Buildings

58,314

Land at Cost

5,516

Buildings at Cost

58,314

Total at Cost

63,830

Accumulated depreciation

$ 5,356

Date of Construction

1980

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Poplar Bluff, MO [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 2,659

Initial Costs, Buildings

38,694

Land at Cost

2,660

Buildings at Cost

38,694

Total at Cost

41,354

Accumulated depreciation

$ 3,553

Date of Construction

1980

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years) | years

East Providence, RI [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

WellnessCenter

Initial Costs, Land

$ 209

Initial Costs, Buildings

1,265

Land at Cost

209

Buildings at Cost

1,265

Total at Cost

1,474

Accumulated depreciation

$ 356

Date of Construction

1979

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years) | years

San Dimas, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 6,160

Initial Costs, Buildings

6,839

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

6,160

Buildings at Cost

6,873

Total at Cost

13,033

Accumulated depreciation

$ 530

Date of Construction

1972

Date Acquired

November 25, 2008

Life on which depreciation in latest income statements is computed (Years) | years

San Dimas, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Medical OfficeBuilding

Initial Costs, Land

$ 1,915

Initial Costs, Buildings

5,085

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

1,915

Buildings at Cost

5,103

Total at Cost

7,018

Accumulated depreciation

$ 394

Date of Construction

1979

Date Acquired

November 25, 2008

Life on which depreciation in latest income statements is computed (Years) | years

West Springfield, MA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

WellnessCenter

Initial Costs, Land

$ 583

Initial Costs, Buildings

3,185

Land at Cost

583

Buildings at Cost

3,185

Total at Cost

3,768

Accumulated depreciation

$ 897

Date of Construction

1976

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Tucson, AZ [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acutecare hospital

Initial Costs, Land

$ 920

Initial Costs, Buildings

6,078

Land at Cost

920

Buildings at Cost

6,078

Total at Cost

6,998

Accumulated depreciation

$ 570

Date of Construction

1987

Date Acquired

April 1, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Warwick, RI [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

WellnessCenter

Initial Costs, Land

$ 1,265

Initial Costs, Buildings

759

Land at Cost

1,265

Buildings at Cost

759

Total at Cost

2,024

Accumulated depreciation

$ 213

Date of Construction

1979

Date Acquired

April 22, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Webster, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acutecare hospital

Initial Costs, Land

$ 988

Initial Costs, Buildings

10,432

Land at Cost

988

Buildings at Cost

10,433

Total at Cost

11,421

Accumulated depreciation

$ 978

Date of Construction

1986

Date Acquired

April 1, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Wichita, KS [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitationhospital

Initial Costs, Land

$ 1,019

Initial Costs, Buildings

18,373

Additions Subsequent to Acquisition, Carrying Costs

Land at Cost

1,019

Buildings at Cost

18,374

Total at Cost

19,393

Accumulated depreciation

$ 1,721

Date of Construction

1992

Date Acquired

April 4, 2008

Life on which depreciation in latest income statements is computed (Years) | years

Addison, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitationhospital

Initial Costs, Land

$ 2,013

Initial Costs, Buildings

22,531

Land at Cost

2,013

Buildings at Cost

22,531

Total at Cost

24,544

Accumulated depreciation

$ 845

Date of Construction

2008

Date Acquired

June 17, 2010

Life on which depreciation in latest income statements is computed (Years) | years

Shenandoah, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitationhospital

Initial Costs, Land

$ 2,033

Initial Costs, Buildings

21,943

Land at Cost

2,033

Buildings at Cost

21,943

Total at Cost

23,976

Accumulated depreciation

$ 823

Date of Construction

2008

Date Acquired

June 17, 2010

Life on which depreciation in latest income statements is computed (Years) | years

Richardson, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Rehabilitationhospital

Initial Costs, Land

$ 2,219

Initial Costs, Buildings

17,419

Land at Cost

2,219

Buildings at Cost

17,419

Total at Cost

19,638

Accumulated depreciation

$ 653

Date of Construction

2008

Date Acquired

June 17, 2010

Life on which depreciation in latest income statements is computed (Years) | years

Hill County, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Acute caregeneral hospital

Initial Costs, Land

$ 1,120

Initial Costs, Buildings

17,882

Land at Cost

1,120

Buildings at Cost

17,882

Total at Cost

19,002

Accumulated depreciation

$ 1,498

Date of Construction

1980

Date Acquired

September 17, 2010

Life on which depreciation in latest income statements is computed (Years) | years

Webster, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acutecare hospital

Initial Costs, Land

$ 663

Initial Costs, Buildings

33,751

Land at Cost

663

Buildings at Cost

33,751

Total at Cost

34,414

Accumulated depreciation

$ 844

Date of Construction

2004

Date Acquired

December 21, 2010

Life on which depreciation in latest income statements is computed (Years) | years

Tomball, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

Long term acutecare hospital

Initial Costs, Land

$ 1,298

Initial Costs, Buildings

23,982

Land at Cost

1,298

Buildings at Cost

23,982

Total at Cost

25,280

Accumulated depreciation

$ 600

Date of Construction

2005

Date Acquired

December 21, 2010

Life on which depreciation in latest income statements is computed (Years) | years

Gilbert, AZ [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

General AcuteCare

Initial Costs, Land

$ 150

Initial Costs, Buildings

15,553

Land at Cost

150

Buildings at Cost

15,553

Total at Cost

15,703

Accumulated depreciation

$ 389

Date of Construction

2005

Date Acquired

January 4, 2011

Life on which depreciation in latest income statements is computed (Years) | years

Corinth, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

LTACH

Initial Costs, Land

$ 501

Initial Costs, Buildings

21,175

Land at Cost

501

Buildings at Cost

21,175

Total at Cost

21,676

Accumulated depreciation

$ 485

Date of Construction

2008

Date Acquired

January 31, 2011

Life on which depreciation in latest income statements is computed (Years) | years

Bayonne, NJ [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

General AcuteCare

Initial Costs, Land

$ 2,003

Initial Costs, Buildings

51,495

Land at Cost

2,003

Buildings at Cost

51,495

Total at Cost

53,498

Accumulated depreciation

$ 2,360

Date of Construction

1918

Date Acquired

February 4, 2011

Life on which depreciation in latest income statements is computed (Years) | years

San Diego, CA [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

General AcuteCare

Initial Costs, Land

$ 12,663

Initial Costs, Buildings

52,431

Land at Cost

12,663

Buildings at Cost

52,431

Total at Cost

65,094

Accumulated depreciation

$ 1,202

Date of Construction

1973

Date Acquired

February 9, 2011

Life on which depreciation in latest income statements is computed (Years) | years

Northland, MO [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

LTACH

Initial Costs, Land

$ 834

Initial Costs, Buildings

17,182

Land at Cost

834

Buildings at Cost

17,182

Total at Cost

18,016

Accumulated depreciation

$ 394

Date of Construction

2007

Date Acquired

February 14, 2011

Life on which depreciation in latest income statements is computed (Years) | years

DeSoto, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

LTACH

Initial Costs, Land

$ 1,067

Initial Costs, Buildings

10,701

Land at Cost

1,067

Buildings at Cost

10,700

Total at Cost

11,767

Accumulated depreciation

$ 111

Date of Construction

2008

Date Acquired

July 18, 2011

Life on which depreciation in latest income statements is computed (Years) | years

New Braunfels, TX [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

LTACH

Initial Costs, Land

$ 1,100

Initial Costs, Buildings

7,883

Land at Cost

1,100

Buildings at Cost

7,882

Total at Cost

8,982

Accumulated depreciation

$ 49

Date of Construction

2007

Date Acquired

September 30, 2011

Life on which depreciation in latest income statements is computed (Years) | years

Hoboken, NJ [Member]

Real Estate and Accumulated Depreciation [Line Items]

Type of Property

General AcuteCare

Initial Costs, Land

$ 1,387

Initial Costs, Buildings

44,351

Land at Cost

1,388

Buildings at Cost

44,350

Total at Cost

45,738

Accumulated depreciation

$ 289

Date of Construction

1863

Date Acquired

November 4, 2011

Life on which depreciation in latest income statements is computed (Years) | years

[1]	Includes real-estate cost included in real estate held for sale of $40,460 and $113,151 for 2010 and 2009, respectively. Excludes intangible lease assets that are included in real estate held for sale of $1,361 and $25,848 for 2010 and 2009, respectively.

Real Estate And Accumulated Depreciation (Changes In Total Real Estate Assets Including Real Estate Held For Sale) (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Real Estate And Accumulated Depreciation [Abstract]

Balance at beginning of period

$ 990,635

^[1]

$ 934,601

^[1]

$ 943,700

Acquisitions

240,474

146,854

421

Additions

1,011

1,709

5,550

Dispositions

(40,460)

(92,529)

(15,070)

Other

(564)

Balance at end of period

$ 1,191,096

990,635

^[1]

934,601

^[1]

Real estate held for sale

40,460

113,151

Intangible lease assets held-for-sale

$ 1,361

$ 25,848

[1]	Includes real-estate cost included in real estate held for sale of $40,460 and $113,151 for 2010 and 2009, respectively. Excludes intangible lease assets that are included in real estate held for sale of $1,361 and $25,848 for 2010 and 2009, respectively.

Real Estate And Accumulated Depreciation (Changes In Accumulated Depreciation; Including Real Estate Assets Held For Sale) (Details) - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Real Estate And Accumulated Depreciation [Abstract]

Balance at beginning of period

$ 68,662

^[1]

$ 51,638

^[1]

$ 30,581

Depreciation

29,523

22,664

21,389

Depreciation on disposed property

(4,755)

(5,640)

(332)

Balance at end of period

$ 93,430

68,662

^[1]

51,638

^[1]

Accumulated depreciation of real estate held for sale

3,716

6,350

Accumulated amortization of intangible lease assets

$ 591

$ 3,978

[1]	Includes accumulated depreciation in real estate held for sale of $3,716 and $6,350 for 2010 and 2009, respectively. Excludes accumulated amortization related to intangible lease assets that are included in real estate held for sale of $591 and $3,978 for 2010 and 2009, respectively.

Mortgage Loan On Real Estate (Schedule Of Mortgage Loan On Real Estate) (Details)
$ in Thousands

12 Months Ended

Dec. 31, 2011

USD ($)

Mortgage Loans on Real Estate [Line Items]

Carrying Amount of Mortgages, Federal income tax purposes

$ 165,000

Long-Term First Mortgage Loan [Member]

Mortgage Loans on Real Estate [Line Items]

Prior Liens

Face Amount of Mortgages

165,000

Carrying Amount of Mortgages

165,000

^[1]

Principal Amount of Loans Subject to Delinquent Principal or Interest

Long-Term First Mortgage Loan [Member] | Desert Valley Hospital [Member]

Mortgage Loans on Real Estate [Line Items]

Interest rate

10.10%

Final Maturity Date

2022

Prior Liens

^[2]

Face Amount of Mortgages

70,000

Carrying Amount of Mortgages

70,000

^[1]

Principal Amount of Loans Subject to Delinquent Principal or Interest

^[3]

Long-Term First Mortgage Loan [Member] | Desert Valley Hospital [Member]

Mortgage Loans on Real Estate [Line Items]

Interest rate

10.80%

Final Maturity Date

2022

Prior Liens

^[2]

Face Amount of Mortgages

20,000

Carrying Amount of Mortgages

20,000

^[1]

Principal Amount of Loans Subject to Delinquent Principal or Interest

^[3]

Long-Term First Mortgage Loan [Member] | Chino Valley Medical Center [Member]

Mortgage Loans on Real Estate [Line Items]

Interest rate

10.10%

Final Maturity Date

2022

Prior Liens

^[2]

Face Amount of Mortgages

50,000

Carrying Amount of Mortgages

50,000

^[1]

Principal Amount of Loans Subject to Delinquent Principal or Interest

^[3]

Long-Term First Mortgage Loan [Member] | Paradise Valley Hospital [Member]

Mortgage Loans on Real Estate [Line Items]

Interest rate

9.80%

Final Maturity Date

2022

Prior Liens

^[2]

Face Amount of Mortgages

25,000

Carrying Amount of Mortgages

25,000

^[1]

Principal Amount of Loans Subject to Delinquent Principal or Interest

^[3]

[1]	The aggregate cost for Federal income tax purposes is $165,000.
[2]	There were no prior liens on loans as of December 31, 2011.
[3]	The mortgage loan was not delinquent with respect to principal or interest.

Mortgage Loan On Real Estate (Changes In Mortgage Loans) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Mortgage Loan On Real Estate [Abstract]
Balance at beginning of year	$ 165,000	$ 200,164	$ 185,000
New mortgage loans and additional advances on existing loans		7,836	15,164
Mortgage loans on real estate including additions during year	165,000	208,000	200,164
Collection of principal		(43,000)
Deductions during year		(43,000)
Balance at end of year	$ 165,000	$ 165,000	$ 200,164